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Abstract 
Breastfeeding in infancy, when compared with formula feeding, is associated 
with a reduced incidence of components of the metabolic syndrome later in 
life.  One potential mechanism is via an effect on lipid metabolism and 
storage, manifesting as altered adiposity and ectopic lipid deposition.  
 
I have examined the null hypothesis: no association is detectable between 
infant feeding and adiposity or ectopic lipid in infancy, through a meta-analysis 
of published studies and a prospective cohort study of healthy infants 
employing gold standard direct measurement techniques (magnetic 
resonance imaging and spectroscopy).   
 
Eleven studies were identified for meta-analysis: in formula-fed compared to 
breastfed infants, fat mass was lower at 3-4 months [mean difference (95% 
confidence interval)]: [-0.09 kg (-0.18, -0.01 kg)] and 6 months [-0.18 kg (-
0.34, -0.01 kg)]. Conversely, at 12 months, fat mass was higher in formula-fed 
infants [0.29 kg (-0.03, 0.61 kg)] than in breastfed infants.  Eighty-seven 
infants were included in a prospective cohort, of which 73 were investigated at 
two time points.  In healthy, term, breastfed infants adipose tissue accretion 
between birth and 2-3 months ages was predominantly within subcutaneous 
rather than internal adipose tissue compartments, and a significant increase in 
intrahepatocellular lipid was detected: median [interquartile range] 0.653 
[0.367-1.900] after birth and 1.837 [1.408-2.429] at 2-3 months.  Comparing 
breastfed with formula fed infants within this cohort no significant differences 
were detected in total adipose tissue, adipose tissue distribution or 
intrahepatocellular lipid between birth and 2-3 months.  Significant 
associations were detected between maternal BMI, rate of weight gain in early 
infancy and gender, and adipose tissue partitioning at 2-3 months. 
 
While method of feeding is associated with altered infant fat mass up to 6 
months, no association is detectable with adipose tissue partitioning or 
ectopic hepatic lipid at 2-3 months.  
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 “… Aegyrthus, who being fed in a shepherd cottage with only goat’s milk, 
waxed thereupon so goatish and lecherous, that he defiled not only 
Agamemnom’s bed, but also neighed (in a manner) at every man’s wife” 
- Thomas Muffet, 1655, Health’s Improvement  
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PCA: Principal component analysis 
PLS: Partial least squares projections to latent structures 
PLS-DA: Partial least square-discriminant analysis  
PRISMA: Preferred reporting items for systematic reviews and meta-analyses 
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PROBIT: Promotion of breastfeeding intervention trial 
RD: Relaxation delay 
RF: Radiofrequency 
SD: Standard deviation 
SDS: Standard deviation score 
SFT: Skin fold thickness 
TAG: Triacylglycerol 
TAT: Total adipose tissue 
TATI: Total adipose tissue index 
TBF: Total body fat  
TBK: Total body potassium  
TBM: Total body mass  
TBW: Total body water 
tm: Mixing time 
TMS: Tetramethylsilane 
TNF-α: Tumour necrosis factor α 
TOBEC: Total body electrical conductivity 
TSP: Trimethylsilyl propionic acid 
UCP-1: Uncoupling protein 1 
WAT: White adipose tissue 
WHO: World Health Organization 
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Chapter 1 
Background 
 
1.1 Introduction  
Babies have been fed substances other than maternal breast milk since 
prehistory: infant feeding cups are among the most ancient containers 
discovered, figure 1.1.  The idea that this might have long-term consequences 
for the infant is similarly long held (Temkin, 1956). 
 
 
Figure 1.1: Neolithic feeding cup. Africa, c1000 BC (Wellcome Library London) 
 
Since the twentieth century various studies have examined putative effects of 
infant feeding.  For some health benefits – protection from infection during the 
period of breastfeeding and higher intelligence among children breastfed in 
infancy – high quality studies support a causal link (Kramer et al., 2008, 
Kramer et al., 2001).  For other widely quoted benefits – improved 
cardiometabolic health and reduced obesity in later life – the evidence 
remains ambiguous (Asplund et al., 1962b) and potential mechanisms 
unknown.  It is these latter benefits that work undertaken for my thesis is 
directly relevant to: if being breastfed in infancy is associated with beneficial 
effects on obesity and metabolism in adult life, it is plausible that these are 
mediated through alterations in body composition and adiposity which 
manifest in infancy.  I have tested the null hypothesis that breastfeeding is not 
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associated with differences in body composition, adipose tissue distribution 
and hepatic ectopic lipid in infancy.  There exists a paucity of reference data 
describing adipose tissue and ectopic lipid in infants; therefore I will describe 
the longitudinal changes seen in early life. 
 
To provide background I will briefly summarise the differences between breast 
and formula feeding – from which any long-term effects derive – before 
reviewing the evidence for and against breastfeeding in infancy influencing 
later metabolic health.  I will then discuss one potential mechanism: adipose 
tissue and lipid metabolism.  I will review the metabolic importance of adipose 
tissue, the development of adiposity in early life and techniques used to 
measure adiposity.  Finally I will summarise the areas of uncertainty that I will 
go on to examine. 
 
1.2 Differences between breastfeeding and formula feeding  
The differences between breast milk and formula milk are manifold: the former 
is a human biological fluid containing hundreds components, while the latter a 
highly processed and regulated food of bovine origin (Appendix 1, table 1A).  
In addition to macronutrient and micronutrient differences, disparities exist in 
the mechanism of milk delivery (suckling in comparison with bottle-feeding) 
that may have behavioral implications. 
 
1.2.1 Macronutrient differences: 
Differences between the macronutrient content of formula and the measured 
macronutrients in pooled expressed breast milk are well documented 
(Crawley and Westland, 2011, Lawrence and Lawrence, 2005) (Appendix 1, 
table 1A), but substantially underestimate the true differences in 
macronutrients received by an infant suckling at the breast compared to an 
infant fed artificial formula by bottle.  Human milk analysis is generally based 
upon the entire expressed content of one breast, whereas during normal 
suckling the infant tends not to empty a single breast.  As the composition of 
milk changes throughout the feed (Mitoulas et al., 2002), the average 
composition of milk obtained through suckling will not be the same as the 
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average composition of a whole breast. Healthy term babies ingest almost 
90% of the total feed’s milk volume within the first 4 minutes of a 10-minute 
suckle (Lucas et al., 1979), which suggests that breastfed infants consume a 
greater proportion of low fat fore-milk than is measured in expressed breast 
milk.  By sampling suckled breast milk intermittently during a feed, it has been 
demonstrated that suckled breast milk has a typical total energy of 
58kcal/100ml and total fat of 2.5g/100ml (4.3g/100kcal) (Lucas et al., 1980), 
significantly lower than values obtained by analysis of expressed breast milk 
(Appendix 1, table 1A). Furthermore, a recent systematic review and meta-
analysis of studies measuring metabolisable energy content in breastfed 
infants found mean metabolisable energy values to be 0.62kcal/g (Reilly et al., 
2005b), significantly lower than the assumed metabolisable energy content for 
breast milk of 0.68kcal/g, used for targeting energy content in formula milk.  In 
addition to differences in the macronutrient composition, suckled infants 
consume lower volumes of milk during the first year compared to formula fed 
infants (Heinig et al., 1993).  The combination of different volumes ingested 
and different compositions means that formula fed infants have a 15-25% 
higher total energy intake, greater protein intake from 3 to 18 months (Heinig 
et al., 1993), and lower fat intake at 3 months (Noble and Emmett, 2006), 
table 1.1.  Further differences exist in both the composition of fatty acids and 
in the orientation of fatty acids on the triacylglycerol molecule (Pierce et al., 
1964) between breast milk and artificial formula, which lead to differences in 
the absorption and metabolism of fatty acids (Pierce et al., 1964), and while 
formula milk closely mimics the protein composition of human milk, in 
particular the casein:whey ratio, significant differences are detectable in 
plasma amino acid levels between breastfed and formula fed infants (Wharton 
et al., 1994), suggesting considerable differences in protein composition 
between feeding types. 
 
1.2.2 Differences in non-nutritive compounds 
Unlike infant formula, breast milk also contains a range of non-nutritive 
compounds.   Hormones such as leptin, ghrelin, adiponectin and resistin are 
found in human breast milk (Ozarda et al., 2012) and animal models suggest 
that gastrointestinal absorption and systemic action occur in the neonatal 
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period following ingestion of physiological concentrations of hormones such 
as leptin (Sanchez et al., 2005).  Similar effects have yet to be demonstrated 
in humans, however positive associations between maternal breast milk and 
infant serum hormone concentrations are seen in some studies (Ucar et al., 
2000), suggesting that breast milk hormones may act as a potential mediator 
in the development of appetite regulation (Savino et al., 2009).   
 
Feeding type 
Milk volume 
intake (g/day) 
Energy 
(kcal/day) 
Protein 
(g/day) Fat (g/day) 
Breastfeeding     
3 months 812 (133) 535 (81) 6.8 (1.1) 37 
6 months (with 
solids) 769 (171) 612 (100) 8.1 (2.3)  
12 months (with 
solids) 448 (251) 825 (158) 22.5 (9.8)  
Bottlefeeding     
3 months 905 (162) 614 (110) 11.3 (2.0) 31 
6 months (with 
solids) 941 (238) 755 (136) 14.1 (2.5)  
12 months (with 
solids) 732 (286) 970 (229) 24.6 (7.0)  
Table 1.1: Infant feeding and macronutrient intakes by age. Values are mean 
(standard deviation). Energy and protein from Heinig et al. 1993, fat from Noble and 
Emmett 2006. 
 
In addition, other bioactive proteins are present in breast milk in relatively high 
concentrations: α-lactalbumin, lactoferrin and lysozyme, which appear to have 
bacteriocidal effects (Lonnerdal, 2010), and growth factors such as insulin like 
growth factor I and II, which have local, and potentially systemic effects 
(Larnkjaer et al., 2012, Michaelsen et al., 2013).  Human milk also contains 
hundreds of human milk oligosaccharides (HMOs) that influence gut 
microbiome, have anti-infective properties and may play a role in providing 
essential nutrients (Gingerich et al., 1987).   
 
1.2.3 Behavioural differences 
In addition to disparities in the composition of milk ingested, there are 
differences in how milk intake is regulated by breastfed and formula fed 
babies. Infants are well known to regulate their intake to meet nutritional 
Newborn feeding and infant phenotype 
 28 
needs, reducing intake in the face of more energy dense feeds (Fomon et al., 
1975, Dewey et al., 1991).  Evidence suggests that during bottle feeding 
mothers visually assess consumption and override infant self-regulation, in 
contrast with breastfeeding mothers who are unable to monitor and influence 
intake in the same way (Crow et al., 1980), which may have implications for 
nutrient consumption, appetite regulation and satiety signaling. 
 
1.2.4 Growth differences between breastfed and formula fed infants 
A gross indicator of the magnitude of the discrepancy – macronutrient, 
micronutrient and behavioural – between breastfed and formula-fed infants is 
the well documented differential effect on growth: by 12 months formula fed 
babies weigh on average 400-600g more than breastfed babies (Dewey, 
1998, Dewey et al., 1995).  To account for this World Health Organization 
growth charts were revised in 2006 to reflect the growth of healthy, exclusively 
breastfed children (WHO, 2009) as opposed to a largely formula-fed 
population.  Increasingly, evidence supports an association between the 
trajectory of early life growth and later life body composition and cardio-
metabolic disease risk (Wells, 2007a).  The majority of these studies have 
used birth weight as a marker of fetal growth, demonstrating an association 
between low birthweight and increased subsequent disease risk.  The 
strongest association seems to be seen after adjustment is made for later 
size, suggesting that rate of growth during early life (comprising fetal and 
postnatal growth) is implicated, with the worst outcomes seen among those 
born small who subsequently become large.  Therefore any association 
between infant feeding method and later health may be mediated via the 
altered postnatal growth rate seen among formula fed infants. 
  
1.3 Long-term beneficial effects of breastfeeding  
The data outlined thus far are largely undisputed: differences exist between 
breastfeeding and formula feeding and there is an association between infant 
feeding and short-term differences in growth.  The nature of any association 
between infant feeding and long-term effects is more uncertain.   
 
Newborn feeding and infant phenotype 
 29 
That early life events can influence later health has been well demonstrated in 
animal models: Widdowson and McCance elegantly showed in a rodent 
model that undernourishment during the period of lactation led to decreased 
weight gain throughout later life when compared to control pups, despite both 
groups having access to unrestricted diets subsequently, and that an identical 
level of nutrient restriction later in life led to only short-lived effects 
(Widdowson and McCance, 1963).  This demonstrated that critical periods in 
development exist, where short-term alterations in nutrition and growth are 
associated with long-term effects. These findings have subsequently been 
confirmed in a range of animal models (McMillen and Robinson, 2005) and 
are supported by human studies suggesting that both intrauterine factors, 
crudely implied by birthweight, and postnatal factors, programme later life 
metabolic and cardiovascular health (Eriksson et al., 2001, Barker et al., 
1989, Barker et al., 2005).  
 
A limited number of studies have examined the association between infant 
feeding and cardiovascular disease or mortality directly.  A systematic review 
in 2004 identified four papers (25,166 adults) and found no significant 
protective effect of breastfeeding on cardiovascular mortality (pooled estimate 
1.04, 95% CI 0.83, 1.30) (Martin et al., 2004).  This low number of studies 
may reflect difficulties in accurately determining infant feeding retrospectively 
in historical cohorts.  A greater number of studies examine the link between 
method of infant feeding and aspects of metabolic health measurable earlier 
in adult life such as body mass index (BMI), obesity, cholesterol, raised blood 
pressure and type 2 diabetes. 
 
1.3.1 Long-term effects of breast-feeding on body mass index or obesity 
Multiple observational studies have examined the association between infant 
feeding and later life obesity or BMI.  These have been synthesised in several 
systematic reviews, all of which show lower levels of obesity among offspring 
breastfed compared to those formula fed (Arenz et al., 2004, Owen et al., 
2005b), or among individuals breastfed for longer durations (Harder et al., 
2005).  However, these systematic reviews combine studies with 
heterogeneous findings and many large studies find no evidence of an 
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association between breastfeeding in infancy and lower BMI or reduced risk of 
obesity in later life (Li et al., 2003, Parsons et al., 2003). 
 
These studies, and the systematic reviews derived from them, are limited by 
uncertainty surrounding the degree to which confounding factors (rather than 
breastfeeding per se) explain any effects seen: breastfeeding is strongly 
associated with maternal factors such as obesity (Lepe et al., 2011), 
socioeconomic class (Ibanez et al., 2012) and mode of delivery (Prior et al., 
2012) which in turn are associated with offspring outcomes such as BMI 
(Goldani et al., 2011). Where studies have attempted to adjust for 
confounding factors the association between formula feeding and obesity is 
weaker (Arenz et al., 2004), and when individual patient level data is used 
(allowing for the most accurate treatment of confounding) an association is 
effectively abolished after combined adjustment (Owen et al., 2005a) (figure 
1.2).   
 
Figure 1.2: Mean difference (diamond with 95% CI) in BMI between 
breast-fed and bottle-fed participants, pooled from eleven studies with 
different levels of adjustment, from Owen et al. 2005a. 
 
No method of controlling for confounding is ideal, so attempts have been 
made to reduce confounding through study design: using sibling pair analyses 
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or comparing cohorts with different confounding structures.  Three sibling pair 
studies, which minimise the influence of socioeconomic factors, have been 
published: all of which find a significantly protective effect of longer duration of 
breastfeeding on later obesity (Metzger and McDade, 2010, Gillman et al., 
2006, Nelson et al., 2005).  In contrast, one study (Brion et al., 2011) 
compared cohorts with different confounding structures (Great Britain and 
Brazil) and found that an association between breastfeeding and lower BMI 
was detectable in the British, but not the Brazilian cohort.  Within the Brazilian 
cohort the socioeconomic-BMI association was in the opposite direction to 
that seen in the Britain, suggesting that the association seen in the British 
cohort represents confounding. 
 
The gold standard study design to remove the influence of confounding is the 
randomised controlled trial.  While this is ethically and practically unfeasible in 
the context of infant feeding, a cluster randomised controlled trial of 
breastfeeding promotion, the Promotion of Breast-feeding Intervention Trial 
(PROBIT), has examined the effect of differing durations of breastfeeding, and 
provides further evidence against an association between infant feeding and 
later obesity.  This trial compared outcomes in healthy term infants born in 
clinics randomly assigned to receive a breast-feeding promotion intervention 
or standard care, and found no significant differences between intervention 
and control children in weight, BMI, waist or hip circumference or skinfold 
thickness at 6 years (Kramer et al., 2007), or in BMI, fat mass index skin fold 
thicknesses or waist circumference at 11.5 years (Martin et al., 2013).  While 
the intervention in PROBIT was effective in significantly increasing 
breastfeeding in the intervention groups, initiation of breastfeeding was 
universal in both intervention and control groups.  Therefore this trial 
compares “some” breastfeeding (in the control group) with “more” and “more 
exclusive” breastfeeding (in the intervention group).  As a result the control 
arm fails to represent infants exclusively formula fed from birth or shortly after, 
a group commonly seen in the United Kingdom and other developed 
countries.   
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These inconsistent results mean that uncertainty regarding the long-term 
association between infant feeding and late life obesity remains, especially for 
infants fully formula fed from birth or shortly after, and suggests that while 
method of feeding appears not to be a major determinant of adult obesity, it 
may be associated with a modest alteration in later BMI. 
 
1.3.2 Long-term effects of breast-feeding on insulin resistance and type 
2 diabetes 
Observational studies examining the incidence of type-2 diabetes in later life 
in relation to infant feeding have also been systematically reviewed and 
synthesised.  In the seven studies identified, individuals breastfed as infants 
had a lower risk of diabetes (OR 0.61, 95%CI 0.44, 0.85) when compared to 
individuals fed formula.  Furthermore, in contrast to meta-analyses of studies 
examining obesity, a similar effect size is seen following adjustment for 
confounders (including birth weight and parental diabetes) (Owen et al., 
2006).  It was not possible to systematically adjust for potential confounders in 
all included studies however, and to my knowledge no attempts have been 
made to replicate these findings using other study designs such as cluster 
randomised trials or sibling-pair analyses, so the possibility that residual 
confounding explains the differences seen cannot be excluded.  Despite this 
caveat, current evidence suggests a significant protective association 
between breastfeeding in early life and a reduced risk of later type-2 diabetes. 
 
1.3.3 Infant feeding and plasma lipids 
Given the considerable differences in lipid composition (Pierce et al., 1964) 
and quantity (Noble and Emmett, 2006) between breast milk and artificial 
formula, it is unsurprising that numerous studies have examined plasma lipid 
concentrations in relation to infant feeding.  A systematic review and meta-
analysis identified 37 published papers, comprising 10,681 individuals and 52 
estimates: 26 in infants and nine in adults (Owen et al., 2002).  Significantly 
higher cholesterol was found among breastfed infants examined before 12 
months (0.64 mmol/l, 95% CI 0.50, 0.79 mmol/l), in keeping with known 
nutritional differences between these groups.  By adult life however, the 
converse was seen: higher serum cholesterol in adults formula fed in infancy 
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(0.18 mmol/l, 95% CI 0.06, 0.30 mmol/l).  Further analysis using individual 
patient data to allow adjustment for confounding (socio-economic position, 
BMI and smoking status) found a similar magnitude of difference after 
adjustment (0.15 mmol/l, 95% CI 0.06, 0.23 mmol/l) (Owen et al., 2008).  To 
my knowledge the relationship between plasma lipids and infant feeding has 
not been examined using other study designs, so while the possibility that 
residual or unidentified confounding factors explain these differences remains, 
the weight of evidence points toward an association between breastfeeding in 
infancy and lower serum cholesterol concentrations in adult life. 
 
1.3.4 Infant feeding and blood pressure 
A systematic review and meta-analysis published in 2003 (19,763 individuals 
– infants, children and adults) found a higher mean systolic blood pressure in 
individuals’ formula fed as infants (1.1mmHg, 95%CI 0.4, 1.8mmHg) (Owen et 
al., 2003).  However, significant heterogeneity and decreasing effect sizes in 
larger studies were noted raising concerns about publication bias.  A 
subsequent systematic review and meta-analysis including additional studies 
and excluding infants (17,503 individuals) found a similar mean difference in 
systolic blood pressure (1.4mmHg, 95% CI 0.6, 2.2 mmHg) (Martin et al., 
2005), although concerns about publication bias remained.  Differences in 
diastolic blood pressure were considerably smaller in both meta-analyses.  In 
contrast, PROBIT found no effect of breastfeeding promotion on blood 
pressure at 6 years of age (Kramer et al., 2007). Therefore while 
observational data support an association between formula feeding in infancy 
and higher blood pressure in adult life, concerns remain about confounding 
and publication bias. 
 
1.3.5 Infant feeding and later metabolic health 
In summary, a considerable body of observational evidence supports an 
association between infant feeding and altered later life insulin sensitivity, 
blood pressure and lipid profile, and a potentially more modest association 
with later life BMI.  
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These components of adverse health – insulin resistance, raised blood 
pressure, dyslipidaemia and obesity – are related in pathophysiology and 
aetiology as facets of the “metabolic syndrome” (Alberti et al., 2005, 2001).  
The logical corollary therefore is to examine what is widely considered a key 
determinant of the metabolic syndrome: adipose tissue distribution and 
ectopic lipid deposition (Despres and Lemieux, 2006, Tchernof and Despres, 
2013). 
 
1.4 Metabolic importance of adipose tissue and ectopic lipid 
The ability to store excess energy is an important evolutionary adaptation, and 
the medium used in mammals – triacylglycerol – has two important properties: 
it is calorie dense (9kcal/g compared to 4.5kcal/g for carbohydrate and 4kcal/g 
for protein) and insoluble in water, which allows the accumulation of high 
levels without adverse osmotic effects.  Triacylglycerol in humans is almost 
exclusively stored within adipocytes, forming adipose tissue depots 
throughout the body.  Until recently adipocytes were thought to exist as either 
white adipocytes in white adipose tissue (WAT), or brown adipocytes 
comprising brown adipose tissue (BAT).  White adipose tissue primarily stores 
energy in the form of triacylglycerol, while BAT metabolises fatty acids in 
order to generate heat via non-shivering thermogenesis, facilitated via 
uncoupling protein 1 (UCP-1) (Spiegelman and Flier, 2001).  Brown adipose 
tissue is well documented in human infants (Aherne and Hull, 1966) where it 
is vital in preventing hypothermia, and it is increasingly clear that active BAT 
is also present in adults (Cypess et al., 2009) and may play role in obesity 
(Saito et al., 2009).  While mammalian brown adipocytes are recognised to 
derive from muscle precursor cells (being therefore distinct from white 
adipocytes), “beige” (sometimes referred to as “brite”) fat cells have been 
recently identified that derive from progenitor cells found within white adipose 
tissue (Wu et al., 2012).  This explains the observed phenomenon of 
“browning” of white adipose tissue, whereby it can be induced to increase 
expression of UCP-1 (Guerra et al., 1998), and recent work suggests that 
metabolically active adult brown fat is actually comprised of “beige” fat cells, 
rather than true brown adipocytes (Wu et al., 2012).  It is therefore unclear 
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whether humans have true brown adipose tissue (as opposed to “beige” fat) 
at any point (even in the neonatal period), or whether brown adipocytes are 
replaced by “beige” cells before adulthood, and highlights how limited our 
understanding is of adipose tissue development and metabolism in early life 
(Cannon and Nedergaard, 2012). Differentiating brown from white adipose 
tissue in-vivo is difficult, and to date has required fusion positron emission and 
computed tomography (Cypess et al., 2009).  This technique is unsuitable for 
use in paediatric populations due to the significant radiation exposure 
associated with it, and while recent work suggests that differentiation of BAT 
from WAT may be possible using magnetic resonance imaging (MRI) (Hu et 
al., 2012), this has yet to be confirmed in-vivo. Therefore for the purpose of 
this thesis I will concentrate on undifferentiated adipose tissue as found in 
human infants, accepting that while the exact composition (in particular the 
proportion of white, “beige” and brown adipocytes) remains undetermined, it is 
currently accepted that this is predominantly comprised of WAT. 
 
In additional to their primary function of energy storage and release, 
adipocytes play a central role in the control of energy balance and 
homeostasis, regulating food intake, energy expenditure and glucose 
homeostasis through endocrine and non-endocrine means.  Adipocytes 
regulate energy balance via orexigenic and anorexigenic pathways within the 
hypothalamus, mediated by the secretion of adipokines such as leptin (Rosen 
and Spiegelman, 2006).  This and other adipokines, such as adiponectin, 
resistin, omentin and visfatin, and inflammatory cytokines such as TNF-α 
secreted by adipocytes, also exert effects on glycaemic control (Rosen and 
Spiegelman, 2006).  In addition, non-esterified fatty acids, while primarily 
released by adipocytes as an energy source, influence glucose homeostasis 
in muscle, liver and adipose tissue (Roden et al., 2000).   
 
Not all adipose tissue influences energy balance and glucose homeostasis 
equally however.  Adipose tissue forms anatomically defined deposits in 
humans, and it has long been recognised that the distribution of adipose 
tissue is more strongly linked with cardiovascular metabolic health than total 
adipose tissue (Vague, 1956).  Subsequent work has clearly delineated 
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structural and functional differences between adipose tissue depots, most 
strikingly between internal abdominal and subcutaneous adipose tissue 
(Hamdy et al., 2006). 
 
1.4.1 The metabolic importance of regional adipose tissue distribution 
Whole body adipose tissue is generally divided into two main compartments, 
subcutaneous and internal adipose tissue.  Subcutaneous adipose tissue is 
usually defined as that found between the skin and the aponeuroses or fascia 
of the muscle (Shen et al., 2003).  Within the trunk, abdominal subcutaneous 
adipose tissue can be further divided into two anatomically distinct 
compartments separated by a fascial plane (Markman and Barton, 1987): 
deep and superficial subcutaneous adipose tissue, figure 1.3.  Internal 
adipose tissue includes internal abdominal (or intra-abdominopelvic) and 
internal non-abdominal (intrathoracic) adipose tissue, with internal abdominal 
adipose tissue comprised by intraperitoneal (incorporating greater omentum 
and mesentery) and retroperitoneal adipose tissue.  The term “visceral 
adipose tissue”, while commonly used and often considered interchangeable 
with internal abdominal adipose tissue, variably includes retroperitoneal in 
addition to intraperitoneal adipose tissue.  For clarity internal abdominal 
adipose tissue will be used henceforth in preference to visceral adipose 
tissue.   
 
Internal abdominal adipose tissue differs from subcutaneous adipose tissue at 
the structural and functional level.  Internal abdominal adipose tissue contains 
larger, more insulin resistant adipocytes, is more vascular, more heavily 
innervated and contains greater numbers of inflammatory cells when 
compared to subcutaneous adipose tissue (Marin et al., 1992, Weisberg et al., 
2003). The venous drainage differs between adipose tissue depots; much of 
the internal adipose tissue compartment drains directly via the portal vein 
while subcutaneous adipose tissue drains via the systemic system.   
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Figure 1.3: Abdominal MR imaging of an infant.  Showing abdominal superficial 
subcutaneous, abdominal deep subcutaneous and internal abdominal adipose tissue 
compartments; magnification baby to image = x0.305 
 
At a cellular level, adipocytes within internal abdominal adipose tissue have a 
higher level of expression of glucocorticoid receptors (Rebuffe-Scrive et al., 
1985), androgen receptors (Freedland, 2004) and greater sensitivity to 
catecholamine induced lipolysis (Hellmer et al., 1992) when compared to 
adipocytes within subcutaneous depots.  Internal abdominal adipose tissue 
also shows greater expression of adipokines such as adiponectin, and of pro-
infammatory cytokines such as C reactive protein and TNF-α (Lemieux et al., 
2001, Motoshima et al., 2002) than subcutaneous adipose tissue.  Adipocytes 
within internal abdominal adipose tissue are also more insulin resistant (Abate 
et al., 1995) and have greater lipolytic activity (Arner, 1995) than those in 
subcutaneous adipose tissue.   
 
Although differences have been most extensively documented between 
internal abdominal and subcutaneous adipose tissue, similar disparities exist 
between deep and superficial subcutaneous adipose tissue, with deep 
Newborn feeding and infant phenotype 
 38 
subcutaneous adipose tissue bearing a structural and functional similarity to 
internal abdominal adipose tissue (Markman and Barton, 1987, Kelley et al., 
2000). 
 
1.4.2 Adipose tissue and the metabolic syndrome 
Vague’s observation that excess truncal adipose tissue appears more 
metabolically damaging than excess limb adipose tissue (Vague, 1956) has 
led to a series of studies confirming that individuals with upper body rather 
than lower body distribution of excess adiposity have an increased risk of 
cardiovascular disease and type 2 diabetes (Lee et al., 2008).  More 
specifically it is accumulation of internal abdominal adipose tissue that is 
strongly associated with metabolic complications such as insulin resistance, 
dyslipidaemia and cardiovascular disease, independent of total body fat 
(Lemieux et al., 1996, Liu et al., 2010).  Further support for the key role played 
by this depot derives from the observation that removal of internal abdominal 
adipose tissue by omentectomy in conjunction with gastric banding results in 
improved glucose tolerance and insulin sensitivity when compared with gastric 
banding alone (Thorne et al., 2002).  Increased internal abdominal adipose 
tissue is also strongly associated with a spectrum of hepatic abnormalities, 
characterised by increase in hepatic lipid content (Jakobsen et al., 2007), and 
when the independent associations of hepatic lipid and internal abdominal 
adipose tissue to insulin resistance are examined, hepatic lipid rather than 
internal abdominal adipose appears most closely associated with insulin 
resistance (Fabbrini et al., 2009).  Therefore, while it is clear that internal 
abdominal adipose tissue and hepatic lipid accumulation are closely 
associated with cardiometabolic disease, the underlying pathophysiological 
process remains uncertain.   
 
Four main mechanistic models have been proposed: 
1. The portal free fatty acid model: This hypothesis states that it is the flow of 
free fatty acids from internal abdominal adipose tissue via the portal vein, 
to the liver which impairs hepatic metabolism (Bjorntorp, 1990).  Animal 
studies provide strong support for this model (Bergman et al., 2006), but in 
humans it has been shown that the majority of portal free fatty acids 
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originate from subcutaneous adipose tissue (Nielsen et al., 2004) casting 
doubt on this proposed mechanism. 
2. The endocrine function of visceral adipose tissue: This theory proposes 
that visceral adipose tissue produces factors that cause metabolic 
abnormalities (Fontana et al., 2007), and is supported by findings that 
adipose tissue cytokines (adipokines) such as leptin and adiponectin, 
which are postulated to play a role in the dysmetabolic state, are more 
closely correlated with visceral rather than total adipose tissue (Yatagai et 
al., 2003, Cote et al., 2005).  Further support derives from findings that 
hypertrophic adipose tissue, which predominates in visceral adipose 
tissue, is characterised by infiltration of inflammatory cells that are a 
source of inflammatory cytokines such as IL-6 and TNF-α (Weisberg et al., 
2003, Hotamisligil et al., 1993). 
3. The overflow hypothesis: This model states that visceral adipose tissue 
may not impair metabolism directly.  Rather the presence of visceral 
adipose tissue reflects the relative inability of primary adipose tissue 
stores, such as subcutaneous adipose tissue, to expand to store energy 
excess.  In this situation excess lipid accumulates at “ectopic” sites, initially 
internal abdominal adipose tissue depots followed by liver and pancreas, 
leading to the dysmetabolic state characterised by insulin resistance 
(Despres and Lemieux, 2006, Sniderman et al., 2007).  This theory is 
supported by studies of subjects with dysfunctional adipose tissue due to 
partial lipodystrophy, who have increased ectopic and visceral fat and 
studies of thiazolidiniones, which improve glycaemia and cardiometabolic 
risk profiles and induce subcutaneous adipocyte hyperplasia (Yki-Jarvinen, 
2004). 
4. The adiposopathy hypothesis proposes that when healthy adipose tissue 
is able to expand in subcutaneous compartments by hyperplasia it does 
not lead to dysfunction or adverse metabolic consequences.  If 
adipogenesis is impaired, excess energy leads to adipocyte hypertrophy, 
dysfunction and pathogenic adipose tissue endocrine and immune 
responses – termed adiposopathy (Bays et al., 2008), the gross 
anatomical manifestations of which are accumulation of internal abdominal 
adipose tissue and lipid deposition in other organs (Bays et al., 2005). 
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Despite uncertainty regarding the exact mechanism, it is clear that the 
accumulation of internal abdominal adipose tissue and hepatic lipid are key 
factors in the development of metabolic disease in adults.  If, as suggested by 
the wealth of observation data (section 1.2), early life nutrition influences later 
metabolic health, this may be mediated by alterations in internal abdominal 
adipose tissue and hepatic lipid developing during the period of breast or 
formula feeding, and manifesting clinically in later life.  It is therefore important 
to understand early life development of adipose tissue. 
 
1.5 Adipocyte cellularity and early life development of adiposity 
The first cells containing lipid components are detectable from the 14th 
gestational week, with fat lobules appearing thereafter and adipocytes being 
detectable from the 23rd week (Poissonnet et al., 1983).   Humans are rare 
among animal species in having well-developed adipose tissue stores at birth 
(Kuzawa, 1998), with subsequent rapid expansion in infancy (Fomon and 
Nelson, 2002).  In the first year of postnatal life morphological studies suggest 
that subcutaneous adipose tissue expansion occurs almost entirely by 
adipocyte hypertrophy, with increasing adipocyte numbers detectable from 18 
months onwards (Hager et al., 1977).  These morphological studies detect 
only lipid filled cells, potentially underestimating preadipocyte or differentiating 
adipocyte numbers (which have lower lipid content), and subsequent work 
using a marker of cellular proliferation (thymidine kinase) shows that the 
highest levels of cell proliferation (adipocyte hyperplasia) actually occur during 
the first 12 months (Baum et al., 1986).  Work using C14 demonstrates that 
adipocyte number appears largely determined by the end of childhood, figure 
1.4 (Spalding et al., 2008). Taken together, these studies suggest that 
childhood (and infancy in particular) is a highly sensitive period, during which 
adult total adipocyte number is largely determined. 
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Figure 1.4: Total adipocyte number from 595 (n lean = 253; n obese = 342) adult 
individuals (squares) was combined with previous results for children and 
adolescents (circles; n lean = 178; n obese = 120). The adipocyte number 
increases in childhood and adolescence, with the number levelling off and remaining 
constant in adulthood in both lean (blue) and obese (pink) individuals. From Spalding 
et al., 2008. 
In adult life adipocyte populations regenerate continually (approximately 10% 
are replaced yearly) although adipocyte numbers remain remarkably stable 
(Spalding et al., 2008).  With increasing adiposity, adipocyte size increases in 
all anatomical locations until a plateau is reached in massively obese 
individuals (Arner et al., 2010), suggesting that it is only the presence of very 
large adipocytes that triggers generation of additional adipocytes.  The 
number of adipocytes varies between adult individuals, even at similar levels 
of overall adiposity.  Consequently the degree of adipocyte hypertrophy varies 
between individuals, while the mean age of adipocytes and their relative death 
rates do not (Arner et al., 2010), demonstrating that even with rapid adipocyte 
turnover, adipocyte number remains fixed.  Adipocyte size is important 
because it is a critical determinant of function: hypertrophic adipocytes are 
insulin resistant when compared to smaller adipocytes (Arner et al., 2010, 
Bjorntorp et al., 1971).  
 
To summarise, adipocyte number, which appears to be determined relatively 
early in life (with the most critical period seemingly being the first postnatal 
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year), has important long-term implications for adipocyte size, and 
subsequently for metabolic health, in particular in relation to an individual’s 
response to increasing adiposity. 
 
1.6 Tracking of adiposity through life 
Further support for the importance of the infant period in determining 
adipocyte number can be found in the observation that adiposity appears to 
track from infancy into adult life.  Although most studies have relied on 
surrogate measures of adiposity in infancy (such as weight for length Z-score 
or weight centile), they demonstrate a close association between increasing 
infant size and adiposity in adult life (Reilly et al., 2005a, Sayer et al., 2004, 
Charney et al., 1976). 
 
1.7 Techniques for quantification of adipose tissue and ectopic lipid 
If, on the basis of the evidence reviewed, we accept the following proposals:  
1. Breastfeeding, in comparison with formula feeding, is associated with a 
more beneficial metabolic health profile in adult life. 
2. Adipose tissue, or more specifically adipose tissue distribution and ectopic 
lipid, play key roles in the development of adverse metabolic health. 
3. Adipose tissue cellularity and structure are at least in part determined in 
early childhood. 
It is clear that infant feeding might modulate later metabolic health through 
effects on adipose tissue development, in particular adipose tissue 
distribution, arising in infancy.  Further investigation of this proposal requires 
in-vivo quantification of adiposity, which can be achieved using various 
indirect or direct techniques, each with corresponding advantages and 
limitations. 
 
1.7.1 Indirect techniques 
Indirect assessment of the relative make up of an individual (body 
composition) to enable quantification of the proportion made up by fat, 
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requires models describing the human body in measurable components, 
figure 1.5, (Wang et al., 1992).  
 
Atomic Molecular Cellular Tissue/organ Whole body 
N, Ca, P, S, 
K, Na, Cl, etc. 
Minerals 
(bone, soft 
tissue) 
Extracellular 
solids 
Other tissues 
(bone, etc.) 
Lower limbs 
H Protein Visceral 
organs 
Extracellular 
fluid Trunk 
C Lipid 
Bone 
Cells 
(adipocytes, 
etc.) 
Skeletal 
muscle 
Upper limbs 
O Water Adipose 
tissue 
Neck 
Head 
Figure 1.5: Five levels of human body composition, from Wang (Wang et al., 
1992) 
Indirect methods for determining body composition tend to use a molecular 
model of body composition, often further reducing this model to fat mass (FM) 
comprising the lipid component, and fat free mass (FFM) comprising mineral, 
protein, carbohydrate and water components.  This is further complicated by 
commonly used nomenclature with the terms “lipid” and “fat” often used 
interchangeably.  “Lipid” includes triacylglycerol (previously triglycerides), 
phospholipids and structural lipids while “fat” is commonly used to refer to 
triacyglycerol.  Conversely, direct methods use a tissue/organ model of body 
composition and measure adipose tissue volume, which excludes 
phospholipids and structural lipids, as well as ectopic organ lipid.  For 
consistency I will only use “fat” when describing literature that uses that term, 
otherwise the terms adipose tissue and lipid will be used as appropriate.    A 
further limitation of two-component techniques, of particular relevance to 
paediatric studies, is their reliance on the assumption that the proportions of 
fat-free mass that are water, protein and mineral are known and constant, a 
situation which may not be true in children (Wells and Fewtrell, 2006).  
Commonly used indirect techniques are outlined below: 
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1. Bioelectrical impedance analysis (BIA): This technique measures 
impedance of the body to a small electric current in order to estimate total-
body water (TBW).  From this FFM is calculated on an assumption about 
the proportion of the body’s FFM is water (Lee and Gallagher, 2008).  The 
relationship between impedance and TBW is influenced by age and other 
population characteristics, thus even with paediatric specific equations 
among healthy children BIA results in errors of +/- 8% fat (Wells et al., 
1999) when compared to 4 compartment models.   
2. Total body electrical conductivity (TOBEC): This technique is based on 
similar principles to BIA and uses the electrical conductivity of the whole 
body to predict its composition.  The infant is placed within or passed 
through a large coil of wire (solenoid) and changes in the electromagnietic 
field indicate the conductivity of the tissues in the infant.  Raw conductivity 
values are converted into values for total body water using equations 
derived empirically, and these are used to calculate FFM.  Total body 
electrical conductivity measures are influenced by environmental factors 
and the hydration of the infant and the agreement of TOBEC with other 
measures is poor, with only limited reference data available for infants 
(Wells and Fewtrell, 2006). 
3. Total body potassium (TBK): Potassium has a naturally occurring 
radioisotope 40K, (0.0118% of all potassium) which decays with a half-life 
of 1.28x109 years.  Using background radiation shielding, total body 40K 
can be estimated, from which total body potassium can be calculated.  
Since potassium is found almost entirely within cells, it provides a good 
estimate of body cell mass.  It can also be used to calculate fat-free mass 
assuming that total body potassium occurs at a constant concentration in 
fat-free mass.  However, it has been demonstrated that the concentration 
of potassium in fat free mass varies in adults (Larsson et al., 2003) and 
children (Cordain et al., 1989), leading to inaccuracies. 
4. Air displacement plethysmography (ADP): This method measures body 
volume allowing determination of total body density.  From this FM and 
FFM are derived assuming specific densities of these two tissues.  An 
infant plethysmography, “Peapod”, is available allowing simple, acceptable 
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measurement of ADP in early life and validation studies indicate high 
levels of accuracy and precision when compared with 4 compartment 
techniques (Ellis et al., 2007, Ma et al., 2004).  However, while the density 
of fat is relatively constant, FFM density varies even in healthy children 
leading to potential inaccuracies (Wells et al., 1999).   More accurate 
methods of measuring density, hydrodensitometry are not applicable in 
infancy due to technical reasons. 
5. Dual energy X-ray absorptiometry (DEXA): This technique was developed 
to measure bone mineral mass, which is calculated from the differential 
absorption of x-rays of two different energies.  This calculation requires 
quantification of overlying soft tissues, therefore allowing calculation of fat 
and fat free mass for the whole body.  The radiation dosage from DEXA is 
small (1-10% of a chest x-ray) (Lee and Gallagher, 2008) and the 
technique is quick and acceptable to children.  As with TOBEC, the bias 
inherent in DEXA measurements varies with age, fatness and disease 
state (Wells et al., 2010, Wosje et al., 2006), leading to inaccuracy, 
especially when comparing groups or changes within an individual gaining 
or losing weight. 
6. Dilutional techniques: These methods use deuterated (2H), tritated (3H) or 
oxygen-labeled (18O) water to determine TBW by dilution.  Following 
administration and equilibration of labeled water, enrichment of the body 
water pool is measured using urine samples.  As with TOBEC calculation 
of FFM relies on assumptions between TBW and FFM, with similar 
limitations.   
 
Multicomponent models, which combine several of the above techniques to 
measure separate components provide the most accurate quantification of 
body composition at the molecular level, but are correspondingly more 
invasive and expensive.  Furthermore multicomponent reference techniques, 
while providing the most accurate estimate of total body fat, are unable to 
accurately delineate adipose tissue distribution or ectopic lipid deposition.  
Although DEXA allows delineation between limb and trunk fat, and thus 
limited examination of adiposity distribution, it fails to discriminate between the 
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adipose tissue depots of greatest metabolic importance: internal abdominal 
and subcutaneous abdominal.   
 
Therefore while indirect techniques have been invaluable in determining body 
composition at the two-component level in children and infants, and 
examining how this changes as part of growth and development (Fomon, 
1967, Fomon and Nelson, 2002), they are unsuitable for examining adiposity 
in detail, which requires direct measurement techniques. 
 
1.7.2 Direct techniques 
Direct techniques include ultrasound, computed tomography (CT) and 
magnetic resonance imaging (MRI).  These techniques use an organ-based 
system of body composition (figure 1.5) and in contrast to indirect techniques 
that estimate the mass of a body component, quantify the volume of an organ 
(such as adipose tissue).  Direct quantification avoids the inaccuracies 
inherent in estimating the density of a tissue in a rapidly changing population 
like children or infants as long as the directly measured value (volume) is 
used.  Commonly used direct techniques are outlined below: 
 
1. Ultrasound: This method is easily accessible, non-invasive and involves no 
radiation exposure.  Although feasible in infants, with good intra- and inter-
observer reproducibility (Holzhauer et al., 2009), it only allows 
measurement of adipose tissue depth rather than volume with 
measurement limited to easily accessible regions: commonly abdominal 
subcutaneous and preperitoneal adipose tissue.  Therefore deriving values 
for whole body adipose tissue requires a series of assumptions (Suzuki et 
al., 1993), leading to similar inaccuracies as found with indirect 
techniques. 
2. Whole body computed tomography (CT): This technique produces cross 
sectional images, allows assessment of regional adipose tissue 
distribution and is considered to be the gold standard technique in adults 
(Cornier et al., 2011). It is however contraindicated as a research tool in 
infants and children due to high levels of ionising radiation. 
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3. Whole body magnetic resonance imaging (MRI):  This approach also 
provides cross-sectional images, directly measuring total adipose tissue 
and regional adipose tissue distribution.  It has been validated against CT 
(Lonn et al., 1999), animal models (Fowler et al., 1992) and cadaver 
measurements (Abate et al., 1994) and is highly reproducible in adults 
(Barnard et al., 1996) and children (Modi et al., 2009).  The absence of 
ionising radiation associated with MRI makes it the gold-standard direct 
technique for use in infants and children for determination of regional 
adipose tissue. 
4. Single slice cross-sectional techniques (MRI and CT): Whole body MRI 
and CT are time consuming, which has led to the development of single 
slice MRI and CT techniques for assessment of abdominal adiposity 
(Sobol et al., 1991).  While these provide more information than indirect 
proxy measurements such as waist hip ratio or BMI, and show good 
correlation with results obtained from whole body imaging in adults 
(Schwenzer et al., 2010), they introduce imprecision when measuring 
adipose tissue volume leading to inconsistencies in estimation compared 
to whole body techniques (Thomas and Bell, 2003).  Furthermore, the 
suitability of single slice techniques in infants has yet to be determined. 
 
Of the techniques available for assessment of body composition and 
adiposity, whole body MRI alone is suitable for use in a paediatric population 
and directly quantifies individual adipose tissue depots.  In addition magnetic 
resonance techniques allow examination of ectopic lipid content within other 
organs (such as liver) through the application of magnetic resonance 
spectroscopy (MRS).  
 
1.7.3 Magnetic resonance techniques (MRI and MRS) 
Magnetic resonance techniques rely upon the behaviour of certain atomic 
nuclei (predominantly 1H but also others: 13C and 15N) in an externally applied 
magnetic field.  These nuclei possess the quantum mechanical property of 
spin or ‘precession’– a source of angular momentum intrinsic to nuclei with an 
odd mass number – and when placed in a static magnetic field they behave 
like magnetic dipoles: aligning either parallel with or against the axis of the 
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magnetic field.  The precession frequency at which a proton spins is 
determined by the strength of the magnetic field.  Specifically, this is 
calculated by the Lamor equation, which, in brief, states that the precessional 
frequency is equal to the gyromagnetic constant (42.58 million) multiplied by 
the magnetic field strength in tesla. Therefore, in a 1.5 tesla MRI scanner 
(42.58x106 x 1.5 = 63.87x106) or a precessional frequency of 63.87MHz. 
 
When radiofrequency (RF) energy (usually as a pulse) is applied to nuclei in a 
static magnetic field, they absorb energy leading to excitation, disturbing their 
alignment (naturation).  Following the removal of RF pulse, nuclei return to 
their original alignment, in the process giving off a radiofrequency signal at the 
resonant frequency of the molecules within the sample, that can be detected 
by a receiver coil.  This signal, known as free induction decay, can be 
resolved by a mathematical process known as Fournier transformation into 
either an image (MRI) or a frequency spectrum (MRS).  Anatomical images 
(MRI) can be used to quantify adipose tissue volume by summating adipose 
tissue area on individual images, and factoring the inter-slice difference.  
Proton MRS produces a frequency spectrum that can be used to determine 
biochemical information about a specific area of interest (for example a 
section of liver).  The precise molecular environments in which nuclei 
(protons) sit influence the speed of their precession or ‘resonant frequency’.  
For example the resonance frequency of a proton in a water molecule differs 
from the frequency of one in a triacylglycerol molecule.  Each molecule has a 
specific resonant frequency, which is represented as a difference in parts per 
million (ppm) from a reference molecule, typically tetramethysilane (TMS) 
(Si(CH3)4), which is used as 0.  Therefore, water at 4.7ppm has a 
precessional frequency 4.7cycles/million slower than TMS, which at 1.5T 
(63.87MHz) means 63.87 x 4.7 = 300.19 cycles/second slower. This is the 
basis for improved resolution at higher field strength. 
 
Although the differences in resonance frequencies are small, they can be 
separated out to form a spectrum.  Spectra are plotted on an axis of chemical 
shift: the frequency and form of the peak relate to the compound, while the 
area under the peak relates to the concentration of the compound.  
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Quantification of hepatic lipid using proton MRS requires evaluation of the two 
dominant peaks within the unsuppressed MR spectrum: water at 4.7ppm and 
lipid at 1.0-1.5 ppm, with values expressed relative to the water peak (Mehta 
et al., 2008).  Magnetic resonance spectroscopy can be applied to in-vitro 
samples in much the same way, commonly referred to as nuclear magnetic 
resonance (NMR) spectroscopy, where higher magnetic field strengths, and 
thus greater signal to noise, allow more detailed identification of spectral 
components. 
 
1.8 Areas of uncertainty 
The hypothesis that I will examine over the following chapters – that being 
breastfed in infancy is associated with alterations in body composition, 
adipose tissue distribution and ectopic lipid that manifest in infancy – builds 
upon previously outlined tenets:  
 
1. Differences exist between breastfeeding and formula feeding that lead to 
differences in early growth. 
2. Formula feeding in comparison with breastfeeding in infancy appears 
associated with components of the metabolic syndrome in adult life. 
3. Adipose tissue and ectopic lipid appear to play key roles in the 
pathogenesis of the metabolic syndrome. 
4. Infancy is a key period of plasticity in the development of adipose tissue. 
5. Magnetic resonance techniques provide the only suitable method to 
quantify adipose tissue distribution and ectopic lipid in infancy. 
 
Prior to testing my null hypothesis: breastfeeding is not associated with 
differences in adipose tissue distribution and hepatic ectopic lipid in infancy, 
other related areas of uncertainty must be addressed: 
 
1. Whether or not an association exists between infant feeding and two-
component body composition (FM and FFM) remains uncertain 
2. The pattern of longitudinal adipose tissue and ectopic lipid development 
seen in healthy infants is unknown.  
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I will first undertake a systematic review and meta-analysis of the published 
literature reporting the relationship between infant feeding and two-component 
body composition to determine if a significant association is detectable using 
indirect measures of adiposity.  To examine adipose tissue distribution and 
ectopic lipid in infancy I will establish a prospective cohort study with 
longitudinal assessments, utilising gold standard direct measures (MRI and 
MRS).  I will discuss statistical aspects relevant to analysis and presentation 
of this data, and use this cohort to determine normal longitudinal change in 
adipose tissue distribution and ectopic lipid in healthy infants before 
investigating the influence of method of feeding.  In the final two experimental 
chapters I will use data from this cohort to explore potential mediators linking 
method of feeding and altered infant adiposity: I will examine the hypotheses 
that firstly, altered body composition in early infancy is associated with rate of 
early weight gain (which differs between breastfed and formula fed infants), 
and secondly, that the concentration of adipose tissue regulating hormones 
known to be present in breast milk is associated with offspring body 
composition.  Finally I will undertake exploratory work to determine whether 
NMR proton spectroscopy in combination with multivariable analysis 
techniques is suitable for the characterising breastmilk metabolites and 
examining correlations with offspring body composition.. 
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Chapter 2 
Methods 
 
I will use systematic review and data synthesis techniques to determine the 
mean association between infant feeding and two-component body 
composition, before setting up a prospective cohort study to apply longitudinal 
in-vivo and in-vitro techniques to examine adiposity and metabolism in relation 
to method of feeding. 
 
2.1 Systematic review and data synthesis  
2.1.1 Systematic review of the published literature 
Literature searches were conducted in PubMed (www.ncbi.nlm.nih.gov), in 
any language, using Medline MeSH (Medical Subject Heading) terms.  
Abstracts, or full copies where abstracts were unavailable, were extracted of 
all identified studies.  Papers suitable for inclusion were identified using a 
priori inclusion and exclusion criteria.  Reference lists and citations of included 
papers were hand-searched in order to identify additional papers suitable for 
inclusion.  Review articles and commentaries were excluded after hand-
searching reference lists and citations for suitable papers.  
 
Data on study design, exposure classification, measurements, outcomes and 
potential sources of bias were extracted from each included paper.  Where 
outcome data were not presented in a form suitable for comparison with other 
studies, authors were contacted and asked to provide this. 
 
2.1.2 Meta-analyses of individual studies 
A fixed effects meta-analysis was undertaken in RevMan5 (The Cochrane 
Collaboration) using the inverse variance method. Heterogeneity was 
assessed using the chi-squared test for Cochrane’s Q statistic (Cochran, 
1954) and by calculating I2 (Higgins and Thompson, 2002).  Cochrane’s Q 
statistic examines the null hypothesis that all studies are evaluating the same 
effects, and the chi-squared test assesses whether observed differences are 
compatible with chance alone.  A low p value from the chi-squared test for 
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Cochrane’s Q statistic provides evidence of heterogeneity in effects. The chi-
squared test is however poor at detecting true heterogeneity among studies 
as significant (Higgins et al., 2003) and therefore an alternative approach is 
used, I2.  This describes the percentage of total variation across studies that is 
due to heterogeneity rather than chance, with larger values signifying 
increased heterogeneity. 
 
Where heterogeneity was present (p<0.05 from the chi-squared test), a 
random effects meta-analysis was carried out.  In this case the pooled 
difference was the estimate of the average effect across study populations, as 
studies were assumed to have different underlying effects. In contrast, for 
fixed effects analyses, studies were assumed to have the same underlying 
effect, which was estimated by the pooled difference.  Results were illustrated 
using forest plots.  Funnel plots were used to investigate for asymmetry.  
Heterogeneity was investigated through sub-group and sensitivity analyses. 
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2.2 Prospective cohort study 
Longitudinal magnetic resonance assessments were carried out on two 
occasions, shortly after birth and before 12 weeks age.  Samples were 
collected at recruitment and at both scan points (T1 and T2). 
 
2.2.1 Patient involvement 
Northwest London Neonatal Network has an established Parent 
Representative Group, made up of parents of children who have required 
neonatal care and those who have been involved in neonatal research 
studies.  Input was obtained from this group regarding acceptability of the 
study, the design of the parent information sheet and recruitment (Appendix 
2A), 
 
2.2.2 Research ethics 
Research Ethics Committee approval was obtained from the Institute of Child 
Health/Great Ormond Street Hospital Research Ethics Committee, 8th 
February 2010, REC reference number 10/H0713/5 (Appendix 2B). 
 
2.2.3 Research subjects 
2.2.3.1 Recruitment 
Mothers and healthy, full term infants were recruited on the postnatal ward at 
Chelsea and Westminster Hospital, following explanation of the study and 
after obtaining written informed consent. Patient information sheet and 
consent form are found in Appendix 2C)  
2.2.3.2 Inclusion criteria 
Healthy term (37-42 weeks post menstrual age) infants of all ethic groups and 
of multiple or singleton pregnancies. 
2.2.3.3 Exclusion criteria 
Exclusion criteria were limited to factors previously shown to have 
associations with study outcomes: infant growth, infant body composition or 
breast milk composition.  The following groups of infants were excluded:  
1. Infants fed on non-standard formula feeds. 
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2. Infants of diabetic mothers: Consumption of diabetic breast milk is 
associated with alteration in anthropometric measures (Plagemann et 
al., 2002).   
3. Infants of mothers who smoke after delivery: Smoking alters maternal 
diet resulting in reduced nutrient intake (Trygg et al., 1995) and altered 
breast milk composition (Laurberg et al., 2004). 
2.2.3.4. Collection of demographic data  
Demographic data was collected from maternal and infant hospital notes and 
from maternal interview, using a standardised data collection form (Appendix 
2D). 
2.2.3.5 Collection of breast-feeding data 
Retrospective definition of feeding method has been demonstrated to 
introduce recall bias and lead to overestimation of breast feeding duration 
(Agampodi et al., 2011, Gillespie et al., 2006); therefore parents were given a 
simple feed diary to complete prospectively during the study period (Appendix 
2E).  Dates of the first formula feed received by the baby, when first 
predominantly formula fed and when first exclusively formula-fed were also 
recorded.  Additionally parents were asked about method of feeding at 
recruitment, at both scan points and at all contact points throughout the study 
period (for example whenever telephone contact was made to arrange 
appointments).  Breastfeeding was defined according to the criteria adopted 
by the World Health Organisation (Labbok and Krasovec, 1990): 
1. Full breastfeeding (including exclusive and almost exclusive) 
2. Partial - High breastfeeding (>80%) 
3. Partial - Medium breastfeeding (20-80%) 
4. Partial - Low breastfeeding (<20%) 
5. Full formula feeding (including token breastfeeding: where 
breastfeeding is not for nutritional purposes) 
2.2.3.6 Collection of formula-feeding data 
Where infants were receiving artificial formula details of the formula brand 
were obtained prospectively at recruitment, at both scan points and at all 
contact points throughout the study period (for example whenever telephone 
contact was made to arrange appointments).  The compositions of 
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commercially available cow’s milk based artificial formulas are provided in 
Appendix 1, table 1A. 
2.2.3.7 Definition of feeding groups 
For analyses by feeding group, babies were defined using a categorical 
classification: Infants were classified as predominantly breastfed (high or full 
breast feeding at both scan points), predominantly formula fed (high or full 
formula feeding at both scan points) or mixed fed (not meeting criteria for 
predominantly breasted or predominantly formula fed). 
 
2.2.4 Anthropometric measurements 
Weight was measured using scales accurate to 0.2 g (Marsden Professional 
Baby Scale, London, UK); length was measured with a Rollametre, accurate 
to 1mm (Raven Equipment Ltd., Dunmow, Essex, UK) and head 
circumference with a nondistensible tape measure accurate to 1mm (Child 
Growth Foundation, London, UK). 
 
2.2.4.1 Maternal pre-pregnancy BMI 
Pre-pregnancy maternal weight was obtained from maternal recall.  Maternal 
height was obtained from measurements made at pregnancy booking. 
 
2.2.5 Magnetic resonance investigations  
Ensuring infants remain settled during the investigation was the key to 
obtaining high quality MR data.  Oral sedation, although commonly used when 
investigations are clinically indicated, is associated with adverse events in up 
to 20% of cases (Sammons et al., 2011, Litman et al., 2010) (Kannikeswaran 
et al., 2009). For these reasons all MR investigations undertaken as part of 
my study were carried out in natural sleep.  This required considerable 
organisation: I ensured that families arrived at least 45 minutes before the 
scheduled imaging time and that the infant was due a feed was due shortly 
after arrival.  Simple checklists (a health questionnaire and infant metal check, 
Appendix 2F) were used to document that the infant was fit for the procedure 
and to ensure that safety protocols were followed. The baby and parents were 
settled in a quiet private room while infant metal check and anthropometric 
measurements were carried out. For noise shielding, putty was applied to the 
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infant’s ears (Coltene/Whaledent, Altstatten, Switzerland; reducing sound 
levels by 22dB) before covering them with protective earmuffs (MiniMuffs, 
Natus Medical Incorporated, San Carlos, CA, USA; reducing sound levels by 
a minimum of 7dB), held in place with a hat.  Single-use chest electrodes 
(Neo Quadtrodes, Invivo, Gainesville, FL, USA) were attached before firmly 
swaddling the baby and leaving the parents and the infant in privacy so they 
could feed and settle the infant to sleep.  Once the infant was soundly asleep 
the family was escorted into the MR control room, where the infant was 
placed on the scanning trolley (figure 2.1) and foam padding was positioned 
comfortably around the infant’s head to provide a final layer of noise shielding 
(reducing noise levels by a further 10dB).   
 
All infants were continuously monitored throughout their research MR 
procedure by a clinician trained in neonatal resuscitation (myself).  Chest 
ECG electrodes and a pedal pulse oximeter were used to monitor the infant’s 
heart rate and oxygen saturation continuously. These parameters were 
recorded at 5-minute intervals throughout the procedure and documented in 
the infant’s research file (Appendix 2G). An increased heart rate commonly 
represented the first indication that a baby was waking so if consistently 
raised or if the baby was heard, scanning was interrupted to allow time for the 
baby to be resettled by the parents. 
 
Key to ensuring continued involvement was making sure that parents felt 
relaxed, informed and involved in the process.  To this end I ensured travel to 
and from scanning was convenient, and explained the investigation and the 
research project in detail during the acquisition of MR images. The final factor 
was ensuring flexibility from parents and the research team. The ability to 
have several families in the department settling their infants allowed me to 
return an alert baby to their room and bring in another sleeping infant, making 
the most efficient use of the available research slots.   
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Figure 2.1: A baby swaddled with noise shielding applied, settled in position 
for MR scanning.  Permission was obtained from parents for use of this image. 
 
2.2.6 Unexpected findings 
As with many research investigations, MR has the potential to detect 
previously unknown findings of uncertain significance (Vasu et al., 2011). In 
cases of incidental findings being detected during research imaging our policy 
was to immediately inform both the parents and their general practitioner of 
any unexpected finding before arranging suitable follow-up.  A paediatric 
radiologist reviewed all MR images obtained during my study in order to check 
for unexpected findings.  I explained this in detail to parents during 
recruitment and emphasised the differences between whole body MR imaging 
for research and diagnostic imaging.  This was particularly important in order 
to avoid parents enrolling their babies into the study under the misconception 
that they will receive a “screening total body scan”. 
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2.3 In-vivo investigations 
2.3.1 Whole body adipose tissue magnetic resonance imaging 
2.3.1.1 Whole body magnetic resonance imaging technique 
Images were acquired on a Phillips 1.5 Tesla system using a T1-weighted 
rapid-spin-echo sequence (repetition time of 500 ms, echo time of 17 ms, 
echo train length of 3) using a Q body coil.  The slice thickness was 5mm and 
interslice difference was 5mm.  Scans lasted approximately 15 minutes.  
Voxel size was 0.31cm×0.31cm×0.31cm. 
2.3.1.2 Analysis of whole body adipose tissue images 
Analysis of all MR images was undertaken independently of the investigators, 
blind to subject identity and feeding group by VardisGroup, (London, UK, 
www.vardisgroup.com). Images were analysed by a single observer using a 
commercially available software program (SliceOMatic, Version 4.2, 
Tomovision, Montreal, Canada).  A filter was used to distinguish between 
different gray level regions on each slice. This was then verified and, where 
necessary, edited using an interactive slice editor program.   Adipose tissue 
volume (cm3) for each slice was calculated as follows: 
 
adipose tissue volume = number of pixels × pixel size × (slice thickness + interslice 
difference) 
 
Slices were integrated by combining the adipose tissue volume of all slices in 
order to calculate total adipose tissue volume.  Individual compartment 
volumes were calculated as described below.  MR image analysis for a single 
infant slice taken at abdominal level is illustrated below (figure 2.2). To gain 
familiarity with the analysis techniques, I performed adipose tissue 
compartment quantification using the described methods for a subgroup of 
babies.  In house analysis carried out in this way in a neonatal population has 
been previously demonstrated to introduce unacceptable intra-observer 
variability (up to 7%) and inter-observer variability (up to 17.6%) (Harrington et 
al., 2002), therefore all body composition data used was analysed by the 
VardisGroup.  Evaluation of variation within data analysed by VardisGroup is 
performed by the periodic inclusion of a random known pre-analysed set. The 
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coefficient of variation for total adipose tissue volume measurements is <3% 
(Modi et al., 2009) and for measurement of subcutaneous and internal 
abdominal adipose tissue is 1% and 5% respectively.  Differences in a test 
dataset greater than this would raise a red flag regarding the analysis quality 
and would trigger review, and if necessary re-analysis. 
 
 
Figure 2.2: Infant MR image analysis 
 
2.3.1.3 Categorisation of adipose tissue compartments 
The adipose tissue depots were separated to measure pixel count in total 
adipose tissue, subcutaneous adipose tissue, and internal adipose tissue. 
Internal adipose tissue was subdivided into internal abdominal and internal 
non-abdominal adipose tissue. Abdominal adipose tissue content was 
obtained by quantifying adipose tissue in the slices from the sacrum to the 
slice containing the top of the liver or base of the lungs.  Subcutaneous 
adipose tissue in this region of the body was termed abdominal subcutaneous 
adipose tissue.  All other internal adipose tissue was considered internal non-
Original grey-scale image First pass computerised 
analysis 
Subcutaneous fat coded 
green 
Internal fat coded red  Manual editing of internal 
fat 
Manual recoding of deep 
subcutaneous fat (blue) 
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abdominal adipose tissue.  Each of six adipose tissue compartments 
(abdominal superficial subcutaneous adipose tissue, non-abdominal 
superficial subcutaneous adipose tissue, abdominal deep subcutaneous 
adipose tissue, non-abdominal deep subcutaneous adipose tissue, internal 
abdominal adipose tissue, non-abdominal internal adipose tissue) were 
quantified individually (figure 2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2 Magnetic resonance spectroscop 
 
2.3.2 Magnetic resonance spectroscopy 
2.3.2.1 Hepatic magnetic resonance proton spectroscopy technique 
1H MR spectra were acquired at 1.5 tesla from the right lobe of the liver using 
a PRESS sequence (Bottomley, 1987), repetition time 1500ms, echo time 
135ms, without water saturation and with 128 signal averages. Transverse 
images of the liver were used to ensure accurate positioning of the (20×20×20 
mm) voxel in the liver, avoiding blood vessels, the gall bladder and fatty 
tissue.  
 
2.3.2.2 Analysis of spectra 
Spectra were analysed in the time domain using the AMARES algorithm 
included in the MRUI software package (Naressi et al., 2001, Vanhamme et 
Total adipose 
tissue 
Superficial 
Subcutaneous  
Deep 
Subcutaneous  
Internal 
Abdominal 
Superficial 
Subcutaneous 
adipose tissue   
Non-Abdominal 
Superficial 
Subcutaneous 
adipose tissue  
Abdominal 
Deep 
Subcutaneous 
adipose tissue  
Non-Abdominal 
Deep 
Subcutaneous 
adipose tissue  
Internal 
Abdominal 
adipose tissue 
 
Non-Abdominal 
Internal 
adipose tissue 
Figure 2.3: Adipose tissue compartments:  Total body adipose tissue can be divided into 
subcutaneous and internal.  Subcutaneous can be further divided into deep and superficial 
compartments.  These depots (superficial subcutaneous, deep subcutaneous and internal adipose 
tissue) can be further separated into abdominal and non-abdominal components.  
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al., 1997).  Peak areas for all resonances were obtained and lipid resonances 
were quantified with reference to water resonance, after correcting for T1 and 
T2 (Thomas et al., 2005).  Hepatic water, known to be relatively constant 
(Emery and Finch, 1954) was used as an internal standard and the results are 
presented as the ratio IHCL CH2/water. 
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2.4 In-vitro studies 
2.4.1 Sample collection and storage 
Samples were obtained on the postnatal ward following recruitment or at 
attendance for MR investigations.  Samples obtained on the postnatal ward 
were immediately frozen at -80°C.  Samples obtained at the MR scanning 
facility were stored in an insulated transport vessel containing freezer blocks 
frozen to -80°C, before transfer to Chelsea and Westminster Hospital and 
freezing at -80°C. 
2.4.1.1 Breast milk 
The mother expressed breast milk samples manually or by breast pump, 
dependent upon her preference.  Hind milk samples, following an infant feed, 
were obtained.  Mothers were not fasted prior to expressing. Samples were 
separated into sample tubes and frozen at -80 °C until analysis. 
 
2.4.2 Sample analysis 
2.4.2.1 Breast milk NMR sample preparation 
Frozen samples were thawed and vortexed. 400 µl of whole milk was pipetted 
into a glass vial and a modified Folch extraction procedure was carried out 
(Folch et al., 1957).  To the whole milk was added 2ml of deuterated 
chloroform (C2HCl3) and methanol in a 2:1 ratio and the solution was 
vortexed. To this was added 600 µl of deuterated water (2H2O), the solution 
was vortexed again and centrifuged at 13,000rpm for 10 minutes.   This 
resulted in 3 phases being formed: an upper aqueous phase, a lower lipid 
phase and a central solid phase.  The upper aqueous phase was pipetted into 
an Eppendorf, and the lower lipid phase was pipetted into a glass vial using a 
glass Pasteur pipette.  The aqueous and lipid phases where vacuum 
evaporated overnight, the aqueous phase was reconstituted in 600 µl of 2H20 
phosphate buffer (containing 0.2M Na2HPO4, 0.043M NaH2PO4, 1mM TSP 
and 3mMNaN3 dissolved in 2H2O), and the lipid phase was reconstituted in 
600 µl of deuterated chloroform (C2HCl3) containing TMS (Si(CH3)4) 0.03% 
(v/v). 60 µl aliquots of all samples were combined for quality control and 400 
µl of this pooled sample was prepared as above. 
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2.4.2.2 NMR spectroscopic analysis 
For breast milk 1H NMR spectroscopy was performed at 300 K on a Bruker 
600 MHz spectrometer (Bruker Biospin, Karlsruhe, Germany) using the 
following standard one-dimensional pulse sequence with saturation of the 
water resonance: Relaxation delay (RD)-90°-t1-90°-tm-90°-acquire free 
induction decay (FID), where 90° represents the applied 90° radio frequency 
(rf) pulse, t1 is an interpulse delay set to a fixed interval of 3ms, RD was 2s 
and tm (mixing time) was 100ms. Water suppression was achieved through 
irradiation of the water signal during RD and tm. Each spectrum was acquired 
using 8 dummy scans, 256 scans, 64 000 time domain points with a spectral 
width of 20 000Hz. Prior to Fourier transformation, the FIDs were multiplied by 
an exponential function corresponding to a line broadening of 0.3Hz. 
 
2.4.2.3 NMR spectroscopy pre-processing 
1H NMR spectra were digitalised over the range of δ 0.35−10.0, imported into 
Matlab, automatically phased and baseline-corrected. All spectra were then 
inspected and further manual phasing was carried out where required. The 
baseline was included in the peak estimation and subtracted before 
integration. Spectra obtained from the aqueous phase of breast milk were 
referenced to the resonance of TSP (trimethylsilyl propionic acid) at 0 ppm, 
and spectra obtained from the lipid fraction of breast milk were referenced to 
the resonance of TMS (tetramethylsilane Si(CH3)4) at 0 ppm, using TopSpin 
2.1 (Bruker Corporation, Billerica, MA, USA). The regions containing the TSP 
or the TMS resonances were removed and spectra were normalised using a 
Matlab script developed in-house to the total spectral area. For breast milk 
samples no scaling method has been previously described and UV, central 
and Pareto scaling were compared and the scaling method which provided 
the best clustering of samples on PCA was used. 
 
2.4.2.4 Determination of breast milk hormone concentration 
Breast milk samples were defrosted and 200µl aliquots were centrifuged at 
15,000rpm at 10°C for 20 minutes.  The lipid plug was drawn off using an 
empty pipette tip and 100µl of the skimmed fraction was pipetted into an 
Eppendorf tube for further analysis. 
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1. Human Insulin 
The concentration of human insulin was determined in two 25µl aliquots of 
skimmed breast milk using the Milipore Human Insulin ELISA kit (Millipore 
Corporation, Billerica, MA, USA), as per manufacturer’s instructions.  This 
ELISA is a solid phase, two-site immunoassay; it uses the direct sandwich 
technique with two separate antibodies (monoclonal mouse anti-human 
insulin antibody and biotinylated mouse anti-human insulin antibody) being 
targeted at separate sites on the human insulin molecule.  It has no cross 
reactivity to human intact proinsulin and it’s major processed intermediate, 
des(31,32) proinsulin.  A colorimetric endpoint from the reaction of bound 
streptovidin-horseradish peroxidase conjugate attached to the secondary 
antibody and 3,3’,5,5’-tetramethylbenzidine, was terminated by the addition of 
acid (0.3M HCl) and was determined using a spectrophotometic plate reader 
at 450nm (Multiskan EX microplate reader, VWR, Radnor, PA, USA).  
Concentrations of milk insulin were calculated using a standard reference 
curve constructed from the insulin standards provided within the kit.  
 
2. Human Leptin 
The concentration of human leptin was determined in two 50µl aliquots of 
skimmed breast milk using the Milipore Human Leptin ELISA kit (Millipore 
Corporation, Billerica, MA, USA), as per manufacturer’s instructions.  This 
ELISA is a solid phase, two-site immunoassay; it uses the direct sandwich 
technique with two separate antibodies (Rabbit anti-Human Leptin Antibody 
and Biotinylated Mouse anti-Human Leptin Antibody) being targeted at 
separate sites on the human leptin molecule.  A colorimetric endpoint from the 
reaction of bound streptovidin-horseradish peroxidase conjugate attached to 
the secondary antibody and 3,3’,5,5’-tetramethylbenzidine was terminated by 
the addition of acid (0.3M HCl) and was determined using a 
spectrophotometic plate reader at 450nm and 620nm (Multiskan EX 
microplate reader, VWR, Radnor, PA, USA).  Concentrations of milk leptin 
were calculated using a standard reference curve constructed from the leptin 
standards provided within the kit. 
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3. Human Ghrelin (active) 
The concentration of human ghrelin was determined in two 25µl aliquots of 
skimmed breast milk using the Milipore Human Ghrelin (active) ELISA kit 
(Millipore Corporation, Billerica, MA, USA), as per manufacturer’s instructions.  
This ELISA uses the sandwich technique to capture human ghrelin molecules 
(active, octonylated form) by anti-human ghrelin IgG and immobilization of the 
resulting complex to the wells of the plate by a pre-titered amount of anchor 
antibodies and simultaneous binding of a second biotinylated antibody to 
ghrelin.  There is no cross reactivity to des-octanoyl-ghrelin.  A colorimetric 
endpoint from the reaction of bound streptovidin-horseradish peroxidase 
conjugate attached to the secondary antibody and 3,3’,5,5’-
tetramethylbenzidine was terminated by the addition of acid (0.3M HCl) and 
was determined using a spectrophotometic plate reader at 450nm and 620nm 
(Multiskan EX microplate reader, VWR, Radnor, PA, USA).  Concentrations of 
milk active ghrelin were calculated using a standard reference curve 
constructed from the ghrelin standards provided within the kit. 
 
4. Human High Molecular Weight Adiponectin 
The concentration of human high molecular weight (HMW) adiponectin was 
determined in two 25µl aliquots of skimmed breast milk using the Human High 
Molecular Weight (HMW) Adiponectin ELISA kit (Millipore Corporation, 
Billerica, MA, USA), as per manufacturer’s instructions.  Sample treatment 
specifically removed hexameric and trimeric forms of adiponectin to allow 
specific measurement of the HMW form.  This ELISA uses the direct 
sandwich technique with two separate antibodies (monoclonal anti-
adiponectin antibody and biotinylated polyclonal anti-adiponectin antibody) 
being targeted at separate sites on the human adiponectin molecule.  A 
colorimetric endpoint from the reaction of bound streptovidin-horseradish 
peroxidase conjugate attached to the secondary antibody and 3,3’,5,5’-
tetramethylbenzidine, was terminated by the addition of acid (0.3M HCl) and 
was determined using a spectrophotometic plate reader at 450nm and 620nm 
(Multiskan EX microplate reader, VWR, Radnor, PA, USA).  Concentrations of 
Newborn feeding and infant phenotype 
 66 
milk HMW adiponectin were calculated using a standard reference curve 
constructed from the adiponectin standards provided within the kit 
 
5. Human Resistin 
The concentration of resistin was determined in two 25µl aliquots of skimmed 
breast milk using the Human Resistin ELISA kit (Millipore Corporation, 
Billerica, MA, USA), as per manufacturer’s instructions.  This ELISA uses the 
direct sandwich technique with two separate antibodies (monoclonal anti-
resistin antibody and biotinylated monoclonal anti-resistin antibody) being 
targeted at separate sites on the human resistin molecule.  A colorimetric 
endpoint from the reaction of bound streptovidin-horseradish peroxidase 
conjugate attached to the secondary antibody and 3,3’,5,5’-
tetramethylbenzidine, was terminated by the addition of stop solution and was 
determined using a spectrophotometic plate reader at 450nm and 620nm 
(Multiskan EX microplate reader, VWR, Radnor, PA, USA).  Concentrations of 
milk resistin were calculated using a standard reference curve constructed 
from the resistin standards provided within the kit. 
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2.5 Statistics 
Data were analyses using IBM SPSS Statistics version 19 (IBM, Armonk, NY, 
USA) unless otherwise stated. 
 
2.5.1 General statistical methods 
Normality of distribution was assessed by visualisation of histograms and Q-Q 
plots and tested using Shapiro-Wilk test (Shapiro and Wilk, 1965). 
 
For normally distributed data parametric tests were used (independent or 
paired sample t-tests).  Non-normally distributed data were tested using non-
parametric techniques (Mann-Whitney U test, Kruskal-Wallis 1-way ANOVA, 
related samples Wilcoxon signed rank test) or log transformed prior to 
parametric analysis if normally distributed following transformation. 
 
Multivariable regression analyses are more robust to deviations from 
normality in the distribution of sample dataset, but require normal distribution 
of the residuals to be valid.  Multivariable regression analyses were carried 
out on untransformed data and the distribution of the residuals examined, 
where the distribution of the residuals was non-normal data were transformed. 
 
2.5.2 Examination of change in body composition 
Change in body composition between first and second scan was examined 
using multivariable regression analyses with the second scan value was the 
dependent variable adjusted for first scan value (independent variable).   
 
2.5.3 Calculation of growth  
Change in weight was calculated as a standard deviation score (SDS) value 
representing the change between birth and second scan SDS values using 
the LMS growth programme (Harlow Healthcare, South Shields, UK, 
www.healthforallchildren.com) (Cole, 1995) updated with the WHO growth 
charts (WHO, 2006).    This is a “conditional reference” and allows for 
regression to the mean effects (Cole, 1995).  This is referred to as “weight 
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gain SDS”.  Conditional values for growth were used as continuous variables 
in all analyses involving growth unless otherwise stated. 
 
2.5.4 Adjustment of adiposity data using indices 
Measures of regional or total adiposity are difficult to interpret in growing 
populations.  To facilitate comparison, indices adjusting adiposity for another 
measure have been proposed.  These aim to minimise correlation between 
the index and the factor adjusted for (the denominator), and commonly used 
indices have been statistically examined for gross measures such as fat mass 
(Wells and Cole, 2002) but not for adjustment of adipose tissue 
compartments.   
 
To determine optimum indices adjusting regional adipose tissue volume for 
body size and better describing the metabolic effects of adiposity, log-log 
regression analyses were performed.  The index to be examined can be 
summarised in the form: 
ABIp = A/Bp 
Where ABIp is the index raised to the power p, A is the adipose tissue depot 
and B is the measure to be adjusted for.  To determine the value of p to which 
B should be raised so that there is minimal correlation between ABIp and B, A 
and B were log-transformed using a natural log to the base e, LogA was 
regressed against LogB and the regression coefficient calculated.  In each 
index the value p was the regression coefficient (Wells and Cole, 2002). 
 
To examine the degree to which the index is able to minimise the correlation 
between the index (ABIp) and the denominator (B) the percentage of variation 
in the index that is attributable to the denominator was calculated (Wells and 
Cole, 2002).   The correlation between ABIsp and B was calculated and the 
correlation coefficient r was used to calculate the percentage of variation in 
ABIsp that is attributable to B using the following equation: 
 
% variation =  !!! !! !!!!!"" 
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2.5.5 Calculation of adipose tissue mass 
Magnetic resonance imaging measures volume, therefore calculation of mass 
requires conversion.  To calculate mass of fat present in adipose tissue 
requires knowledge of both the density of adipose tissue and of the proportion 
of adipose tissue comprised by fat.  While adipose tissue density is widely 
reported as 0.90 kg/litre (Ross et al., 1991, Martin et al., 1994), the proportion 
of adipose tissue comprised by lipid is poorly defined.  It is highly variable 
even within adults (Martin et al., 1994) and changes over rapidly and 
significantly during infancy (Dju et al., 1958) from 0.355 in the first 7 days 
following birth increasing to 0.429 between 1-8 months (Dju et al., 1958).  
Thus conversion of volume into mass requires a series of assumptions, with 
each assumption potentially introducing inaccuracy.  For these reasons 
adipose tissue mass and percentage adipose tissue mass were only 
calculated to allow comparison with other studies.  Where required the 
following equation was used: 
 
Fat mass = ((AT volume, l) х 0.90 х 0.429)/(mass, kg) 
 
2.5.6 Assessment of variability 
Variability was expressed using Bland-Altman plots (Bland and Altman, 1986) 
(the mean difference between each of the two readings plotted against the 
corresponding mean for each participant).  If there was no obvious 
relationship between the difference and the mean, calculation of the mean 
difference and limits of agreement (+/- 1.96 standard deviations) was 
performed (Bland and Altman, 1986). 
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2.6 Multivariate data analysis methods 
NMR spectroscopy determines the global metabolite profile of the biofluid 
examined (breast milk).  Each individual sample produces a spectrum made 
up of up to 22,000 data points (although multiple data points correspond to 
individual metabolites).  Analysing such large data sets is facilitated through 
the use of multivariate analysis methods including principal component 
analysis (PCA), partial least squares projections to latent structures (PLS) and 
the related method orthogonal partial least squares discriminant analysis 
(OPLS-DA). 
 
Initial examination of a dataset is undertaken using an overview of the 
information contained represented using PCA, which represents multivariate 
data as a low dimension plane.  This data visualisation method is useful for 
observing groupings within multivariate data. Data are represented in n-
dimensional space, where n, the number of variables, is transformed into a 
few principal components, which describe the maximum variation within the 
data. The transformation is defined in such a way that the first principal 
component has the largest possible variance (it accounts for as much of the 
variability in the data as possible), and each succeeding component in turn 
has the highest variance possible under the constraint that it be orthogonal to 
(uncorrelated with) the preceding components.  It can be thought of as 
revealing the internal structure of data in a way that best explains the variance 
in the data; PCA data are presented as scores plots and loadings plots.  
Scores plots display the principal components in a graphical fashion.  
Coefficients by which the original variables must be multiplied to obtain the 
principal components are called the loadings.  The numerical value of a 
loading of a given variable on a principal component shows how much the 
variable has in common with that component.  
 
Whereas unsupervised analysis (PCA) will identify components that best 
explain the variance in the data, these may not relate to the variable of 
interest, for example if gender explains a greater proportion of the variance 
than postnatal age the importance of postnatal age may not be discernable 
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from PCA plots.  Supervised analysis is therefore undertaken through the 
partial least square-discriminant analysis (PLS-DA), and orthogonal projection 
to latent structure discriminant analysis (OPLS-DA) (Cloarec et al., 2005).  
These techniques optimally model class differences to systematically identify 
metabolites contributing to the differences between prespecified groups (for 
example between different postnatal ages).  Data are similarly presented as 
scores and loadings plots. Model performance is evaluated using the 
correlation coefficient R2 (goodness to fit) and the crossvalidated correlation 
coefficient Q2 (goodness of prediction), both of which range between 0 and 1.  
R2 provides an indication of how much of the variation within a data set can 
be explained by the various components of the model, while Q2 indicates how 
accurately the data can be predicted. Typically a robust model has R2>0.50 
and Q2>0.40, and Q2>0.90 is regarded as excellent predictive ability. 
 
Identification of major metabolic perturbations within the pattern recognition 
models, PCA, PLS-DA and O-PLS-DA was achieved by analysis of 
corresponding loadings plots in Simca P+ (version 12, Umetrics AB, Sweden). 
Loadings plots were used to identify metabolites driving the difference 
between groups on the basis of frequency in ppm and peak shape by 
reference to spectral databases and libraries.   
 
2.6.1 Accounting for multiple testing 
Multiple testing increases the risk of false discoveries.  To reduce the risk of 
false discoveries (or type II error) when examining the relationship between 
adipose tissue distribution and variables such as infant feeding I have defined 
a-priori a limited the number of adipose tissue ratios.  Metabolic profiling of 
breast milk using proton NMR produces a global metabolite profile consisting 
of over 22,000 spectral points corresponding to an unknown number of 
compounds.  Examining highly multivariable data such as this in relation to 
physiological variables such as adiposity also requires accounting for multiple 
testing. 
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Traditional techniques to account for multiple testing attempt to maintain the 
desired probability that a study produces one or more false discoveries by 
controlling the family wise error rate.  The simplest technique involves a 
Bonferroni correction of the threshold p-value to account for the number of 
tests: the corrected p-value equals the desired probability of producing one or 
more false discoveries (commonly 0.05) divided by the number of tests 
carried out.  When applied to NMR spectra with 22,900 spectral points this 
corresponds to an adjusted threshold p-value of 0.05/22,900 or 2.2×10-6.  This 
approach may however be too conservative as it treats each spectral point as 
an independent metabolite when multiple spectral points make up a single 
metabolite signal, increasing the risk of incorrect retention of the null 
hypothesis (or type I error).  Thus rather than controlling the probability that a 
study produces one or more false discoveries, it may be better to ensure that 
the same ratio of false discoveries to reported discoveries, the marginal false 
discovery rate (FDR).  This can be interpreted as the probability that a 
randomly selected discovery is false.   
 
For analysis of NMR spectral data both Bonferroni p-value threshold 
adjustment and FDR (set at 0.1) will be applied, the latter calculated using 
Benjamini and Hochberg’s FDR (Benjamini and Hochberg, 1986). 
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Chapter 3 
The association between infant feeding and body composition: a 
systematic review and meta-analysis 
 
 
3.1 Introduction 
One mechanism by which infant feeding might influence later life metabolism 
is through altered adiposity. Changes in adult adiposity, such as raised BMI 
(Juonala et al., 2011, Whitaker et al., 1997) and increased fat mass (Sayer et 
al., 2004), are known to track from childhood.  It is plausible that changes 
arising even earlier, in infancy, persist in a similar manner. To test this 
hypothesis I will examine whether method of feeding is linked with altered 
infant body composition, and if any changes persist after weaning.  
 
Growth patterns differ between breast-fed and formula-fed infants (Dewey, 
1998, Dewey et al., 1995).  Attempts to measure the association between 
infant feeding and body composition have been limited by the variety of 
techniques used and small sample sizes, with individual studies reporting 
conflicting results with respect to both the direction and magnitude of effect 
(Butte et al., 2000b, de Bruin et al., 1998, Motil et al., 1997).  Body 
composition changes rapidly and non-linearly over the first year (Butte et al., 
2000a) complicating comparisons between studies where body composition 
has been measured at different ages.  
 
To determine the association between method of feeding and body 
composition in infancy I will undertake a systematic review and meta-analysis 
of longitudinal and cross-sectional studies examining body composition in-
vivo, in relation to breast and formula feeding.    
 
3.1.1 Hypothesis 
I will test the null hypothesis that there is no association between method of 
feeding in infancy (breastfeeding or formula feeding) and body composition 
between birth and 12 months.   
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3.2 Methods  
3.2.1 Literature search 
A systematic review of published studies reporting outcomes of healthy, term 
(37-42 weeks gestation) infants (0-12 months age) was undertaken in 
accordance with PRISMA guidelines (Moher et al., 2009). The outcomes 
studied were FM (kg), FFM (kg) and percentage fat-mass.  I included studies 
employing a body composition model comprising at least two components, 
where determination of at least one component was undertaken using one of 
the following in-vivo techniques: TBK, TOBEC, isotope dilution, ADP, DXA, 
MRI, or CT.  Studies in which body composition was derived through 
measurement of skin fold thickness were excluded because of the poor ability 
of this technique to predict body composition in infancy (de Bruin et al., 
1995a, Davies and Lucas, 1990).  Types of exposure were breastfeeding 
(exclusive or predominant) and formula feeding (exclusive or predominant) as 
defined in each study.  No limit was applied with respect to duration of feeding 
method in either group.  For inclusion, formula should have been a standard 
commercial cow’s milk based product and comparison of breast and formula-
fed groups must have occurred at the same time points with at least one 
measure of body composition performed in the first postnatal year.   
 
A search was conducted as outlined in 2.1.1 for studies published before 24th 
March 2011 using the following Medline MeSH terms, limited to human 
studies: ((Breast feeding) OR (infant formula) OR (infant nutritional 
physiological phenomena)) AND ((body composition) OR (bioelectrical 
impedance) OR (total body electrical conductivity) OR (air displacement 
plethysmography) OR (absorptiometry, photon) OR (total body potassium) OR 
(magnetic resonance imaging) OR (tomography, X-ray computed) OR 
(isotope dilution)). 
 
3.2.2 Data extraction 
The literature search was carried out as specified in section 2.1.2, and data 
on study design, location, population, exposure classification, body 
composition measurement technique, outcome and potential sources of bias 
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were extracted from selected studies. Study quality was assessed in relation 
to the following study level biases: blinding to feeding group by investigators 
measuring outcomes, definition of feeding groups (in particular extent of 
contamination bias arising from formula feeding in the breast-fed group), and 
method of assessment of feeding status (prospective or retrospective).  In 
studies where body composition data were not presented in a form suitable 
for meta-analysis, efforts were made to contact the authors to provide mean 
and standard deviation for fat/adipose tissue mass, fat-free mass and 
percentage fat-mass by feeding group.  If no response to two requests was 
received or if the author was unable to provide additional data the study was 
excluded from the meta-analyses. Where only gender specific values were 
presented these were pooled using standard formulae for combining mean 
and standard deviation data (Borenstein et al., 2009). 
 
3.2.3 Analysis 
A meta-analysis was carried out of studies reporting differences in outcomes 
(fat mass, fat-free mass, percentage fat-mass) between formula-fed and 
breast-fed groups at the following time points: 1-2 months, 3-4 months 
(representing the pre-weaning period), 6 months (weaning), 8-9 months and 
12 months (representing the post-weaning period) as specified in 2.1.2.  The 
mean difference (95% confidence interval) between outcomes, in the formula-
fed group in comparison to the breast-fed group, was calculated at each 
postnatal age point.  Where a study examined the same population at two 
postnatal ages and both ages fell within one pre-defined point, therefore 
rendering both ages eligible for inclusion (for example where data was 
collected at 3 and 4 months), data from the later age was included in the 
meta-analysis.  Choice of the later age was specified a priori and was chosen 
on the assumption that the magnitude of differences would be greater with 
increasing duration of feeding.  Where data were obtained from one 
population at the same postnatal age using two alternate methods, the 
method with the smallest standard deviation was included in the subsequent 
meta-analysis. To examine the robustness of these assumptions, analyses 
were repeated using the alternate values to determine whether this led to a 
different conclusion. 
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Sub-group analyses were planned of studies performed using the same body 
composition technique, where three or more studies reported results at 
comparable postnatal ages, and of gender specific values.  Sub-group 
analysis of results by gender may be subject to selection bias, as studies may 
only report results by gender if a difference is observed.  Therefore sub-group 
analysis by gender was only carried out if meta-regression showed gender 
differences to be significant and if data were available for the majority of 
studies at the relevant time point. 
 
3.3 Results  
3.3.1 Literature search 
The literature search is outlined in figure 3.1.  The search strategy identified 
702 publications; a further eight articles were located following bibliographic 
review of retrieved papers (Anderson, 2009, Bellu, 1997, Carberry et al., 
2010, Hager et al., 1977, Modi et al., 2006, Oakley, 1977, Olhager and 
Forsum, 2003, Jiang et al., 1998).  One paper was unavailable (in full or 
abstract form) for review (Tlaskal et al., 1987).  Following screening of 
abstracts, 35 were reviewed in full text to assess eligibility. Twenty studies 
were excluded following full text review for the following reasons: breast-fed 
infants included only with no comparative formula-fed group (Roggero et al., 
2010), body composition determined using skin fold thickness only (Buyken et 
al., 2008, Karaolis-Danckert et al., 2007, Dewey et al., 1993, Harrison et al., 
1987, Savino et al., 2002, Oakley, 1977), review articles (Wells, 2007a, Ellis, 
2007, Rigo, 2006, Ziegler, 2006, Dewey, 1998), feeding method not provided 
(Ellis et al., 2007, Olhager and Forsum, 2003, de Bruin et al., 1995b, Hager et 
al., 1977), adiposity data not provided (Savino et al., 2004, Rutledge et al., 
1976, Kasa and Heinonen, 1993), and study cohorts (Wells et al., 1998) which 
were part of a larger, included, cohort (Chomtho et al., 2009).  
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Figure 3.1: Flow chart of the search strategy used in this review, set out 
according to the PRISMA statement. The relevant number of papers at each point 
is provided. (BF: breast-fed, FF: formula-fed, SFT: skin fold thickness). 
Records after 
duplicates removed
n = 710
Records screened
n =710
Full-text articles 
excluded: 20
n = 1: BF only (no FF)
n = 6: SFT only
n = 5: review 
n = 4: no record of 
feeding method
n = 3: outcomes not 
recorded
n = 1: included in larger 
cohort
Full-text articles 
assessed for eligibility
n = 35
Abstracts excluded                  
n = 674
Studies included in 
qualitative synthesis
n =15
Studies included in 
quantitative synthesis (meta-
analysis)
n = 11
Records identified through 
database searching
n = 702
Additional records identified 
through other sources
n = 8
Papers unavailable                  
n = 1
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3.3.2 Identified studies  
Fifteen studies remained for inclusion in the systematic review (Eriksson et 
al., 2010, Ay et al., 2009, Chomtho et al., 2009, Ng et al., 2004b, De Curtis et 
al., 2001, Butte et al., 2000b, de Bruin et al., 1998, Motil et al., 1997, Butte et 
al., 1995, Shepherd et al., 1988, Anderson, 2009, Carberry et al., 2010, Modi 
et al., 2006, Bellu, 1997, Jiang et al., 1998) (table 3.1).  For the meta-analysis 
attempts were made to contact authors of seven studies for additional data 
(Anderson, 2009, Ay et al., 2009, Butte et al., 2000b, Chomtho et al., 2009, 
De Curtis et al., 2001, Eriksson et al., 2010, Shepherd et al., 1988), five 
replied (Anderson, 2009, Butte et al., 2000b, Chomtho et al., 2009, Eriksson 
et al., 2010, Shepherd et al., 1988) with one author unable to provide data 
(Shepherd et al., 1988).   
 
There was considerable heterogeneity with respect to study design.  The 
majority of studies employed a longitudinal design although three studies 
were cross-sectional (Bellu, 1997, Butte et al., 1995, Chomtho et al., 2009).  A 
wide range of techniques were used to measure body composition (TBK 
(Shepherd et al., 1988), isotope dilution (Butte et al., 1995, Chomtho et al., 
2009, Motil et al., 1997, Ng et al., 2004b, Jiang et al., 1998), TOBEC (Bellu, 
1997, Butte et al., 1995, de Bruin et al., 1998), DXA (Ay et al., 2009, De Curtis 
et al., 2001), MRI (Modi et al., 2006), ADP (Anderson, 2009, Carberry et al., 
2010, Eriksson et al., 2010) and a multicomponent technique incorporating 
isotope dilution, TBK and DXA (Butte et al., 2000b)).  No studies were found 
which assessed body composition in infancy using CT.  Measurements were 
performed at a range of time points during the first year (table 3.1).   
 
With respect to study quality, no study reported whether investigators blinded 
to feeding group performed body composition measurements.  Feeding 
method was defined prospectively in all studies except one (Bellu, 1997), 
although the definitions used for the feeding groups varied amongst studies 
(table 3.1).  Derivation of fat-mass in all studies was performed using 
reference standards from infant populations.  Eight of the 15 included studies 
derived fat-mass using age-specific values for hydration and density of fat-
free mass (Fomon et al., 1982). 
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Study Population and study detail, how recruited  Body composition technique(s) used, compartment 
measured, model used, reference used for adjustment, 
blinding. 
Study 
groups 
Age at body 
composition 
measurement 
Breastfeeding definition, prospective or retrospective data, 
type of formula 
(Shepher
d et al., 
1988) 
LS; 38-42 weeks, healthy, excluded: diabetes, 
medications, small for dates (not defined).  107 
recruited, 25 dropped out.  Growth between 
10th and 90th centile for both groups. 
Authors unable to provide additional data 
TBK, 4 compartment model: Body mass = FM + FFM 
(FFES + BCM +ECW)  
FFES + BCM calculated from (Hager et al., 1977, Pierson 
et al., 1974), using age specific values, blinding not stated. 
ECW derived from normogram (Friis-Hansen, 1961). 
BF 34 
FF 48 
10 days 
3 months 
Feeding groups pre-defined. 
FF: Exclusively fed whey predominant formula (NAN – Nestle), 
except for water supplementation, for entirety of study. 
BF: Exclusive, except for water supplementation, for entirety of 
study. 
(Butte et 
al., 1995) 
CSS; 20 term, healthy babies examined at 1 
month, and 20 term, healthy babies examined 
at 4 months. Texas, USA. 
Infants examined using two techniques at the same time 
point.  
Doubly labeled water dilution: 2 compartment model. 
TOBEC: 2 compartment model. 
Calculations using density measurements from Fomon 
(Fomon et al., 1982), using age specific values.  Blinding 
not stated. Calculation of FFM from (Cochran et al., 1986). 
BF 10 
FF 10 
1 month Feeding determined prospectively. 
FF: Exclusive Enfamil or Similac. At 4 months six FF infants 
received supplemental foods, providing 8±11% of energy. 
BF: Exclusive. No BF infants received supplemental foods during 
study. 
BF 10 
FF 10 
4 months 
(Bellu, 
1997) 
CSS; 79 healthy, AGA, term infants, measured 
at 12 months age.  Single hospital, Milan, Italy.  
Restricted to 1st or 2nd child, maternal age 20-
30, maternal pre-gravid weight 80-100% of 
ideal, maternal education: high school diploma 
or greater. 
TOBEC. 2 compartment model. Calculation of FFM from 
(Cochran et al., 1986),  using age specific values, blinding 
not stated. 
BF 26 
FF 53 
12 months Feeding determined by retrospective interview.  BF: Exclusively BF 
until 6 month (weaning allowed >5 months), FF: BF for less than 2 
months. 
Age of introduction of solids not significantly different between BF 
and FF groups. Cow’s milk introduced later in BF (9.5 months) vs 
FF group (7.7 months) 
(Motil et 
al., 1997) 
LS; 20 healthy, term babies. Texas, USA. H2
18O dilution. 2 compartment model. Calculations using 
density measurements from Fomon (Fomon et al., 1982), 
using age specific values.  Blinding not stated. 
BF 10 
FF 10 
6 weeks 
3 months 
18 weeks 
6 months 
Feeding groups pre-defined.   BF assessed prospectively. 
BF: Exclusive until 6 months, except in 2 infants who received 
formula after 18 weeks.   
FF: Exclusively FF (variety of  formula feeds used) 
(de Bruin 
et al., 
1998) 
LS; healthy, birthweight >2500g, white, non-
smoking vaginally delivered infants, recruited 
through community midwives, Rotterdam, 
Netherlands.  92 infants recruited, 46 
excluded. 
TOBEC, 2 compartment model: Calculation of FFM from 
(de Bruin et al., 1995b), using age specific values. Blinding 
not stated. 
BF 23 
FF 23 
1 month 
2 months 
4 months 
8 months 
12 months 
Feeding groups pre-defined.  Breastfeeding assessed 
prospectively.  BF: exclusively BF at 1 and 2 months.  7/24 BF and 
6/23 FF infants supplemented at 4 months (fruit/vegetables etc), 
only 1 infant supplemented >10% of intake (24%).  At 8 months 5 
BF still received some BM.  At 12 months no infant received BM. All 
formula came from a single batch (Nutrilon Premium) 
(Jiang et 
al., 1998) 
CSS; healthy full term infants, Xinhui, 
Guangdong Province, China. 
Deuterium dilution. 2 compartment model, age specific 
hydration factors for FFM used from Fomon (Fomon et al., 
1982) adjusted for infancy=Y. Blinding not stated. 
BF 11 
FF 11 
4 months BF: at 4 months no weaning foods or energy containing foods 
provided; at 6 months some weaning but BF still defined as high. 
FF: at 6 months some weaning such that <30% of energy provided 
by FF. BF 9 
FF10 
6 months 
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Study Population and study detail, how recruited  Body composition technique(s) used, compartment 
measured, model used, adjusted for infancy Y/N, 
reference used for adjustment, blinded assessment 
Y/N 
Study 
groups 
Age at body 
composition 
measurement 
Breastfeeding definition, prospective or retrospective data, 
type of formula 
(Butte et 
al., 
2000b) 
LS; 76 healthy, term infants, non-smoking, 
single city, Texas, USA. 
Additional data obtained from authors. 
Multicomponent model: 
TBM=FFM(TBW + protein + glycogen + BMC + non-
osseous material)+FM 
TOBEC-FFM; Deuterium dilution-TBW; TBK-protein; DXA-
BMC 
Calculations using density measurements from Fomon 
(Fomon et al., 1982), using age specific values . Blinding 
not stated. 
BF 40 
FF 36 
0.5 months 
3 months 
6 months 
9 months 
12 months 
Feeding groups pre-defined. 
BF: Exclusively BF for 4 months in all but 4 cases (weaned 
approximately 100 days).  100%, 80%, 58%, 38% of BF group still 
breast feeding at 3, 6, 9, 12 months respectively.  0%, 40%, 48%, 
30% of BF group given formula by 3, 6, 9, 12 months respectively. 
FF: Exclusively FF, 9/36 given small amounts of cereal/fruit before 
4 months.  
(De Curtis 
et al., 
2001) 
LS; 27 healthy, term, AGA babies (not 
defined). Liege, Belgium. 
DXA, 3 compartment model used (FM, FFM, bone mass), 
using age specific values (Rigo et al., 1998). 
Blinding not stated 
13 BF 
14 FF 
Birth 
2 months 
BF: Exclusively BF 
FF: Exclusively fed formula (69kcal energy, 1.4g protein, 3.7g fat, 
7.5g lactose per dl).   
(Ng et al., 
2004b) 
LS; term babies, Singapore. Deuterium dilution, 2 compartment model, age specific 
hydration factors for FFM used (not referenced), blinding 
not stated. 
BF 63 
FF 37 
3 months 
6 months 
12 months 
BF: exclusively BF up to 2 months, FF predominantly or exclusively 
FF.  Solids introduced significantly later in BF vs FF.  BF 
assessment not stated. 
(Modi et 
al., 2006) 
LS; healthy, term, AGA.  Single hospital, 
London, UK. Adjusted data presented in 
paper.  
Additional unadjusted data obtained from 
authors. 
Whole body MRI. 2 component model. AT volume 
measured and converted to fat mass (AT mass in kg = AT 
in litres x 0.9, fat mass in kg = AT mass in kg x 0.45), using 
age specific values. Blinding not stated. 
BF 9 
FF 6 
6 weeks BF: Exclusively BF 
FF: Exclusively FF 
(Chomtho 
et al., 
2009) 
CSS; healthy, term.  Single city, Cambridge, 
UK. 
Additional data obtained from authors 
Deuterium dilution. 2 compartment model, 
age specific hydration factors for FFM used from Fomon 
(Fomon et al., 1982), using age specific values. Blinding 
not stated. 
BF 41 
FF 83 
12 weeks Combination of three cohorts, 1989-1994. 
BF predominantly BF 
(Anderson 
et al., 
2009) 
LS; healthy term, >2500g birthweight babies, 
single unit, Georgia, USA. 
Additional data obtained from authors 
ADP. 2 compartment model. Calculations using density 
measurements from Fomon (Fomon et al., 1982), using 
age specific values, Blinding not stated. 
BF 27 
FF 13 
2 weeks 
4 weeks 
8 weeks 
12 weeks 
Breastfeeding assessed prospectively. 
BF: Exclusively BF up to 12 weeks. 
FF: Received mixed feeds: All commenced on formula on day 1, 
10-100% of feeds non-breastmilk across study period. 
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Table 3.1: Details of studies included in systematic review 
Study Population and study detail, how recruited  Body composition technique(s) used, compartment 
measured, model used, adjusted for infancy Y/N, 
reference used for adjustment, blinded assessment 
Y/N 
Study 
groups 
Age at body 
composition 
measurement 
Breastfeeding definition, prospective or retrospective data, 
type of formula 
(Ay et al., 
2009) 
LS; 298 infants randomly selected from the 
Generation R study (prospective cohort of 
1232 Dutch mother infant pairs representative 
of local population), 252/298 measured at 6 
months.  Dutch ethnicity only. 
DXA. 2 compartment model, Blinding not stated. 
Calculations performed using age specific values (Koo, 
2000). 
252 
infants 
6 months BF data collected prospectively at 2 and 6 months age.  BF defined 
as any breastfeeding at 2 or 6 months. 
(Carberry 
et al., 
2010) 
LS; 77 healthy, term infants, not SGA (>10th 
centile), maternal BMI 18.5-25.  69% follow up 
by 4.5 months. Single hospital, Australia. 
ADP. 2 compartment model. Calculations using density 
measurements from Fomon (Fomon et al., 1982), using 
age specific values.  Blinding not stated. 
30 BF 
20 FF 
Birth 
4.5 months 
BF assessed prospectively. 
BF: Exclusively or predominantly breastfed at 4.5 months. 
(Eriksson 
et al., 
2010) 
LS; healthy, term, singleton babies.  Single 
city, Sweden. 
Additional data obtained from authors 
ADP.  2 compartment model. Calculations using density 
measurements from Fomon (Fomon et al., 1982), using 
age specific values.  Blinding not stated. 
BF 92 
FF 3 
10 days BF assessed prospectively. 
BF: Exclusive BF. 
22% of women had pre-pregnancy BMI 25-29.9, 5% >30.  5% 
smoked during pregnancy.   
BF 85 
FF 7 
12 weeks 
LS: longitudinal study, CSS: cross-sectional study, BF: breast-fed, FF: formula-fed, %FM: percentage fat-mass, FFES: fat-free extracellular solid, BCM: body cell mass, ECW: extracellular water, FFM: fat-free mass, FM: fat-
mass, TBF: total body fat, AT: adipose tissue, TBM: total body mass, TBW: total body water, BMC: bone mineral content, TBK: total body potassium determination, TOBEC: total body electrical conductivity,  ADP:  air 
displacement plethysmography,  DXA: dual X-ray energy absorptiometry, MRI: magnetic resonance imaging 
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3.3.3 Individual study data 
Individual study values for fat mass, fat-free mass and percentage fat-mass, 
by feeding group, are shown in table 3.2.  For studies measuring outcomes at 
time points at and beyond 6 months, feeding in the “breast-fed” groups refers 
to formerly breastfed infants rather than currently breastfed infants (after 
weaning, at approximately 6 months in included studies, diet was no longer 
predominantly breast milk in the “breast-fed” group, details in table 3.1).  
 
 
Table 3.2 (subsequent pages): Body composition data from individual studies 
included in the systematic review. BF: breastfed, FF: formula fed 
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Study Study groups Age 
Fat-mass (kg) Fat-free mass (kg) % fat-mass 
BF FF BF FF BF FF 
(Sheph
erd et 
al., 
1988) 
BF 34 (16 boys), 
FF 48 (20 boys) 10 days 
3 months 
Author contacted – no further data available Boys Girls Boys Girls 
11 
29 
8 
35 
9 
31 
8 
31 
10 days 
3 months 
Pooled Pooled 
9.4 
32.2 
8.4 
31 
(Butte 
et al., 
1995) 
Dilution: 
BF 8, FF 10 
TOBEC: 
BF9, FF 10 
Dilution: 
1 month 
TOBEC: 
1 month 
0.70 (0.28) 
0.81 (0.30) 
0.79 (0.09) 
0.89 (0.18) 
3.86 (0.52) 
3.71 (0.44) 
3.76 (0.24) 
3.67 (0.17) 
15.1 (4.4) 
17.6 (4.7) 
17.4 (1.8) 
19.4 (3.3) 
Dilution: 
BF10, FF 10 
TOBEC: 
BF10, FF 10 
Dilution: 
4 months 
TOBEC: 
4 months 
1.97 (0.40) 
1.94 (0.36) 
1.70 (0.55) 
1.67 (0.38) 
4.55 (0.47) 
4.58 (0.41) 
4.74 (0.427) 
4.78 (0.34) 
30.1 (4.4) 
29.6 (3.4) 
26.1 (6.5) 
25.6 (4.1) 
(Bellu, 
1997) 
BF 26 
FF 53 
12 months 2.18 (0.47) 2.76 (0.39) 6.99 (0.62) 7.38 (0.59) 23.76 (3.06) 27.09 (2.80) 
(Motil et 
al., 
1997) 
BF 10 (7 boys) 
recruited, 7 
measured. 
FF 10 (2 boys) 
recruited, 9 
measured. 
6 weeks 
3 months 
18 weeks 
6 months 
1.13 (0.32) 
1.66 (0.51) 
2.02 (0.58) 
2.11 (0.55) 
0.97 (0.35) 
1.58 (0.34) 
1.99 (0.49) 
2.27 (0.47) 
4.04 (0.4) 
4.66 (0.64) 
5.09 (0.43) 
5.78 (0.63) 
3.78 (0.36) 
4.27 (0.54) 
4.83 (0.5) 
5.35 (0.67) 
22 (4) 
26 (6) 
28 (5) 
26 (5) 
20 (6) 
27 (6) 
29 (6) 
30 (6) 
(de 
Bruin et 
al., 
1998) 
BF 23 (9 boys) 
FF 23 (15 boys) 1 month 
2 months 
4 months 
8 months 
12 months 
Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls 
0.70 (0.20) 
1.17 (0.40) 
1.71 (0.51) 
2.35 (0.42) 
2.71 (0.31) 
0.61 (0.20) 
0.95 (0.24) 
1.49 (0.28) 
2.02 (0.32) 
2.30 (0.34) 
0.68 (0.24) 
1.05 (0.28) 
1.65 (0.42) 
2.21 (0.48) 
2.45 (0.73) 
0.60 (0.11) 
1.03 (0.15) 
1.80 (0.14) 
2.33 (0.31) 
2.62 (0.46) 
3.87 (0.40) 
4.38 (0.41) 
5.08 (0.46) 
6.43 (0.52) 
7.46 (0.60) 
3.51 (0.42) 
3.95 (0.47) 
4.43 (0.48) 
5.86 (0.37) 
6.92 (0.44) 
3.91 (0.36) 
4.43 (0.39) 
5.13 (0.39) 
6.43 (0.47) 
7.79 (0.64) 
3.63 (0.34) 
4.04 (0.36) 
4.83 (0.42) 
6.23 (0.53) 
7.14 (0.55) 
15.2 (3.1) 
20.6 (5.0) 
24.7 (5.6) 
26.7 (3.3) 
26.6 (1.9) 
14.4 (3.8) 
19.1 (3.2) 
25.0 (2.5) 
25.5 (3.2) 
24.9 (3.0) 
14.6 (4.2) 
18.9 (3.3) 
24.1 (3.7) 
25.4 (3.7) 
23.7 (5.4) 
14.2 (2.2) 
20.4 (2.9) 
27.2 (1.9) 
27.3 (3.4) 
26.7 (3.6) 
1 month 
2 months 
4 months 
8 months 
12 months 
Pooled Pooled Pooled Pooled Pooled Pooled 
0.65 (0.20) 
1.04 (0.31) 
1.58 (0.38) 
2.15 (0.36) 
2.46 (0.33) 
0.65 (0.21) 
1.04 (0.24) 
1.70 (0.35) 
2.25 (0.43) 
2.51 (0.65) 
3.65 (0.41) 
4.12 (0.45) 
4.68 (0.47) 
6.08 (0.43) 
7.13 (0.51) 
3.81 (0.35) 
4.29 (0.38) 
5.03 (0.40) 
6.36 (0.49) 
7.56 (0.61) 
14.7 (3.6) 
19.7 (4.0) 
24.9 (4.0) 
26.0 (3.2) 
25.6 (2.6) 
14.5 (3.7) 
19.4 (3.2) 
25.2 (3.2) 
26.1 (3.6) 
24.7 (4.9) 
Jiang et al., 
1998) 
BF 11 (4 boys) 
FF 11 (7 boys) 
4 months 2.014 (0.498) 1.504 (0.364) 4.948 (0.511) 5.065 (0.820) 28.6 (4.0) 23.0 (5.0) 
BF 9 (4 boys) 
FF10 (6 boys) 
6 months 1.907 (0.398) 1.827 (0.687) 5.297 (0.561) 5.854 (0.385) 26.4 (4.2) 23.4 (6.8) 
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Study Study groups Age 
Fat-mass (kg) Fat-free mass (kg) % fat-mass 
BF FF BF FF BF FF 
(Butte et al., 
2000b) 
BF 40 
(14 boys) 
FF 36 
(19 boys) 
0.5 months 
3 months 
6 months 
9 months 
12 months 
Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls Boys Girls 
0.51 (0.38) 
2.03 (0.37) 
2.56 (0.45) 
2.54 (0.59) 
2.59 (0.61) 
0.40 (0.23) 
1.95 (0.43) 
2.44 (0.44) 
2.34 (0.40) 
2.45 (0.49) 
0.35 (0.21) 
1.77 (0.37) 
2.04 (0.41) 
2.02 (0.49) 
2.53 (0.64) 
0.52 (0.21) 
1.82 (0.38) 
2.47 (0.32) 
2.78 (0.46) 
2.91 (0.45) 
3.40 (0.41) 
4.34 (0.35) 
5.63 (0.51) 
6.54 (0.55) 
7.55 (0.78) 
3.25 (0.32) 
4.05 (0.53) 
5.09 (0.47) 
6.08 (0.63) 
6.78 (0.72) 
3.38 (0.33) 
4.41 (0.52) 
5.62 (0.72) 
6.82 (0.76) 
7.19 (0.67) 
3.17 (0.35) 
4.22 (0.37) 
5.42 (0.71) 
6.23 (0.75) 
7.07 (0.65) 
12.76 (8.8) 
31.73 (3.5) 
31.14 (3.9) 
27.75 (4.8) 
25.38 (3.8) 
10.51 (4.9) 
32.49 (6.2) 
32.31 (4.4) 
27.82 (4.6) 
26.55 (4.7) 
9.09 (4.9) 
28.46 (3.8) 
26.62 (4.6) 
22.79 (4.4) 
25.82 (4.4) 
13.97 (5.3) 
29.98 (4.3) 
31.46 (4.4) 
30.9 (5.3) 
29.11 (3.7) 
0.5 months 
3 months 
6 months 
9 months 
12 months 
Pooled Pooled Pooled Pooled Pooled Pooled 
0.437 (0.287) 
1.982 (0.412) 
2.479 (0.440) 
2.409 (0.474) 
2.502 (0.532) 
0.433 (0.210) 
1.795 (0.375) 
2.246 (0.373) 
2.379 (0.475) 
2.708 (0.559) 
3.303 (0.356) 
4.152 (0.477) 
5.276 (0.484) 
6.241 (0.605) 
7.052 (0.736) 
3.277 (0.338) 
4.321 (0.456) 
5.529 (0.716) 
6.539 (0.754) 
7.132 (0.660) 
11.30 (6.51) 
32.22 (5.43) 
31.90 (4.26) 
27.80 (4.67) 
26.14 (4.43) 
11.39 (5.10) 
29.18 (4.07) 
28.91 (4.50) 
26.62 (4.82) 
27.37 (4.09) 
(De Curtis 
et al., 2001) 
13 BF 
14 FF 
Birth 
2 months 
15.2 
24.1 
16.1 
26.7 
(Ng et al., 
2004b) 
BF 63 
FF 37 
3 months 
6 months 
12 months 
22 (6.5) 
22.8 (7.4) 
18.4 (2.9) 
22.7 (5.8) 
22.2 (5.2) 
19.1 (2.9) 
(Modi et al., 
2006) 
BF 9 
FF 6 
6 weeks 0.605 (0.109) 0.652 (0.113) 4.171 (0.418) 4.257 (0.451) 12.61 (1.38) 13.23 (1.30) 
(Chomtho et 
al., 2009) 
BF 41 
FF 83 
12 weeks 1.43 (0.49) 1.44 (0.45) 4.44 (0.49) 4.41 (0.47) 24.09 (6.71) 24.46 (6.36) 
(Anderson, 
2009) 
BF 27 (15 
boys) 
FF 13 (7 boys) 
2 weeks 
4 weeks 
8 weeks 
12 weeks 
12.67 (4.38) 
17.95 (5.13) 
22.41 (5.46) 
24.44 (5.87) 
12.5 (5.19) 
17.25 (4.06) 
20.99 (3.58) 
23.15 (3.83) 
(Ay et al., 
2009) 
252 infants 
(145 boys) 
6 months Breastfeeding at 6 months had a significant positive association with total percentage fat-mass and with truncal percentage fat-mass. 
No association seen for breastfeeding at 2 months. 
(Carberry et 
al., 2010) 
30 BF (15 
boys), 20 FF 
(11 boys) 
Birth 
4.5 months 
0.328 (0.155) 
1.973 (0.440) 
0.346 (0.150) 
1.845 (0.509) 
3.008 (0.317) 
5.093 (0.576) 
3.094 (0.372) 
5.390 (0.504) 
9.64 (3.94) 
27.76 (4.47) 
9.77 (3.65) 
25.2 (5.24) 
(Eriksson et 
al., 2010) 
BF 92 
FF 3 
10 days 0.487 (0.189) 0.561 (0.219) 3.153 (0.374) 3.307 (0.353) 13.02 (3.97) 14.17 (3.43) 
BF 85 
FF 7 
12 weeks 1.67 (0.4) 1.591 (0.426) 4.517 (0.418) 4.519 (0.567) 26.75 (4.50) 25.69 (4.29) 
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3.3.4 Body composition at 1-2 months 
There are no significant mean differences in fat-mass (figure 3.2A), fat-free 
mass (figure 3.2B) or percentage fat-mass (Appendix 3, figure 3A) in formula-
fed compared to breast-fed groups at 1-2 months postnatal age.  
 
Standard deviation data were unavailable in one study (De Curtis et al., 2001) 
which was excluded from the meta-analysis.  From the paper by Butte et al. 
fat-mass and percentage fat-mass data measured by isotope dilution, and fat-
free mass data measured using TOBEC, all had a narrower standard 
deviations than alternate techniques and were therefore included (Butte et al., 
1995).  Where Anderson (Anderson, 2009) and de Bruin (de Bruin et al., 
1998) reported values at 1 and 2 months, the 2 month values were included.  
Repeating analyses using alternate values for the studies by Butte (Butte et 
al., 1995), Anderson (Anderson, 2009) and de Bruin (de Bruin et al., 1998) did 
not alter the significance or direction of results. 
 
A: Fat mass 
 
B. Fat-free mass 
 
Figure 3.2: Forest plot showing differences between formula-fed and breast-fed 
infants at 1-2 months. A: differences in fat mass (kg), B: differences in fat-free 
mass (kg). SD: standard deviation, IV: inverse variance, CI: confidence intervals, 
TOBEC: total body electrical conductivity, MRI: magnetic resonance imaging. 
 
Study or Subgroup
Butte 1995 - dilution
De Bruin 1998 -TOBEC
Modi 2006 - MRI
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Chi² = 1.84, df = 3 (P = 0.61); I² = 0%
Test for overall effect: Z = 0.69 (P = 0.49)
Mean
0.79
1.04
0.652
0.97
SD
0.09
0.24
0.113
0.35
Total
10
23
6
9
48
Mean
0.7
1.04
0.605
1.13
SD
0.28
0.31
0.109
0.32
Total
8
23
9
7
47
Weight
16.6%
26.3%
50.9%
6.2%
100.0%
IV, Fixed, 95% CI
0.09 [-0.11, 0.29]
0.00 [-0.16, 0.16]
0.05 [-0.07, 0.16]
-0.16 [-0.49, 0.17]
0.03 [-0.05, 0.11]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
Study or Subgroup
Butte 1995 - TOBEC
De Bruin 1998 -TOBEC
Modi 2006 - MRI
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Chi² = 3.80, df = 3 (P = 0.28); I² = 21%
Test for overall effect: Z = 0.36 (P = 0.72)
Mean
3.67
4.29
4.257
3.78
SD
0.17
0.38
0.451
0.36
Total
10
23
6
9
48
Mean
3.71
4.12
4.171
4.04
SD
0.44
0.45
0.418
0.4
Total
8
23
9
7
47
Weight
24.8%
44.6%
12.6%
18.0%
100.0%
IV, Fixed, 95% CI
-0.04 [-0.36, 0.28]
0.17 [-0.07, 0.41]
0.09 [-0.37, 0.54]
-0.26 [-0.64, 0.12]
0.03 [-0.13, 0.19]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
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3.3.5 Body composition at 3-4 months 
Formula-fed infants have significantly lower fat-mass (figure 3.3A), 
significantly greater fat-free mass (figure 3.3B) and significantly lower 
percentage fat-mass (Appendix 3, figure 3B) when compared to breast-fed 
babies at 3-4 months age.   
Standard deviation data were unavailable from one study (Shepherd et al., 
1988) which was excluded from meta-analyses.  Data determined using 
TOBEC by Butte et al (Butte et al., 1995) had narrower standard deviations 
than data determined using dilutional techniques, therefore TOBEC data was 
included.  Repeating analyses using alternate values for the study by Butte et 
al (Butte et al., 1995) did not alter the significance, direction or magnitude of 
results.  Removing the study by Jiang et al (Jiang et al., 1998), which was 
carried out in a middle (as opposed to a high income) country, attenuated the 
magnitude of the pooled effect (mean difference [95% confidence intervals]: -
0.07 [-0.16, 0.02] p=0.14) and reduced the heterogeneity (I2 17%). 
A. Fat mass 
B. Fat-free mass 
Figure 3.3: Forest plot showing differences between formula-fed and breast-fed 
infants at 3-4 months. A: differences in fat mass (kg), B: differences in fat-free 
mass (kg). SD: standard deviation, IV: inverse variance, CI: confidence intervals, 
TOBEC: total body electrical conductivity, ADP: air displacement plethysmography. 
Study or Subgroup
Butte 1995 - TOBEC
Butte 2000 - multicomp
Carberry 2010 - ADP
Chomtho - 2009 dilution
De Bruin 1998 -TOBEC
Eriksson 2010 - ADP
Jiang 1998 - dilution
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Chi² = 12.52, df = 7 (P = 0.08); I² = 44%
Test for overall effect: Z = 2.10 (P = 0.04)
Mean
1.67
1.795
1.845
1.44
1.7
1.591
1.504
1.58
SD
0.38
0.375
0.509
0.45
0.35
0.426
0.364
0.34
Total
10
36
20
83
23
7
11
9
199
Mean
1.94
1.982
1.973
1.43
1.58
1.67
2.014
1.66
SD
0.36
0.412
0.44
0.49
0.38
0.4
0.498
0.51
Total
10
40
30
41
23
85
11
7
247
Weight
7.3%
24.4%
10.3%
24.0%
17.2%
7.2%
5.8%
4.0%
100.0%
IV, Fixed, 95% CI
-0.27 [-0.59, 0.05]
-0.19 [-0.36, -0.01]
-0.13 [-0.40, 0.15]
0.01 [-0.17, 0.19]
0.12 [-0.09, 0.33]
-0.08 [-0.41, 0.25]
-0.51 [-0.87, -0.15]
-0.08 [-0.52, 0.36]
-0.09 [-0.18, -0.01]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
Study or Subgroup
Butte 1995 - TOBEC
Butte 2000 - multicomp
Carberry 2010 - ADP
Chomtho - 2009 dilution
De Bruin 1998 -TOBEC
Eriksson 2010 - ADP
Jiang 1998 - dilution
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Chi² = 10.72, df = 7 (P = 0.15); I² = 35%
Test for overall effect: Z = 2.50 (P = 0.01)
Mean
4.78
4.321
5.39
4.41
5.03
4.519
5.065
4.27
SD
0.34
0.456
0.504
0.47
0.4
0.567
0.82
0.54
Total
10
36
20
83
23
7
11
9
199
Mean
4.58
4.152
5.093
4.44
4.68
4.517
4.948
4.66
SD
0.41
0.477
0.576
0.49
0.47
0.418
0.511
0.64
Total
10
40
30
41
23
85
11
7
247
Weight
9.1%
22.6%
10.9%
30.4%
15.6%
5.4%
3.1%
2.8%
100.0%
IV, Fixed, 95% CI
0.20 [-0.13, 0.53]
0.17 [-0.04, 0.38]
0.30 [-0.01, 0.60]
-0.03 [-0.21, 0.15]
0.35 [0.10, 0.60]
0.00 [-0.43, 0.43]
0.12 [-0.45, 0.69]
-0.39 [-0.98, 0.20]
0.13 [0.03, 0.23]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
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3.3.6 Body composition at 6 months 
Formula-fed babies have significantly lower fat-mass (figure 3.4A) and 
percentage fat-mass (Appendix 3, figure 3C) when compared to breast-fed 
babies at 6 months.  No significant differences are detected in fat-free mass 
(figure 3.4B).   
Despite attempts to contact authors, further data remained unavailable for one 
study (Ay et al., 2009), which was excluded from meta-analyses. This study 
(Ay et al., 2009) reported a significant positive association between breast 
feeding at 6 months and percentage fat-mass at 6 months, measured using 
DXA.   
A. Fat mass 
B. Fat-free mass 
Figure 3.4: Forest plot showing differences between formula-fed and breast-fed 
infants at 6 months. A: differences in fat mass (kg), B: differences in fat-free 
mass (kg). SD: standard deviation, IV: inverse variance, CI: confidence intervals. 
Study or Subgroup
Butte 2000 - multicomp
Jiang 1998 - dilution
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Chi² = 2.18, df = 2 (P = 0.34); I² = 8%
Test for overall effect: Z = 2.13 (P = 0.03)
Mean
2.246
1.827
2.27
SD
0.373
0.687
0.47
Total
36
10
9
55
Mean
2.479
1.907
2.11
SD
0.44
0.398
0.55
Total
40
9
7
56
Weight
79.2%
10.6%
10.2%
100.0%
IV, Fixed, 95% CI
-0.23 [-0.42, -0.05]
-0.08 [-0.58, 0.42]
0.16 [-0.35, 0.67]
-0.18 [-0.34, -0.01]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
Study or Subgroup
Butte 2000 - multicomp
Jiang 1998 - dilution
Motil 1997 - dilution
Total (95% CI)
Heterogeneity: Tau² = 0.10; Chi² = 6.23, df = 2 (P = 0.04); I² = 68%
Test for overall effect: Z = 0.83 (P = 0.40)
Mean
5.529
5.854
5.35
SD
0.716
0.385
0.67
Total
36
10
9
55
Mean
5.276
5.297
5.78
SD
0.484
0.561
0.63
Total
40
9
7
56
Weight
41.9%
33.7%
24.5%
100.0%
IV, Random, 95% CI
0.25 [-0.02, 0.53]
0.56 [0.12, 0.99]
-0.43 [-1.07, 0.21]
0.19 [-0.25, 0.63]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
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3.3.7 Body composition at 8-9 months 
Formula-fed babies have significantly greater fat-free mass when compared to 
breast-fed babies at 8-9 months (figure 3.5B).  No significant differences are 
detected in fat-mass or percentage fat-mass (figures 3.5A and Appendix 3, 
figure 3D). 
A. Fat mass 
B. Fat-free mass 
Figure 3.5: Forest plot showing differences between formula-fed and breast-fed 
infants at 8-9 months. A: differences in fat mass (kg), B: differences in fat-free 
mass (kg). SD: standard deviation, IV: inverse variance, CI: confidence intervals, 
TOBEC: total body electrical conductivity. 
Study or Subgroup
Butte 2000 - multicomp
De Bruin 1998 -TOBEC
Total (95% CI)
Heterogeneity: Chi² = 0.66, df = 1 (P = 0.42); I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)
Mean
2.379
2.25
SD
0.475
0.43
Total
36
23
59
Mean
2.409
2.15
SD
0.474
0.36
Total
40
23
63
Weight
53.5%
46.5%
100.0%
IV, Fixed, 95% CI
-0.03 [-0.24, 0.18]
0.10 [-0.13, 0.33]
0.03 [-0.13, 0.19]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
Study or Subgroup
Butte 2000 - multicomp
De Bruin 1998 -TOBEC
Total (95% CI)
Heterogeneity: Chi² = 0.01, df = 1 (P = 0.93); I² = 0%
Test for overall effect: Z = 2.79 (P = 0.005)
Mean
6.539
6.36
SD
0.754
0.49
Total
36
23
59
Mean
6.241
6.08
SD
0.605
0.43
Total
40
23
63
Weight
42.6%
57.4%
100.0%
IV, Fixed, 95% CI
0.30 [-0.01, 0.61]
0.28 [0.01, 0.55]
0.29 [0.09, 0.49]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
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3.3.8 Body composition at 12 months 
Formula-fed babies have significantly greater fat-free mass when compared to 
breast-fed babies at 12 months (figure 3.6B).  No significant differences are 
detected in fat-mass or percentage fat-mass (figures 3.6A and Appendix 3, 
figure 3E). 
 
A. Fat mass 
 
B. Fat-free mass 
 
Figure 3.6: Forest plot showing differences between formula-fed and breast-fed 
infants at 12 months. A: differences in fat mass (kg), B: differences in fat-free 
mass (kg). SD: standard deviation, IV: inverse variance, CI: confidence intervals, 
TOBEC: total body electrical conductivity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study or Subgroup
Bellu 1997 - TOBEC
Butte 2000 - multicomp
De Bruin 1998 -TOBEC
Total (95% CI)
Heterogeneity: Tau² = 0.06; Chi² = 9.85, df = 2 (P = 0.007); I² = 80%
Test for overall effect: Z = 1.79 (P = 0.07)
Mean
2.76
2.708
2.51
SD
0.39
0.559
0.65
Total
53
36
23
112
Mean
2.18
2.502
2.46
SD
0.47
0.532
0.33
Total
26
40
23
89
Weight
35.6%
33.6%
30.8%
100.0%
IV, Random, 95% CI
0.58 [0.37, 0.79]
0.21 [-0.04, 0.45]
0.05 [-0.25, 0.35]
0.29 [-0.03, 0.61]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
Study or Subgroup
Bellu 1997 - TOBEC
Butte 2000 - multicomp
De Bruin 1998 -TOBEC
Total (95% CI)
Heterogeneity: Chi² = 2.88, df = 2 (P = 0.24); I² = 31%
Test for overall effect: Z = 3.35 (P = 0.0008)
Mean
7.38
7.132
7.56
SD
0.59
0.66
0.61
Total
53
36
23
112
Mean
6.99
7.052
7.13
SD
0.62
0.736
0.51
Total
26
40
23
89
Weight
38.3%
31.9%
29.8%
100.0%
IV, Fixed, 95% CI
0.39 [0.10, 0.68]
0.08 [-0.23, 0.39]
0.43 [0.11, 0.75]
0.30 [0.13, 0.48]
Formula-fed Breast-fed Mean Difference Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Decreased in FF Increased in FF
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3.3.9 Pooled mean difference in fat mass over the first year 
Figure 3.7 displays the results obtained from forest plots for pooled mean 
differences in fat mass during the first year.  While fat mass is significantly 
higher among breastfed babies at 3-4 and 6 months, by 8-9 months no 
significant difference is seen and by 12 months there is a trend towards higher 
fat mass in formula fed infants. 
Figure 3.7: Pooled mean differences and 95% confidence intervals for fat-mass 
(kg) in formula-fed infants relative to breast-fed infants, by age. A fixed effects 
meta-analysis was undertaken in RevMan5 using the inverse variance method. This 
was performed separately for each postnatal age point. Where heterogeneity was 
present (p<0.05 from the chi-squared test) a random effects meta-analysis was 
carried out. 
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3.3.10 Pooled mean difference in fat-free mass over the first year 
Figure 3.8 displays the results obtained from forest plots for pooled mean 
differences in fat-free mass, showing higher fat-free mass in the formula fed 
group throughout the first year. 
 
 
Figure 3.8: Pooled mean differences and 95% confidence intervals for fat-free 
mass (kg) in formula-fed infants relative to breast-fed infants, by age. A fixed 
effects meta-analysis was undertaken in RevMan5 using the inverse variance 
method. This was performed separately for each postnatal age point. Where 
heterogeneity was present (p<0.05 from the chi-squared test) a random effects meta-
analysis was carried out. 
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3.3.11 Pooled mean difference in percentage fat mass over the first year 
Figure 3.9 displays the results obtained from forest plots for pooled mean 
differences in percentage fat mass, showing a similar pattern to that seen for 
absolute fat mass, higher percentage fat mass at 3-4 and 6 months in the 
breast-fed infants with no significant different at 8-9 months and a trend 
towards the opposite, higher percentage fat mass in formula fed infants by 12 
months. 
Figure 3.9: Pooled mean differences and 95% confidence intervals for 
percentage fat mass in formula-fed infants relative to breast-fed infants, by 
age. A fixed effects meta-analysis was undertaken in RevMan5 using the inverse 
variance method. This was performed separately for each postnatal age point. 
Where heterogeneity was present (p<0.05 from the chi-squared test) a random 
effects meta-analysis was carried out. 
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3.3.12 Funnel plots 
Funnel plots of studies at 3-4 months (Appendix 3, figure 3G) show no visual 
evidence of asymmetry. There was no evidence of funnel plot asymmetry for 
analyses at other time points (Appendix 3 figures 3F, 3H-3J), though the small 
number of studies make this difficult to evaluate reliably. 
 
3.3.13 Meta-analysis of results measured using a single technique 
Examination of the validity of combining data acquired using different 
techniques was undertaken using subgroup analyses of results from a single 
technique at 3-4 months and at 6 months. 
 
At 3-4 months ADP was used to measure percentage fat-mass in three 
studies (Anderson, 2009, Carberry et al., 2010, Eriksson et al., 2010); meta-
analysis reveals a significant reduction in percentage fat-mass (mean 
difference [95%CI]) (-1.72 [-3.47, 0.03], p=0.05; fixed effects, heterogeneity 
I2=0%, p=0.75) in formula-fed compared to breast-fed infants (Appendix 3, 
figure 3K).   This is of the same magnitude and direction of effect as that seen 
in the primary analysis (mean difference [95%CI]) (-1.46 [-2.75, -0.17]). 
 
At 3-4 months, five studies using isotope dilution reported results for 
percentage fat-mass (Butte et al., 1995, Chomtho et al., 2009, Jiang et al., 
1998, Motil et al., 1997, Ng et al., 2004b), and four studies for fat-mass and 
fat-free mass (Butte et al., 1995, Chomtho et al., 2009, Jiang et al., 1998, 
Motil et al., 1997).  Meta-analysis reveals no significant differences: 
percentage fat-mass (-1.36 [-3.98, 1.25], p=0.31; random effects, 
heterogeneity I2=61%, p=0.04, Appendix 3, figure 3L), fat-mass (-0.11kg [-
0.25, 0.03], p=0.13; fixed effects, heterogeneity I2=57%, p=0.07, Appendix 3, 
figure 3M), fat-free mass (-0.01kg [-0.16, 0.14], p=0.89, fixed effects, 
heterogeneity I2=0%, p=0.42, Appendix 3, figure 3N).   For comparison results 
from the primary analyses at 3-4 months are percentage fat mass: -1.46 [-
2.75, -0.17], fat mass: -0.09 [-0.18, -0.01], and fat-free mass: 0.13 [0.03, 0.23]. 
 
At 6 months, using isotope dilution, 3 studies reported results for percentage 
fat-mass (Jiang et al., 1998, Motil et al., 1997, Ng et al., 2004b); meta-
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analysis of these studies finds no significant difference (-0.33 [-2.39, 1.72], 
p=0.75; fixed effects, heterogeneity I2=45%, p=0.16, Appendix 3, figure 3O).  
Results from the primary analysis for percentage fat mass at this point are      
-1.71 [-3.14, -0.29]. 
 
3.3.14 Gender specific effects of infant feeding on body composition 
Only two studies (Butte et al., 1995, de Bruin et al., 1998) provided mean and 
standard deviation data describing the influence of method of feeding on body 
composition by gender, table 3.1. Planned subgroup analysis by gender was 
not performed due to the limited number of studies reporting at comparable 
time points. 
 
3.3.15 Infant feeding and regional adiposity 
Only one study reported regional adiposity in relation to method of feeding (Ay 
et al., 2009).  This paper used DEXA to examine truncal and peripheral fat 
distribution.  They report a direct association between truncal percentage fat-
mass and breastfeeding, but not between peripheral percentage fat-mass and 
breastfeeding, at 6 months.  
 
A further paper (Modi et al., 2006) used whole body MRI to measure adipose 
tissue distribution in appropriate for gestational age and growth-restricted 
infants at 6-8 weeks.  The influence of feeding on the appropriate weight for 
gestational age group was a secondary outcome and no data describing 
adipose tissue distribution by feeding group was included.  
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3.4 Discussion  
In this systematic review and meta-analysis I identify significant differences in 
the body composition of healthy, term, breast-fed and formula-fed infants 
during the first year. Combining data from 15 studies and over 1000 infants I 
show that compared to breast-fed babies, formula-fed babies have higher fat-
free mass throughout the first year (figure 3.8), lower fat-mass at 3-4 and 6 
months, and a trend towards higher fat-mass 12 months (figure 3.7).  These 
results are supported by other data: circulating leptin is higher in breast-fed 
compared with formula-fed babies up to 4 months of age but not later in 
infancy (Savino et al., 2005) in keeping with greater fat-mass in breast-fed 
babies at 3-4 and 6 months but not at 12 months.  Higher protein intake 
(Heinig et al., 1993) and higher resting energy expenditure (Motil et al., 1997) 
are seen in formula-fed when compared to breast-fed infants, consistent with 
higher fat-free mass in formula-fed infants.    
3.4.1 Implications of findings 
If we accept the presumption that maternal breast milk is the ideal nutrition for 
infants and that the pattern of body composition seen in healthy breastfed 
babies is optimal, these findings demonstrate that formula-fed infants are 
insufficiently adipose in the pre-weaning period (figure 3.7), and that infant 
formulas do not support the normal trajectory of adipose tissue development.  
The apparent switch from higher adiposity in breast-fed babies at 3-4 months 
(figure 3.3), to higher adiposity in formula-fed babies at 12 months (figure 3.6) 
suggests a complex relationship between adiposity in early infancy and that in 
later infancy.  
 
One explanation is formula feeding restricts adipose tissue growth in the pre-
weaning period, with subsequent “catch-up growth”.  A similar pattern is seen 
in small for gestational age infants, who have lower fat mass at birth but 
catch-up during infancy and have higher fat mass in later in life (Meas, 2010). 
This supports a potential mechanism by which infant feeding programs later 
metabolic health: formula feeding in early life leads to changes in adipose 
tissue, detectable as alterations in fat mass, which persist into adult life where 
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they become canalised (Waterland and Garza, 1999).  In demonstrating 
significant differences in two-component body composition this meta-analysis 
provides support for this hypothesis at an approximate level, fat mass.  The 
logical next question, given the differences in function between adipose tissue 
compartments, is whether infant feeding modifies adipose tissue distribution, 
in addition to size.  Only one paper (indirectly) measured regional adiposity 
(Ay et al., 2009) and found a significant association between truncal fat mass 
and breastfeeding.  This suggests an association between early nutrition and 
adipose tissue distribution, but requires confirmation using direct 
measurement techniques. 
 
The temporal changes in body composition identified and the association with 
feeding raise questions about the role of body fat in infancy.  Human babies 
are unique in having the most well developed body fat stores at birth of any 
mammal (Kuzawa, 1998). Addition accretion of fat-mass during milk feeding 
increases body fat further, peaking at approximately 6 months. It has been 
suggested that this acts as an evolutionary mechanism to provide a steady 
energy substrate for the infant brain and to fund growth (Kuzawa, 1998, 
Zafon, 2007) during the precarious weaning period - the human brain 
consumes approximately 50-60% of total metabolic expenditure during the 
first year and ketones appear to be the preferred substrate (Hasselbalch et 
al., 1996). The logical corollary is that higher body fat during the first 6 months 
is physiologically optimal.  This is supported by the findings presented here, 
and suggests that in early infancy, higher adiposity, rather than being 
considered detrimental, should be strived for.  This has implications for infant 
formula design and for neonatal and paediatric nutritional practice.  It is also 
plausible to hypothesise a link between lower levels of body fat at weaning 
described here in formula-fed infants, and the lower cognitive scores seen in 
children who are formula fed in infancy (Kramer et al., 2008).  
 
The physiological implications of the higher fat-free mass seen in formula 
feeding (figure 3.8) are uncertain.  While fat-mass is a relatively homogenous 
(comprised predominantly of adipose tissue and ectopic lipid) lean mass 
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reflects all other tissues (including bone, muscle, organs and non-fat 
connective tissue).  
 
3.4.2 Strengths and limitations 
This meta-analysis combines studies employing different methods to assess 
infant body composition, therefore the extent to which these are comparable 
must be considered.  Butte et al found significant differences in fat-mass 
estimated using TOBEC, TBK, DXA and 2H20 isotope dilution, but no 
evidence of variation in the relative effect of feeding on body composition 
estimated using different methods (Butte et al., 1999).  This supports the 
validity of my analysis examining the difference in body composition between 
feeding groups, rather than absolute body composition.  In addition, I 
examined the effect of different measurement techniques through sub-group 
analyses of studies using the same technique at a comparable postnatal age.  
Sufficient studies (three or more) were only available for a minority of time 
points, however in four of the five cases where this sub-group analysis was 
possible I found differences of the same magnitude and direction as the 
analyses in which methods were combined.  This supports the validity of 
combined analysis of results from different in-vivo body composition 
measurement techniques. 
A major limitation of body composition studies using indirect techniques in 
paediatric populations is the rapid maturation of body tissues during childhood 
(Fomon et al., 1982).  Thus the assumptions inherent in the derivation of fat or 
fat-free mass may not be stable throughout childhood.  It is reassuring 
therefore that all studies included in this meta-analysis used reference 
standards appropriate for infants (table 3.1).  Significant differences in body 
composition exist in relation to gender in adults (Geer and Shen, 2009), 
though  differences in infancy appear less pronounced (Fields et al., 2009).  I 
examined the effect of gender using meta-regression, but it was not 
appropriate to perform sub-group analyses by gender due to the limited 
evidence of effect and small number of studies.  Studies of infant feeding are 
liable to important study level biases, such as recall bias if breast feeding is 
assessed retrospectively (Adair, 2009), and contamination bias related to 
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formula feeding in the breast feeding group.  With a single exception (Bellu, 
1997), breastfeeding was assessed prospectively in all included studies 
limiting recall bias, however definition of feeding groups varied widely and no 
study reported using WHO criteria for exclusive breast feeding, suggesting 
that contamination bias may represent an important source of heterogeneity. 
Choice of infant feeding is also subject to a number of important confounding 
influences, such as prematurity and maternal diabetes, that may also affect 
body composition.  I attempted to limit this through the use of strict inclusion 
criteria.  An additional issue is that the limited number of studies at time points 
other than 3-4 months will have resulted in limited power to detect important 
differences.  This is of particular relevance at 12 months where, in contrast to 
findings at 3-4 months, there is a suggestion that formula-fed infants have 
higher fat-mass in comparison with those that are breast-fed.  Finally, the use 
of percentage fat-mass as a proxy for adiposity in body composition studies 
has been criticised for methodological and statistical reasons (Wells and 
Victora, 2005, Cole et al., 2008), hence my decision to focus on measures of 
fat and fat-free mass.  Representation of fat-mass using alternatives such as 
fat-mass index to adjust for body size (Wells and Victora, 2005) has been 
recommended but I was unable to include this in our analyses as such data 
were available in only three papers (Modi et al., 2006, Chomtho et al., 2009, 
Eriksson et al., 2010), and not at comparable time points.  
Consideration must also be given to the degree to which the exposures 
(breast feeding or formula feeding) are comparable between studies. 
Geographical differences in fatty acid composition are described between 
populations with large differences in diet (Martin et al., 2012): studies included 
in this meta-analysis were based predominantly Western European, Australia 
or North America, minimising differences related to diet.  Furthermore within 
subject variation (between hind- and foremilk, temporally over a lactation and 
the diurnal cycle) is considerable and is probably greater than any regional 
variation.  Differences related to method of feeding encompass more than 
macronutrient intake: differences in gut microbiota and the prevalence of 
gastrointestinal infections differ between regions, in particular between 
developed and developing countries. By confining included studies to those 
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undertaken in middle or high resource settings I have limited to some extent 
the effect of differences related to infectious disease burden, however 
important disparities may still exist between high and middle income settings 
(such as the study by Jiang et al. (Jiang et al., 1998)). Composition of infant 
formula is regulated by regional and international guidelines (Alimentarius, 
2007) and hence minimal geographical variation exists.  Limiting analyses to 
studies using commercially available cows milk formulas removed the 
differences related to soy-based and experimental formulas. 
The factors discussed above, in particular differences in measurement 
techniques and in exposures between populations (specifically between 
middle and high income populations where the study by Jiang et al was 
included) likely explain the considerable heterogeneity seen in some 
analyses. Therefore while considerable differences in body composition 
related to method of feeding are present in some populations, more negligible 
differences may exist in other groups.  Unfortunately the limited data available 
precludes further investigation of population characteristics associated with 
method of feeding differences in body composition. 
3.4.3 Conclusions 
I have demonstrated that differences in fat mass and fat-free mass exist 
between breastfed and formula fed infants, and that formula-fed infants 
appear inadequately adipose in comparison with breastfed babies in the first 6 
months.  These findings lead to rejection of my null hypothesis – that 
breastfeeding is not associated with differences in body composition – and 
point to a potential mechanism by which infant feeding might impact on later 
life health, through effects on adipose tissue development. Confirmation, 
using direct measurement of adipose tissue size, is required to confirm these 
results. Accumulating evidence from long-term cohort studies indicates that 
body composition in childhood tracks into adult life (Victora et al., 2007), the 
data presented here suggest that initiating events may well arise earlier, in 
infancy, and result from early feeding choices.   
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Chapter 4 
Examination and validation of statistical methods 
 
4.1 Introduction  
To examine the association between infant feeding and adiposity I have 
acquired longitudinal measures of adiposity from a prospective cohort of 
infants as described in Chapter 2.  Prior to analysis the following key 
statistical aspects need addressing: techniques of adjustment of adiposity and 
normality of the distribution. In addition, while the measurement variability of 
whole body MRI quantification of adiposity has been previously described 
(Modi et al., 2009), similar data for proton MRS quantification of IHCL in 
infants has not. 
 
4.1.1 Adjustment of adiposity 
Measures of body composition and adiposity are frequently adjusted, the 
mathematical technique used and the choice of measurement adjusted for 
depend on the underlying reason.  Common reasons include: 
 
1. To provide a measure of adiposity that is independent of body size, 
thereby allowing comparison between groups or over time. 
2. To better describe the metabolic load of adiposity by adjusting one 
component for another component with which it is correlated but that 
has an opposing effect. 
Adjustment is particularly important when adiposity is measured during 
periods of rapid change, such as infancy.   
 
4.1.1.1 Adjustment of adiposity for body size 
The most commonly used method to adjust adiposity for body size is by 
calculating percentage fat mass, however this remains highly correlated with 
body mass and conceals increases in adiposity (Wells and Victora, 2005).  
Furthermore, conversion of adipose tissue volume (measured by MRI) into 
mass requires applying assumptions regarding the density of adipose tissue 
that have uncertain validity in infancy (discussed in 2.5.6).  For these reasons 
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I will not use percentage fat mass to adjust adiposity for body size (although I 
will calculate adipose tissue mass where comparison is required). 
 
Another approach is to adjust adiposity for an alternative measure of size, 
height (or length).  Adjustment for height usually involves generating an index 
by which height should be raised in order to minimise the correlation between 
the index and height.  In adults height2 is accepted as the appropriate index, 
and most tissues and organs examined, including adipose tissue, have been 
shown to scale with height2 in adults (Heymsfield et al., 2007). However in 
childhood, the most appropriate index varies between fat mass and fat-free 
mass, and with age (Wells and Cole, 2002).  Appropriate indices have not to 
my knowledge been explored in relation to regional adiposity in infancy. 
 
A further method of adjusting adiposity for body size is by including a measure 
of body size as a regression coefficient.  This has disadvantages in that it 
requires parametric regression methods, so may not be appropriate for data 
that is not normally distributed, and may not be as easy to interpret as an 
index of adiposity. 
 
4.1.1.2 Adjustment of adiposity to describe metabolic load 
A second reason to adjust adiposity is to better describe the metabolic load of 
body fat.  For two-component measures of body composition a common aim 
is to adjust a component of metabolic risk (such as fat mass) for a component 
having the opposing metabolic effect (such as fat-free mass).  A similar 
adjustment is applicable between regional adipose tissue depots that have 
opposing metabolic roles, such as internal abdominal and superficial 
subcutaneous depots (Wronska and Kmiec, 2012).  Adjusting adipose tissue 
depots for each other in this way allows more detailed assessment, but as a 
large number of ratios can be produced care must be taken to define ratios of 
interest a-priori to avoid introducing type II error through multiple testing. In 
this thesis I am interested in adjusting the following adipose tissue depots, for 
the following reasons: 
1. Internal abdominal adipose tissue adjusted for abdominal superficial 
subcutaneous adipose tissue: These abdominal depots appear to have 
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metabolically opposing effects, and are analogous to ratios commonly 
used in adults and older children (Benfield et al., 2008).   
2. Internal abdominal adipose tissue adjusted for non-abdominal
superficial subcutaneous adipose tissue: These depots include the
largest single adipose tissue compartment, non-abdominal superficial
subcutaneous adipose tissue, and appear to have metabolically
opposing effects (Liu et al., 2010, Manolopoulos et al., 2010)
The aim of adjusting regional adiposity in this way is the same as adjusting for 
body size: to remove any correlation between the ratio and the denominator. 
Although ratios of adipose tissue are widely used, for example the visceral to 
subcutaneous abdominal adipose tissue ratio in adults (Kaess et al., 2012), to 
my knowledge there has been no examination in infants of the mathematical 
validity of these ratios (their ability to minimise correlation with the 
denominator).   
4.1.2 Examination of normality in the distribution of adiposity measures 
Parametric statistical tests offer greater power to detect differences compared 
to non-parametric techniques, especially in small datasets, but can be 
sensitive to violations of normality.  Some measures of adiposity, such as 
IHCL, have been shown to be skewed (Modi et al., 2011), requiring 
transformation for parametric testing.  Other measures, such as adipose 
tissue compartment volumes and ratios (Allison et al., 1995), require 
assessment of normality of distribution prior to application of parametric tests. 
4.1.3 Examination of variability in infant hepatic proton magnetic 
resonance spectroscopy 
Variation in results is introduced by the process of analysis, both between 
individuals (inter-observer) and within the same individual (intra-observer). 
The magnitude of this variation has been examined and quantified for 
magnetic resonance imaging measures of adipose tissue volume in infants 
(Modi et al., 2009) and for hepatic proton magnetic resonance spectroscopy in 
adults (Thomas et al., 2005).  To my knowledge no examination has been 
undertaken for hepatic proton magnetic resonance spectroscopy in infants. 
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A further characteristic of hepatic magnetic resonance spectroscopy is it only 
quantifies lipid within the measurement voxel (8cm3), and provides no data for 
the rest of the liver.  Heterogeneity of liver lipid measured by MRS has been 
examined in adults, where substantial inter-individual variation in IHCL was 
seen (Thomas et al., 2005).  To my knowledge no such work has been 
undertaken in infancy.  
4.2 Aims 
The aims of this chapter are to determine the following in an infant population: 
1. An index for adjusting regional and total adipose tissue volume for
length that minimises correlation with length and allows comparison
both between adipose tissue indices and over time.
2. The degree to which the adipose tissue depot ratios internal abdominal
adipose tissue:abdominal superficial subcutaneous adipose tissue and
internal abdominal adipose tissue:non-abdominal superficial
subcutaneous adipose tissue are effective in minimising correlation
with the denominator.
3. Whether adipose tissue volumes, indices and ratios, and IHCL are
normally distributed, and if found to be non-normally distributed
determine appropriate transformation to facilitate parametric testing.
4. Inter-observer, intra-observer and within subject variability for MRS
measures of hepatic lipid in infants.
4.3 Methods 
4.3.1 Adjustment of adiposity 
To minimise variance due to sample size, analyses were undertaken using a 
combined data set including infants examined for this thesis, and healthy, 
term, appropriate weight for gestational age (WHO, 2009) infants acquired for 
previous studies (Modi et al., 2011).  Analyses were undertaken separately for 
the neonatal period (under 4 weeks) and for the period 2-3 months. 
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Measurement techniques were consistent between datasets and were 
undertaken as described in Chapter 2.   
 
4.3.1.1 Adjustment of adiposity for body size 
Adjustment of adipose tissue depots for length was performed using the 
formula: 
Adipose tissue indexp = adipose tissue volume/lengthp 
 
Where p is the power to which the denominator is to be raised. To determine 
the value of p a natural log-natural log regression analysis was performed as 
described in chapter 2.5.6. Values for p were calculated for each adipose 
tissue depot.  
 
Calculating indices in this manner produced different values of p for each 
adjusted measure.  Comparison between adjusted measures requires a single 
value of p suitable for use in all adjustments for length.  A summary p, 
denoted sp, was therefore calculated from the median p, rounded to the 
nearest integer. Validity of sp was evaluated by calculating percentage 
variation in the index that was attributable to the denominator as described in 
2.5.4.  For any measures A and B (in this case adipose tissue volume and 
length respectively), where the percentage variation of A/Bsp explained by B 
was <10% in all cases this value was accepted.  A cut-off of 10% was chosen 
in line with previously reported acceptable percentage variation (Wells and 
Cole, 2002).  If percentage variation was >10%, the closest alternative value 
of sp was be calculated and revalidated as above until a value where 
percentage variation was <10% was found in all cases. 
 
4.3.1.2 Regional adipose tissue ratios 
The regional adipose tissue depot ratios internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue and internal 
abdominal adipose tissue:non-abdominal superficial subcutaneous adipose 
tissue were calculated using the combined dataset.  Correlation analysis was 
used to explore the relationship between abdominal superficial subcutaneous 
adipose tissue and internal abdominal adipose tissue:abdominal superficial 
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subcutaneous adipose tissue, and between non-abdominal superficial 
subcutaneous adipose tissue and internal abdominal adipose tissue:non-
abdominal superficial subcutaneous adipose tissue.  The correlation 
coefficient was used to determine the percentage variation in internal 
abdominal adipose tissue:abdominal superficial subcutaneous adipose tissue 
and in internal abdominal adipose tissue:non-abdominal superficial 
subcutaneous adipose tissue attributable to the denominator, as described in 
2.5.4. 
 
Natural log-natural log regression analysis was the undertaken for the 
relationships between internal abdominal adipose tissue and abdominal 
superficial subcutaneous adipose tissue, and between internal abdominal 
adipose tissue and non-abdominal superficial subcutaneous adipose tissue, to 
calculate the indices internal abdominal adipose tissue/(abdominal superficial 
subcutaneous adipose tissue)p and internal abdominal adipose tissue/(non-
abdominal superficial subcutaneous adipose tissue)p, where p is the relevant 
regression coefficient, and has the effect of minimising the correlation 
between the index and the denominator, as described in 2.5.4. 
 
4.3.2 Testing normality of distribution 
A dataset comprising infants included in this thesis was used and results were 
compared with the combined dataset.  As small for gestational age infants 
were not recruited, large for gestational age infants were also excluded to 
avoid skewing the dataset.  The distribution of each measure of adiposity was 
visually examined using histograms and Q-Q plots.  Normality was formally 
assessed using the Shapiro-Wilk test (Shapiro and Wilk, 1965) as this test is 
the most powerful normality test for low sample sizes (Razali and Wah, 2011).  
Where data were not normally distributed (p<0.05 from the Shapiro-Wilk test), 
a natural log transformation was undertaken prior to retesting as above.   
 
4.3.3 Variation in hepatic magnetic resonance spectroscopy 
Intra-observer, inter-observer and within subject variability were examined. A 
dataset comprising only infants from this thesis cohort was used.  
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To examine intra-observer variability in MRS analyses, hepatic spectra were 
selected in random order for repeated analyses on separate days, blinded to 
subject identifiers and previous analysis results. To examine inter-observer 
variability in MRS analyses, hepatic spectra were analysed independently by 
Dr Thomas (ELT) (senior scientist with over 20 years of MRS analysis 
experience) and myself.  To examine within subject variability paired MRS 
voxels were obtained as previously described, at two different points within 
the liver, among a subgroup of randomly selected babies, figure 4.1. 
 
Figure 4.1: Paired voxels and spectra from an infant measured at different 
positions within the right lobe of the liver.  Spectral peaks corresponding to water 
are visible at 4.7ppm and to CH2 at 1.3ppm. 
 
Variability was expressed using Bland-Altman plots and by calculation of the 
mean difference and limits of agreement as described in 2.5.8.  The 
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coefficient of variation was calculated to allow comparison with previous 
studies. 
4.4 Results  
4.4.1 Cohort characteristics 
Two cohorts were used in analyses: the thesis cohort was used to test 
normality of distribution and the variation in MRS measured IHCL, and a 
combined cohort to examine indices adjusting for body size. 
Descriptive characteristics for the thesis cohort are presented in table 4.1 and 
for the combined cohort in table 4.2. 
T1 T2 
Number 87 73 
Scan age (days) 13 [8-19] 63 [57-70] 
Weight (kg)* 3.656 (0.548) 5.402 (0.661) 
Length (m)* 0.528 (0.025) 0.592 (0.027) 
Total AT (l) 0.745 [0.621-0.936] 1.540 [1.331-1.801] 
ASSCAT (l) 0.104 [0.077-0.136] 0.257 [0.211-0.323] 
NASSCAT (l) 0.525 [0.446-0.696] 1.088 [0.935-1.270] 
ADSCAT (l) 0.017 [0.011-0.022] 0.039 [0.031-0.050] 
NADSCAT (l) 0.013 [0.010-0.015] 0.020 [0.016-0.023] 
IAAT (l) 0.017 [0.013-0.022] 0.030 [0.023-0.041] 
NAIAT (l) 0.055 [0.045-0.070] 0.086 [0.070-0.118] 
Table 4.1: Descriptive characteristics of thesis cohort for time points T1 and T2 
used for evaluation of normality and variability in MRS.  Data median 
[interquartile range], except * where data are mean (SD). ADSCAT: Abdominal deep 
subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
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 T1 T2 
Number 227 75 
Scan age (days) 11 [5-16] 63 [51-70] 
Weight (kg)* 3.511 (0.491) 5.340 (0.646) 
Length (m)* 0.526 (0.025) 0.591 (0.027) 
Total AT (l) 0.761 [0.638-0.913] 1.526 [1.332-1.781] 
ASSCAT (l) 0.109 [0.085-0.129] 0.256 [0.213-0.316] 
NASSCAT (l) 0.542 [0.463-0.665] 1.085 [0.934-1.265] 
ADSCAT (l) 0.015 [0.011-0.021] 0.040 [0.031-0.050] 
NADSCAT (l) 0.012 [0.009-0.015] 0.020 [0.016-0.023] 
IAAT (l) 0.020 [0.014-0.020] 0.030 [0.023-0.042] 
NAIAT (l) 0.056 [0.045-0.070] 0.086 [0.071-0.117] 
Table 4.2: Descriptive characteristics of combined cohort for time points T1 
and T2 used for evaluation of adjusted indices of adiposity. Data median 
[interquartile range], except * where data are mean (SD). ADSCAT: Abdominal deep 
subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 
4.4.2 Adjustment of adiposity for body size 
As described in Chapter 2 (2.5.4), to determine indices minimising correlation 
between adipose tissue volumes and length, regression coefficients (p) and 
95% confidence intervals for natural log converted adipose tissue depot 
volumes regressed against natural log converted length were calculated and 
are presented in table 4.3. 
 T1 T2 
Total AT  2.2 (1.6, 2.9) 2.0 (0.8, 3.3) 
ASSCAT  2.2 (1.3, 3.0) 1.9 (0.3, 3.6) 
NASSCAT  2.3 (1.6, 3.0) 2.1 (0.8, 3.3) 
ADSCAT  3.9 (2.5, 5.2) 0.7 (-2.4, 3.9) 
NADSCAT  1.9 (1.0, 2.9) 2.2 (-0.4, 4.4) 
IAAT  1.1 (-0.1, 2.3) -1.0 (-3.1, 1.2) 
NAIAT  1.8 (0.9, 2.7) 2.9 (1.2, 4.5) 
Table 4.3: Regression coefficients (95%CI) from log-log regression analyses of 
adipose tissue compartments and length: Values are calculated by log 
transforming each adipose tissue compartment to the base e, and regressing the log 
of the adipose tissue compartment on the log of the length. ADSCAT: Abdominal 
deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 
The median regression coefficient was 2.0, and this value was used to 
calculate adipose tissue indices for each adipose tissue depot.  Percentage 
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variation in adipose tissue indexes (calculated raising length to the power of 2, 
as described in Chapter 2, 2.5.6) that is attributable to length is summarised in 
table 4.4.  As this value was <10% for all adipose tissue depots no further 
analysis was undertaken. 
 T1 T2 
 r % variation r % variation 
Total AT  0.03 0.1 0.02 0.0 
ASSCAT  0.01 0.0 0.01 0.0 
NASSCAT  0.05 0.1 0.02 0.0 
ADSCAT  0.17 1.5 -0.06 0.2 
NADSCAT  -0.03 0.1 0.09 0.4 
IAAT  -0.10 0.5 -0.29 4.3 
NAIAT  -0.03 0.1 0.11 0.6 
Table 4.4: Regression coefficients and percentage variation in adipose tissue 
indexes attributable to the denominator. Calculated raising length to the power of 
2. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal 
superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; 
NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-
abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous 
adipose tissue. 
 
 
4.4.3 Adjustment of adipose tissue for metabolic load 
The ratios internal abdominal adipose tissue:abdominal superficial 
subcutaneous adipose tissue and internal abdominal adipose tissue:non-
abdominal superficial subcutaneous adipose tissue for the combined dataset 
are presented in table 4.5. 
 T1 T2 
IAAT:ASSCAT 0.20 (0.08) 0.13 (0.05) 
IAAT:NASSCAT 0.039 (0.014) 0.032 (0.013) 
Table 4.5: Mean (SD) adipose tissue ratios calculated using the combined 
dataset. ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: 
Internal abdominal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous 
adipose tissue. 
 
Correlation coefficients between internal abdominal adipose tissue:abdominal 
superficial subcutaneous adipose tissue and abdominal superficial 
subcutaneous adipose tissue, and between internal abdominal adipose 
tissue:non-abdominal superficial subcutaneous adipose tissue and non-
abdominal superficial subcutaneous adipose tissue, and percentage variation 
attributable to the denominator are shown in table 4.6. 
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 T1 T2 
 r % variation r % variation 
IAAT:ASSCAT -0.29 4.3 -0.33 5.6 
IAAT:NASSCAT -0.19 1.8 -0.27 3.7 
Table 4.6: Regression coefficients and percentage variation in adipose tissue 
ratios attributable to the denominator. ASSCAT: Abdominal superficial 
subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NASSCAT: 
Non-abdominal deep subcutaneous adipose tissue. 
 
Regression coefficients (p) and 95% confidence intervals, for natural log 
converted numerator regressed against natural log converted denominator 
were calculated to determine the power to which the denominator should be 
raised to minimise correlation between the numerator and the denominator.  
Results are presented in table 4.7 for internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue and internal 
abdominal adipose tissue:non-abdominal superficial subcutaneous adipose 
tissue. 
 T1 T2 
IAAT:ASSCAT 0.6 (0.5, 0.8) 0.6 (0.3, 0.8) 
IAAT:NASSCAT 0.8 (0.6, 0.9) 0.5 (0.2, 0.9) 
Table 4.7: Regression coefficients (95%CI) from log-log regression analyses of 
adipose tissue ratios: Values are calculated by log transforming each adipose 
tissue compartment to the base e, and regressing the log of the numerator on the 
natural log of the denominator. ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NASSCAT: Non-abdominal 
deep subcutaneous adipose tissue. 
 
 
The median regression coefficient was 0.6, rounded to the closest integer 1.  
As the percentage variation attributable to the denominator for both indices 
was less than 10%, table 4.5, no further analyses were undertaken.  Scatter 
plots showing correlation between the internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue and abdominal 
superficial subcutaneous adipose tissue and between internal abdominal 
adipose tissue:non-abdominal superficial subcutaneous adipose tissue and 
non-abdominal superficial subcutaneous adipose tissue are shown in 
Appendix 4, figures 4A-4B and 4C-4D respectively. 
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4.4.4 Testing the normality of the distribution 
Descriptive data for the thesis cohort are presented in table 4.8. 
T1 T2 
Number 87 73 
Mean Median Mean Median 
Scan age (days) 13 (8) 13 [8-19] 63 (13) 63 [57-70] 
Total AT (l) 0.809 (0.264) 0.745 [0.621-0.936] 1.572 (0.391) 
1.540 [1.331-
1.801] 
ASSCAT (l) 0.114 (0.047) 0.104 [0.077-0.136] 0.269 (0.084) 
0.257 [0.211-
0.323] 
NASSCAT (l) 0.586 (0.191) 0.525 [0.446-0.696] 1.110 (0.271) 
1.088 [0.935-
1.270] 
ADSCAT (l) 0.018 (0.010) 0.017 [0.011-0.022] 0.040 (0.016) 
0.39 [0.031-
0.050] 
NADSCAT (l) 0.013 (0.004) 0.013 [0.010-0.015] 0.022 (0.014) 
0.020 [0.016-
0.023] 
IAAT (l) 0.019 (0.008) 0.017 [0.013-0.022] 0.033 (0.014) 
0.030 [0.023-
0.041] 
NAIAT (l) 0.060 (0.021) 0.055 [0.045-0.070] 0.097 (0.035) 
0.086 [0.070-
0.118] 
IHCL 1.522 (1.944) 0.822 [0.493-1.767] 2.336 (1.803) 
1.818 [1.379-
2.659] 
TAT index (l/m2) 2.88 (0.86) 2.68 [2.24-3.27] 4.47 (1.00) 
4.48 [3.83-
5.10] 
ASSCAT index 
(l/m2) 
0.41 (0.15) 0.37 [0.30-
0.47] 0.77 (0.22) 
0.76 [0.62-
0.92] 
NASSCAT index 
(l/m2) 
2.09 (0.62) 1.94 [1.63-
2.39] 1.15 (0.53) 
1.05 [0.82-
1.45] 
ADSCAT index 
(l/m2) 
0.06 (0.03) 0.06 [0.04-
0.08] 0.11 (0.04) 
0.11 [0.09-
0.14] 
NADSCAT index 
(l/m2) 
0.05 (0.01) 0.05 [0.04-
0.05] 0.06 (0.04) 
0.06 [0.04-
0.07] 
IAAT index (l/m2) 0.07 (0.03) 0.06 [0.05-0.08] 0.10 (0.04) 
0.09 [0.06-
0.11] 
NAIAT index (l/m2) 0.21 (0.07) 0.20 [0.17-0.25] 0.27 (0.09) 
0.25 [0.21-
0.33] 
IAAT:ASSCAT 0.172 (0.062) 0.166 [0.124-0.213] 0.129 (0.050) 
0.115 [0.090-
0.157] 
IAAT:NASSCAT 0.033 (0.012) 0.031 [0.023-0.040] 0.121 (0.139) 
0.079 [0.045-
0.137] 
Table 4.8: Descriptive characteristics of thesis cohort used for testing 
adiposity measures for normality.  For comparison mean (SD) and median [IQR] 
are provided. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: 
Abdominal superficial subcutaneous adipose tissue; IAAT: Internal abdominal 
adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; 
NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-abdominal deep 
subcutaneous adipose tissue. 
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Large for gestational age babies were removed prior to assessing the 
distribution.  Histograms of adiposity are presented in Appendix 4, figures 4E-
4L.  Results from the Shapiro-Wilk test for normality for each measure of 
adiposity are presented in table 4.9. 
 
 T1 T2 
Total AT (l) <0.01 0.13 
ASSCAT (l) <0.01 0.36 
NASSCAT (l) <0.01 <0.01 
ADSCAT (l) <0.01 0.61 
NADSCAT (l) 0.03 <0.01 
IAAT (l) <0.01 <0.01 
NAIAT (l) <0.01 <0.01 
IHCL <0.01 <0.01 
TAT index (l/m2) <0.01 0.67 
ASSCAT index (l/m2) <0.01 0.88 
NASSCAT index (l/m2) <0.01 <0.01 
ADSCAT index (l/m2) <0.01 0.76 
NADSCAT index (l/m2) 0.13 <0.01 
IAAT index (l/m2) <0.01 <0.01 
NAIAT index (l/m2) <0.01 <0.01 
IAAT:ASSCAT 0.08 <0.01 
IAAT:NASSCAT 0.05 <0.01 
Table 4.9: Results from Shapiro-Wilk test for normality of distribution of 
adiposity and adipose tissue indices for the thesis cohort, n=85.  Small and 
large for gestational age infants removed.  Values <0.05 (red) signify rejection of the 
null hypothesis (that the distribution is normally distributed) and suggest a non-
normal distribution. ADSCAT: Abdominal deep subcutaneous adipose tissue; 
ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-
abdominal deep subcutaneous adipose tissue. 
 
 
Tests for normality may be influenced by small sample sizes.  Therefore to 
check that the results obtained were due to sample size, the same tests were 
carried out in the larger combined cohort.  No differences were noted between 
the two datasets (results from normality tests for the combined data set are 
found in appendix 4, table 4A). 
 
Natural log transformation (Ln) of adipose tissue volumes and indices was 
undertaken, and results from tests for normality are presented in table 4.10. 
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 T1 T2 
LnTAT (l) 0.40 - 
LnASSCAT (l) 0.76 - 
LnNASSCAT (l) 0.13 0.28 
LnADSCAT (l) 0.88 - 
LnNADSCAT (l) 0.16 <0.01 
LnIAAT (l) 0.79 0.43 
LnNAIAT (l) 0.52 0.66 
LnIHCL 0.31 <0.01 
LnTAT index (l/m2) 0.25 - 
LnASSCAT index (l/m2) 0.97 - 
LnNASSCAT index (l/m2) 0.15 0.24 
LnADSCAT index (l/m2) 0.98 - 
LnNADSCAT index (l/m2) - <0.01 
LnIAAT index (l/m2) 0.82 0.13 
LnNAIAT index (l/m2) 0.84 0.97 
LnIAAT:ASSCAT - 0.28 
LnIAAT:NASSCAT 0.77 0.02 
Table 4.10: Results from Shapiro-Wilk test for normality of distribution of 
natural log transformed adiposity and adipose tissue indices n=85.  Small and 
large for gestational age infants removed.  Values <0.05 signify (red) rejection of the 
null hypothesis (that the distribution is normally distributed) and suggest a non-
normal distribution. ADSCAT: Abdominal deep subcutaneous adipose tissue; 
ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-
abdominal deep subcutaneous adipose tissue. 
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4.4.5 Variation in hepatic magnetic resonance spectroscopy 
4.4.5.1 Inter-observer variation 
Inter-observer variation was assessed using 69 pairs of IHCL measures taken 
at T1.  A Bland Altman plot for inter-observer variation is presented in figure 
4.2. 
 
Figure 4.2: Bland Altman plot of inter-observer variation in IHCL data. The 
dashed red line indicates the mean difference and solid red lines indicate 95% limits 
of agreement. 
The mean difference between observers is -0.02 and upper and lower 95% 
limits of agreement are -0.40 and 0.38.  Therefore 95% of the differences 
between measurements of the same spectra by two different observers would 
be expected to lie in this interval. 
 
4.4.5.2 Intra-observer variation 
Intra-observer variation was assessed for analyses performed by the author, 
CG (using 16 IHCL measures) and those performed ELT (using 13 IHCL 
measures) at T1 and T2.   
 
-1 
-0.8 
-0.6 
-0.4 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
1 
0 2 4 6 8 10 12 14 
In
te
r-
ob
se
rv
er
 d
iff
er
en
ce
 in
 IH
C
L 
Mean IHCL by two observers 
Newborn feeding and infant phenotype 
 115 
A Bland Altman plot for intra-observer variation in analyses undertaken by CG 
is presented in figure 4.3.  The mean difference between duplicate 
measurements is 0.06 and the upper and lower limits of agreement are -0.51 
and 0.75. Therefore 95% of the differences between measurements of the 
same spectra at different times would be expected to lie in the interval -0.51 to 
0.75. 
 
 
Figure 4.3: Bland Altman plot of intra-observer variation in IHCL for CG. The 
dashed red line indicates the mean difference and solid red lines indicate 95% limits 
of agreement. 
A Bland Altman plot for intra-observer variation in analyses undertaken by 
ELT is presented in figure 4.4.  The mean difference between duplicate 
measurements performed by ELT is 0.05 and the upper and lower limits of 
agreement are -0.09 and 0.19. Therefore 95% of the differences between 
measurements of the same spectra by ELT at different times would be 
expected to lie in the interval -0.09 to 0.19. 
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Figure 4.4: Bland Altman plot of intra-observer variation in IHCL for ELT. The 
dashed red line indicates the mean difference and solid red lines indicate 95% limits 
of agreement. 
 
 
4.4.5.3 Within subject variation 
Within subject (or regional) variation in IHCL was assessed in 19 infants (6 at 
T1, 13 at T2).  A line plot showing IHCL measurements at different voxels 
within the same infant is presented in figure 4.5.  A Bland Altman plot for 
within subject variation is presented in figure 4.6.   
 
The mean difference between measures taken in different regions of the 
same infant’s liver is 0.36 and upper and lower limits of agreement are -1.24 
and 2.14.  Therefore 95% of the differences between measurements taken at 
different points within the same liver would be expected to lie in the interval -
1.24 to 2.14.  This corresponds to a mean (range) coefficient of variation of 
26.8% (0.4-103.3).  
-1 
-0.8 
-0.6 
-0.4 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
1 
0 1 2 3 4 5 6 
In
tr
a-
ob
se
rv
er
 d
iff
er
en
ce
 in
 IH
C
L 
Mean IHCL by two measurements preformed by ELT 
Newborn feeding and infant phenotype 
 117 
 
Figure 4.5 Scatter plot showing the relationship between intrahepatocellular 
lipid measured at different voxels within the same infant. 
 
Figure 4.6: Bland Altman plot of regional within subject variation in IHCL. The 
dashed red line indicates the mean difference and solid red lines indicate 95% limits 
of agreement. 
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4.5 Conclusions  
Direct techniques such as MRI allow detailed quantification of adiposity but 
require appropriate adjustment to allow meaningful and valid comparisons.  
Indices (such as body mass index) are widely used to adjust body 
composition, are easily interpreted and have been statistically validated in 
adults (Allison et al., 1995) and children (Wells and Cole, 2002).  Indices 
adjusting regional adipose tissue compartments have not been subject to 
similar investigation in infancy.  This is of particular importance when 
adjusting for body size: humans have a number of distinct adipose tissue 
compartments with different metabolic effects, hence the need to compare 
compartments while accounting for size.  This is further complicated in that an 
index that effectively adjusts one adipose tissue compartment (by minimising 
the correlation with the body size) may not be effective for another 
compartment (remaining highly correlated with the body size), and meaningful 
comparison requires a single index for use across all compartments.  
 
Using log-log regression I have demonstrated that the appropriate power to 
which length should be raised to minimise correlation between adipose tissue 
volume and length in infancy, differs between compartments (and is as high 
as 4).  Using the median value of 2 (adipose tissue volume/length2) results in 
an index in which length explains less than 5% of the variance in the index for 
all compartments.  I will apply this index to adjust for body size in analyses 
involving adipose tissue depots.  An alternative approach is using multiple 
regression analyses to adjust adipose tissue volumes for length.  Where 
multiple regression analyses are appropriate (where the distribution of 
residuals is normal) this will be undertaken in addition to allow comparison of 
these two adjustment methods. 
 
Although widely used and easy to understand as a measure of the metabolic 
load of adiposity, common ratios of internal abdominal to subcutaneous 
adipose tissue do not appear to have been statistically validated (in their 
ability to minimise correlation between the index and the denominator) in 
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childhood.  Here I have shown that both internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue and internal 
abdominal adipose tissue:non-abdominal superficial subcutaneous adipose 
tissue (another ratio of interest) are statistically valid in minimising correlation 
between the ratio and the denominator in infants.  These ratios will be used 
henceforth where description of metabolic differences in adipose tissue 
partitioning is required. 
 
Parametric tests have greater power to detect significance than non-
parametric tests, but rely on normally distributed data.  Examination of data 
collected for this thesis demonstrated significant deviation from the normal 
distribution for a number of adipose tissue compartments, indices and ratios, 
and for IHCL.  Where data were not normally distributed, natural log 
transformation was satisfactory in achieving a normal distribution in most 
cases and will therefore be used prior to parametric analyses.  Where natural 
log transformation failed to achieve a normal distribution (non-abdominal deep 
subcutaneous adipose tissue, non-abdominal deep subcutaneous adipose 
tissue index, IHCL and internal abdominal adipose tissue:non-abdominal 
superficial subcutaneous adipose tissue, all at T2) non-parametric tests will be 
used.  Multiple regression testing relies on a normal distribution of the 
residuals to be valid, so untransformed data will be used for these analyses 
and the distribution of the residuals checked.  Where the distribution of the 
residuals deviates from normality regression analyses will be undertaken 
using Ln transformed data. 
 
Variability is unavoidable when measuring any biological phenomenon, 
regardless of the techniques used.  Measurement of IHCL in adults, using 
identical techniques to those applied here, is associated with a mean inter-
observer co-efficient of variation of 6.0% (Thomas et al., 2005), and magnetic 
resonance imaging for measurement of adipose tissue volume using blinded 
external analysis (as used here) has a co-efficient of variation of <3% (Modi et 
al., 2009).  I have chosen to present the variability in IHCL measurements 
found in my cohort using upper and lower limits of agreement as suggested 
by Bland and Altman, rather than using the coefficient of variation (Bland and 
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Altman, 1986) which can conceal considerable lack of agreement between 
measurements.  The upper and lower limits of agreement for inter-observer 
differences are considerable (differences of between -0.4 and 0.38), and the 
magnitude of this difference, 0.78, is comparable to the difference between 
the lowest value and the median IHCL at T1, 0.82.  The intra-observer limits 
of agreement are smaller, with the tightest limits found for data analyses by 
Dr. Thomas (a senior research scientist with 20 years experience of analyzing 
MR spectra). To limit variation, IHCL data for analyses will be from 
measurements made by ELT.  
Another source of variability, unrelated to measurement or analysis technique, 
is heterogeneity of lipid distribution within the liver.  Liver lipid is known to vary 
at the microscopic (Ratziu et al., 2005) and macroscopic level (measured by 
MRS) in adults with non-alcoholic fatty liver disease (Capitan et al., 2012), 
and at the macroscopic level in healthy adults (Thomas et al., 2005, Capitan 
et al., 2012) and infants at post-mortem (Emery and Finch, 1954).  Our 
findings indicate for the first time that considerable heterogeneity exists in the 
distribution of IHCL within the liver in healthy infants.  This is in keeping with 
that previously only described among stillborn infants and those dying in the 
neonatal period (Emery and Finch, 1954).  The difference between the 95% 
limits of agreement for IHCL, measured at different points within the same 
liver, is greater in magnitude than the median values for IHCL.  Measurement 
of IHCL in this cohort was carried out in the right lobe for all infants and is 
therefore comparable between infants and over time for the same infant if 
results are accepted to represent IHCL within the right lobe of the liver and 
are not extrapolated to represent the lipid content of the whole liver.  The 
quantification of whole liver lipid in adults is feasible using chemical shift 
imaging (the Dixon method), but this technique has not been applied in infants 
to date and presents technical and procedural challenges due to the 
prolonged breath hold required. 
Newborn feeding and infant phenotype 
 121 
4.6 Summary  
In an infant population the following indices are effective at statistically 
adjusting for the denominator value, and will be used throughout this thesis: 
1. To adjust regional adipose tissue volumes (AT) for size:  
ATIndex, litres/metres2= (AT, litres)/(l, metres)2 
2. To express the metabolic load of adiposity:  
internal abdominal adipose tissue:abdominal superficial subcutaneous 
adipose tissue 
internal abdominal adipose tissue:non-abdominal superficial 
subcutaneous adipose tissue 
The distributions of a number of measures of adiposity deviate from normal in 
infancy.  Where adiposity measures are not normally distributed log 
transformation will be used prior to parametric testing, except for the following 
measures where non-parametric tests will be used: non-abdominal deep 
subcutaneous adipose tissue, non-abdominal deep subcutaneous adipose 
tissue index, IHCL and internal abdominal adipose tissue:non-abdominal 
superficial subcutaneous adipose tissue at T2.  Multiple regression analyses 
will be used without transformation of results if the distribution of the residuals 
is normally distributed. 
 
Variation is introduced between observers in the analysis of infant hepatic 
MRS. To minimise variation measures performed by a single observer (Dr. 
Thomas) will be used.  Considerable heterogeneity in hepatic IHCL is found 
within individual infants.  Standardised measurement of the right lobe allows 
comparison between infants and over time, but these values are not 
representative of total hepatic IHCL in infancy. 
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Chapter 5 
Regional adipose tissue and ectopic lipid deposition in healthy breast-
fed babies 
 
5.1 Introduction  
Substantial changes in fat and fat-free mass are well described during normal 
infant growth (Fomon and Nelson, 2002, Fomon et al., 1982, Butte et al., 
2000a, Fomon, 1967): in the first six months the percentage body mass 
comprised by fat approximately doubles (figure 5.1).   
 
 
Figure 5.1: A comparison of percent fat mass of boys and girls, ages 0.5 to 24 
months, enrolled in the CNRC study (Butte et al., 2000) against data from 
Fomon (Fomon et al., 1982). CNRC: Children’s Nutrition Research Center, FM: fat 
mass, WT: weight. Reproduced from Butte et al., 2000.  
These descriptions however, fail to delineate between metabolically important 
adipose tissue compartments and ectopic lipid stores (Thomas et al., 2012a).  
Before examining the association between infant feeding and adipose tissue 
distribution and ectopic lipid, it is important to determine the trajectory of 
development seen in a group of healthy infants. 
 
Modern techniques such as MRI and MRS allow in-vivo quantification of 
individual adipose tissue depots and ectopic lipid but their application in 
infancy has been limited.  Where studies of infants have examined adipose 
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tissue distribution, as opposed to fat mass, they have concentrated on the 
immediate postnatal period (Modi et al., 2006, Harrington et al., 2004, Modi et 
al., 2011).  Only two studies report adipose tissue distribution after 14 days, 
both using MRI.  Olhager et al. reported a cross sectional study of 46 healthy 
infants measured once at ages up to 4 months (Olhager et al., 2003) and 
suggested that adipose tissue expansion in early infancy occurs 
predominantly within the subcutaneous depot (figure 5.2).  Conversely Modi et 
al. report a longitudinal study of 21 healthy infants measured at birth and at 6 
weeks (Modi et al., 2006) and demonstrated that the ratio of intra-abdominal 
to subcutaneous adipose tissue (combining deep and superficial abdominal 
subcutaneous depots) did not change significantly (0.029 at birth and 0.027 at 
6 weeks), suggesting adipose tissue expansion occurs at similar rates in 
internal and subcutaneous depots. These conflicting results, likely explained 
by differences in study design (cross sectional versus longitudinal), small 
sample sizes and heterogeneity in feeding (breast, mixed and formula fed 
infants were included), illustrate that the normal development of infant adipose 
tissue distribution remains to be characterised. 
 
Lipid deposited within the liver and other organs, commonly referred to as 
“ectopic” lipid, is strongly associated with insulin resistance in adults (Fabbrini 
et al., 2009) and children (Schwimmer et al., 2008), and has been proposed 
as a causal mediator in the development of insulin resistance (Kumashiro et 
al., 2011).  While extreme fatty infiltration of the liver has long been described 
in infants with severe malnutrition (Williams, 1935), data describing healthy 
infants are scarce.  Only one study, using MRI in healthy term infants (Modi et 
al., 2011), reports intrahepatocellular lipid (IHCL) in the immediate neonatal 
period: median (interquartile range) CH2/water ratio was 0.24 (0.05-0.91) and 
a strong correlation between IHCL and postnatal age at scan was noted, 
although again cross-sectional data precluded firm conclusions.  Another 
study using computerised tomography (CT) was unable to detect fatty 
infiltration of the liver in infants (Kammen et al., 2001), although this may 
reflect the selective, retrospective nature of the cohort and insensitivity of CT 
in detecting hepatic lipid. Technical limitations have limited assessment of 
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ectopic lipid in other organs, such as intramyocellular and pancreatic lipid, in 
young children.  
 
 
Figure 5.2: Subcutaneous and non-subcutaneous AT (litres) vs age 
(days).  Reproduced from Olhager et al., 2003. 
 
 
An important aspect of neonatal and infant adipose tissue development 
relates to mechanistic explanations of metabolic disease, such as the adipose 
tissue overflow (Sniderman et al., 2007) and adiposopathy hypotheses (Bays 
et al., 2005), both outlined in 1.4.2. Both overflow and adiposopathy 
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hypotheses predict that among healthy infants receiving an optimal diet such 
as breast milk, adipose tissue expansion will be confined to subcutaneous 
rather than internal abdominal compartments, without significant hepatic lipid 
accumulation.  I will test these hypotheses by quantifying changes in adipose 
tissue distribution and hepatic lipid during infancy.   
 
A further question is the degree to which other factors influence postnatal 
adiposity.  Gender has long been linked with adult adipose tissue distribution 
(Vague, 1956), a relationship thought to be mediated by sex hormones, 
although the hormones and pathways involved remain to be elucidated, in 
part because the age at which gender differences manifest is unknown.  Other 
perinatal factors, such as increasing maternal BMI, are associated with higher 
internal abdominal adipose tissue and IHCL (Modi et al., 2011) in the 
immediate postnatal period, and it has been proposed that this reflects 
maternal BMI altering the developmental trajectory of offspring lipid stores. 
Further examination of this hypothesis requires longitudinal assessment in 
relation to maternal BMI, and has not been reported to date.   
 
5.2 Aims  
The primary aim is to describe the longitudinal changes in adipose tissue 
distribution and IHCL in healthy, fully breastfed and appropriate weight for 
gestational age term babies. 
 
Secondary aims are to examine the relationship between gender and 
adiposity at 2-3 months, and between maternal BMI and offspring adiposity at 
2-3 months. 
 
5.3 Hypotheses  
I will test the following hypotheses: 
1. By three months increases in superficial subcutaneous adipose tissue 
volume will predominate over increases in internal abdominal adiposity; 
manifesting as a decrease in the ratios internal abdominal adipose 
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tissue:abdominal superficial subcutaneous adipose tissue and internal 
abdominal adipose tissue:non-abdominal superficial subcutaneous 
adipose tissue between T1 and T2. 
2. There will be no detectable increase in IHCL between T1 and T2.
3. There will be no differences in adipose tissue distribution between male
and female infants T2.
4. There will be no detectable association between increasing maternal
BMI and increasing offspring internal abdominal adipose tissue or IHCL
at T2.
5.4 Experimental design 
Prospective cohort study as described in chapter 2.  Recruitment was 
targeted to meet a sample size calculated to detect differences related to 
infant feeding method (as described in Chapter 6).  Post-hoc sample size 
calculations indicate that a group of 38 infants will provide a power to detect a 
difference of 0.46 standard deviations difference in regional adipose tissue 
compartments and 0.5 standard deviations difference in IHCL between first 
and second scan (Hodges and Lehmann, 1956). 
5.5 Results 
5.5.1 Cohort demographic details 
Thirty-eight infants were fully breastfed or received >80% of feeds as breast 
milk at both scan points.  Thirty-two infants were Caucasian, five were of 
mixed origin and one of African origin.  Mean (standard deviation) maternal 
BMI at booking was 23.5kgm-2 (4.6 kgm-2). Demographic details are 
presented in table 5.1. 
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Birth T1 T2 
Age, days* - 13 [9-17] 63 [58-69] 
Post-menstrual age 
age, weeks* 
40.3 [39.0-41.3] 42.6 [41.9-43.1] 49.9 [48.4-50.7] 
Weight, kg 3.452 (0.394) 3.663 (0.419) 5.398 (0.661) 
Weight SDS 0.02 (0.79) -0.23 (0.78) -0.17 (0.87) 
Length, m - 0.533 (0.024) 0.596 (0.025) 
Length SDS - 0.54 (0.89) 0.67 (0.90) 
OFC, cm 34.9 (1.2) 36.6 (1.4) 39.9 (1.2) 
OFC SDS 0.14 (0.88) 0.77 (0.91) 0.78 (0.88) 
Table 5.1 Demographic data for fully breast-fed infants: Values are mean 
(standard deviation) except * where values are median [interquartile range]. OFC: 
occipito-frontal circumference, SDS: standard deviation score. 
5.5.2 Longitudinal change in regional adipose tissue volumes and IHCL 
Summary values for total and regional adipose tissue volumes, and IHCL at 
T1 and T2 are presented in table 5.2.  Total adipose tissue approximately 
doubled between T1 and T2, and significant increases were detected in all 
depots and in IHCL (figure 5.3).  The magnitude of increase differed 
significantly with the largest relative change between T1 and T2 seen in 
abdominal superficial subcutaneous and abdominal deep subcutaneous 
adipose tissue depots. 
T1 T2 % change 
Total adipose tissue 0.718 [0.634-0.914] 
1.494 [1.336-
1.780] 
94 [71-
141] 
Abdominal superficial 
subcutaneous adipose tissue 
0.099 [0.078-
0.125] 
0.251 [0.206-
0.308] 
126 [93-
126] 
Non-abdominal superficial 
subcutaneous adipose tissue 
0.512 [0.461-
0.686] 
1.085 [0.934-
1.245] 
95 [66-
126] 
Abdominal deep 
subcutaneous adipose tissue 
0.015 [0.011-
0.021] 
0.039 [0.030-
0.048] 
145 [71-
230] 
Non-abdominal deep 
subcutaneous adipose tissue 
0.012 [0.009-
0.015] 
0.019 [0.016-
0.023] 
53 [20-
110] 
Internal abdominal adipose 
tissue 
0.017 [0.014-
0.022] 
0.028 [0.021-
0.040] 67 [9-144] 
Non-abdominal internal 
adipose tissue 
0.055 [0.045-
0.066] 
0.086 [0.068-
0.117] 
61 [23-
126] 
IHCL 0.653 [0.367-1.900] 
1.837 [1.408-
2.429] 
160 [19-
398] 
Table 5.2 Summary values for adipose tissue compartments and IHCL: Values 
at T1 and T2 are in litres; data are presented as median [interquartile range].  
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5.5.3 Longitudinal change in adipose tissue indices 
Adipose tissue indices, adjusting for body size at T1 and T2, are presented in 
table 5.3.  Proportionally greater increases were seen in subcutaneous when 
compared to internal abdominal adipose tissue depots, demonstrated by the 
significant decreases in the ratios internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue and internal 
abdominal adipose tissue:non-abdominal superficial subcutaneous adipose 
tissue ratio between T1 and T2, table 5.3.  Increasing adiposity is paralleled 
by decreasing internal abdominal adipose tissue:abdominal superficial 
subcutaneous adipose tissue ratio, figure 5.4. 
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Figure 5.3: Box plot of IHCL 
at first and second scan. 
p<0.001 from related-samples 
Wilcoxon rank signed test.   
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 T1 T2 p-value 
TAT index (TATI) 2.57 [2.24-
3.06] 
4.18 [3.80-
4.95] 
<0.001 
ASSCAT index 
(ASSCATI) 
0.36 [0.29-
0.43] 
0.71 [0.60-
0.89] 
<0.001 
NASSCAT index 
(NASSCATI) 
1.88 [1.63-
2.25] 
3.69 [3.27-
4.38] 
<0.001 
ADSCAT index 
(ADSCATI) 
0.05 [0.04-
0.05] 
0.11 [0.09-
0.14] 
<0.001 
NADSCAT index 
(NADSCATI) 
0.04 [0.03-
0.05] 
0.05 [0.04-
0.07] 
<0.001 
IAAT index (IAATI) 0.06 [0.05-
0.08] 
0.08 [0.06-
0.11] 
0.01 
NAIAT index (NAIATI) 0.20 [0.15-
0.23] 
0.25 [0.19-
0.23] 
<0.001 
IAAT:ASSCAT ratio 0.19 [0.13-
0.23] 
0.11 [0.09-
0.17] 
<0.001 
IAAT:NASSCAT ratio 0.031 [0.024-
0.043] 
0.029 [0.021-
0.038] 
0.048 
Table 5.3 Summary values for adipose tissue ratios: Values are median 
[interquartile range] and significance represents the difference between T1 and T2, 
calculated using a related samples Wilcoxon rank signed test. ADSCAT: Abdominal 
deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
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Figure 5.4: Line chart showing total adipose tissue (TAT) index, black, and 
internal abdominal to superficial subcutaneous abdominal adipose tissue 
(IAAT:ASSCAT) ratio, red, at T1 and T2.  Points represent medians and error bars 
inter-quartile ranges. 
5.5.4 Correlation between IHCL and regional adipose tissue stores 
The increase in IHCL between T1 and T2 was unexpected.  A post-hoc 
analysis was carried out to examine the relationship between IHCL and 
individual adipose tissue depots.  No correlation was found between IHCL and 
total adipose tissue or individual adipose tissue depots at T1 (table 5.4) or at 
T2 (table 5.5).   
 R value p-value 
Total AT 0.02 0.91 
ASSCAT 0.12 0.54 
NASSCAT 0.04 0.84 
ADSCAT 0.03 0.86 
NADSCAT -0.30 0.12 
IAAT -0.18 0.36 
NAIAT -0.11 0.58 
Table 5.4: Correlation between IHCL and regional adipose tissue depots at T1. 
Correlations calculated using Pearson correlation between natural log transformed 
data. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal 
superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; 
NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-
abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous 
adipose tissue. 
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R value p-value 
Total AT 0.13 0.49 
ASSCAT 0.13 0.48 
NASSCAT 0.06 0.74 
ADSCAT -0.14 0.56 
NADSCAT 0.21 0.27 
IAAT 0.18 0.35 
NAIAT 0.12 0.52 
Table 5.5: Correlation between IHCL and regional adipose tissue depots at T2. 
Spearman’s rank correlation. ADSCAT: Abdominal deep subcutaneous adipose 
tissue; ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-
abdominal deep subcutaneous adipose tissue. 
To examine whether greater adiposity was associated with higher IHCL 
accumulation (rather than IHCL per se) the correlations between total and 
regional adipose tissue at T2 and change in IHCL were examined.  No 
significant correlations were detected, table 5.6.  No significant correlation 
was detected between the change in adipose tissue compartments and the 
change in IHCL between T1 and T2, table 5.7. 
R value p-value 
Total AT 0.18 0.32 
ASSCAT 0.16 0.41 
NASSCAT 0.11 0.56 
ADSCAT 0.00 0.99 
NADSCAT 0.09 0.65 
IAAT 0.27 0.15 
NAIAT 0.31 0.09 
Table 5.6: Correlation between change in IHCL between T1 and T2, and 
regional adipose tissue depots at T2. Spearman’s rank correlation. ADSCAT: 
Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial 
subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: 
Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-abdominal 
internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose 
tissue.  
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 Change in volume (l) R value p-value 
Total AT 0.723 [0.509-0.945] 0.16 0.38 
ASSCAT 0.129 [0.105-0.197] 0.17 0.38 
NASSCAT 0.512 [0.368-0.678] 0.12 0.53 
ADSCAT 0.023 [0.013-0.034] 0.04 0.83 
NADSCAT 0.007 [0.003-0.012] 0.04 0.82 
IAAT 0.010 [0.002-0.020] 0.22 0.25 
NAIAT 0.035 [0.017-0.054] 0.32 0.08 
Table 5.7: Correlation between change in IHCL and change in regional adipose 
tissue depots between T1 and T2. Data are median [interquartile range] 
Spearman’s rank correlation. ADSCAT: Abdominal deep subcutaneous adipose 
tissue; ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-
abdominal deep subcutaneous adipose tissue. 
 
5.5.5 Relationship between gender and outcomes 
Twenty-seven male and eleven female infants were included in the cohort.  
Demographic and anthropometric characteristics by gender are displayed in 
table 5.8.  Significant anthropometric gender differences were detected at T2. 
 Male Female 
Birth   
GA, weeks* 40.3 [39.0-41.3] 40.1 [39.4-41.1] 
Weight, kg 3.492 (0.399) 3.354 (0.379) 
OFC, cm 35.1 (1.3) 34.3 (0.6) 
T1   
Age, days* 13 [8-19] 13 [9-16] 
Weight, kg 3.7683 (0.426) 3.617 (0.415) 
OFC, cm 36.8 (1.3) 35.9 (1.3) 
Length, m 0.533 (0.025) 0.531 (0.020) 
T2   
Age, days* 64 [59-70] 61 [49-68] 
Weight, kg 5.557 (0.691) 5.009 (0.373) 
OFC, cm 40.2 (1.3) 39.3 (1.3) 
Length, m 0.600 (0.026) 0.585 (0.017) 
Table 5.8 Demographic and anthropometric characteristics by gender. Data are 
expressed as mean (standard deviation) except where * denotes median [IQR]. 
 
 
No significant differences were detected between males and females in total 
AT, regional AT depots or IHCL in unadjusted analyses at T1 or T2.  There 
were no significant differences detected in the percentage change for total AT 
or any regional AT depot (table 5.9). 
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T1 T2 % change 
Male Female Male Female Male Female 
Total AT 0.710 [0.635-0.897] 
0.767 [0.616-
1.015] 
1.563 [1.292-
1.847] 
1.455 [1.360-
1.589] 
95 [71-
144] 
91 [34-
127] 
ASSCAT 0.097 [0.077-0.120] 
0.106 [0.091-
0.151] 
0.250 [0.202-
0.311] 
0.251 [0.230-
0.272] 
135 [98-
211] 
110 [77-
163] 
NASSCAT 0.512 [0.454-0.654] 
0.564 [0.457-
0.727] 
1.111 [0.924-
1.294] 
1.071 [0.935-
1.121] 
101 [73-
130] 
81 [30-
117] 
ADSCAT 0.015 [0.010-0.021] 
0.017 [0.012-
0.023] 
0.039 [0.028-
0.047] 
0.042 [0.031-
0.050] 
139 [76-
230] 
176 [34-
252] 
NADSCAT 0.012 [0.009-0.014] 
0.012 [0.009-
0.015] 
0.020 [0.015-
0.024] 
0.019 [0.016-
0.021] 
61 [17-
104] 
43 [16-
137] 
IAAT 0.017 [0.014-0.022] 
0.018 [0.012-
0.023] 
0.031 [0.021-
0.042] 
0.026 [0.020-
0.031] 
71 [15-
143] 
63 [-10-
169] 
NAIAT 0.055 [0.047-0.065] 
0.050 [0.041-
0.071] 
0.086 [0.066-
0.116] 
0.095 [0.073-
0.126] 
57 [21-
102] 
109 [24-
157] 
IHCL 0.649 [0.353-3.007] 
0.667 [0.428-
1.401] 
1.846 [1.530-
2.551] 
1.767 [1.327-
2.544] 
183 [56-
424] 
101 [     
-38-366] 
Table 5.9 Unadjusted values for adipose tissue compartments (in litres) and 
IHCL by gender: Data are median [interquartile range]. ADSCAT: Abdominal deep 
subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
There are well-documented differences in body size between male and 
female infants, so adjustment for body size was carried out.  No significant 
differences were detected between male and female infants after adjustment 
for length using adipose tissue indices or in the ratio of internal abdominal 
adipose tissue to abdominal superficial subcutaneous adipose tissue or 
internal abdominal adipose tissue to non-abdominal superficial subcutaneous 
adipose tissue, table 5.10.  Significant differences in weight between male 
and female infants (p=0.007 at T2) were detected; therefore multivariate 
regression analysis was carried out adjusting for weight at scan.  After 
adjustment, total, abdominal superficial subcutaneous, non-abdominal 
superficial subcutaneous and non-abdominal internal adipose tissue volumes 
were significantly higher in female when compared to male infants at T2 (table 
5.11, figure 5.5).  No significant difference was detected in other regional 
adipose tissue depots or in IHCL. 
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 T1 p-value T2 p-value 
Males Females Males Females 
TATI 2.53 [2.25-2.76] 2.68 [2.21-3.57] 0.26* 4.16 [3.69-5.07] 4.26 [3.97-4.78] 0.65 
ASSCATI 0.34 [0.27-0.43] 0.37 [0.32-0.52] 0.12* 0.69 [0.56-0.92] 0.74 [0.64-0.87] 0.41 
NASSCATI 1.81 [1.64-2.12] 1.96 [1.63-2.53] 0.22* 4.03 [3.08-4.69] 3.60 [3.27-4.01] 0.99* 
ADSCATI 0.05 [0.04-0.08] 0.06 [0.04-0.08] 0.43* 0.10 [0.09-0.12] 0.12 [0.08-0.16] 0.43 
NADSCATI 0.04 [0.03-0.05] 0.04 [0.03-0.05] 0.95* 0.05 [0.04-0.07] 0.05 [0.04-0.06] 0.96** 
IAATI 0.06 [0.05-0.08] 0.06 [0.04-0.08] 0.71* 0.09 [0.06-0.11] 0.08 [0.05-0.09] 0.71* 
NAIATI 0.20 [0.14-0.22] 0.19 [0.14-0.26] 0.71* 0.24 [0.19-0.32] 0.26 [0.21-0.36] 0.38* 
IAAT:ASSCAT  0.22 [0.14-0.24] 0.15 [0.12-0.18] 0.09* 0.12 [0.09-0.18] 0.10 [0.08-0.13] 0.19* 
IAAT:NASSCAT 0.035 [0.024-
0.046] 
0.029 [0.024-
0.035] 0.27* 
0.030 [0.021-
0.039] 
0.028 [0.020-
0.032] 0.48** 
 
Table 5.10: Adipose tissue mass index and adipose tissue ratios by gender: P-values represents the difference between male and female 
data from paired t-test, except where * denotes a paired t-test of natural log transformed data, and ** denotes an independent samples Mann-
Whitney U test. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: 
Internal abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal 
adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
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Table 5.11 Values for adipose tissue compartments (in litres) and IHCL by gender, adjusted for scan weight: Values are mean (95% 
confidence intervals). p-values represents the difference between male and female data from multivariable regression analyses. * Denotes that 
the residuals were not normally distributed and natural log transformation was undertaken prior to regression analyses; mean difference and 
95% CI are anti-logged. Red = significant at p≤0.05. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial 
subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; 
NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 
  
 T1 p-value T2 p-value 
Males Females Males Females 
Total AT 0.747 (0.697 to 0.797) 
0.817 (0.735 to 
0.899) 
0.15 1.450 (1.358 to 
1.542) 
1.679 (1.533 to 
1.825) 
0.01 
ASSCAT 0.100 (0.091 to 0.109) 
0.116 (0.101 to 
0.130) 
0.06 0.239 (0.215 to 
0.262) 
0.297 (0.260 to 
0.334) 
0.01 
NASSCAT 0.543 (0.507 to 0.578) 
0.596 (0.539 to 
0.654) 
0.12 1.031 (0.968 to 
1.094) 
1.168 (1.067 to 
1.268) 
0.03 
ADSCAT 0.017 (0.014 to 0.019) 
0.018 (0.014 to 
0.022) 
0.47 0.037 (0.031 to 
0.042) 
0.046 (0.037 to 
0.055) 
0.08 
NADSCAT 0.012 (0.010 to 0.013) 
0.012 (0.010 to 
0.015) 
0.56 0.018 (0.015 to 
0.022)* 
0.021 (0.015 to 
0.028)* 
0.53* 
IAAT 0.019 (0.016 to 0.022) 
0.018 (0.013 to 
0.023) 
0.68 0.033 (0.026 to 
0.039) 
0.032 (0.022 to 
0.042) 
0.96 
NAIAT 0.057 (0.049 to 0.066) 
0.056 (0.042 to 
0.071) 
0.83 0.090 (0.078 to 
0.101) 
0.113 (0.095 to 
0.131) 
0.04 
 
IHCL* 0.760 (0.446 to 1.296)* 
0.882 (0.363 to 
2.143)* 
0.77* 2.030 (1.498 to 
2.751)* 
1.704 (1.044 to 
2.779)* 
0.55* 
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Higher adipose tissue in girls 
Higher adipose tissue 
in boys Higher adipose tissue in girls 
Higher adipose tissue 
in boys 
Mean difference in adipose tissue at T1, litres Mean difference in adipose tissue at T2, litres 
Figure 5.5: Mean difference in adipose tissue compartment and total adipose, tissue by gender (boys compared to girls) at T1 and T2.  
Adjusted for body weight at scan, error bars represent 95% confidence intervals ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: 
Abdominal superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 
T1 T2 
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5.5.6 Relationship between maternal BMI and outcomes 
To examine the associations between maternal BMI and total adipose tissue, 
internal abdominal adipose tissue and IHCL at T1 and T2, multivariable 
analyses, with adjustment for gender and weight at T1 and T2 respectively 
were performed.   
 
No significant associations were detected at T1, total adipose tissue: B=0.000 
litres (95% CI -0.010 to 0.010; p=0.97); internal abdominal adipose tissue: 
B=0.000 litres (95% CI 0.000 to 0.001; p=0.37); LnIHCL: B=-0.012 (95% CI -
0.111 to 0.087; p=0.75, multivariable regression was performed on natural log 
transformed IHCL due to non-normal distribution of residuals for IHCL). 
 
At T2 a significant association was detected between maternal BMI and 
internal abdominal adipose tissue: each unit increase in maternal BMI was 
associated with an increase in internal abdominal adipose tissue of 0.001 
litres (95% CI 0.000 to 0.003; p=0.018, adjusted R2 0.24), figure 5.6.  No 
significant association was detected with total adipose tissue: B=0.006 litres 
(95% CI -0.015 to 0.027; p=0.58) or with LnIHCL:  B= -0.027 (95% CI -0.092 
to 0.038; p=0.40).  When internal abdominal adipose tissue was examined as 
a ratio of internal abdominal adipose tissue to abdominal superficial 
subcutaneous adipose tissue, with adjustment for gender, a similar significant 
association was seen: each unit increase in maternal BMI was associated 
with an increase in internal abdominal adipose tissue:abdominal superficial 
subcutaneous adipose tissue ratio of 0.004 (95% CI 0.001 to 0.008, p=0.016, 
adjusted R2 0.30).   
 
To examine the association between maternal BMI and the change in adipose 
tissue depots and LnIHCL, analyses were repeated adjusting outcomes at T2 
for outcomes at T1.  A significant association remained between maternal BMI 
and internal abdominal adipose tissue after adjustment for gender, weight at 
T2 and internal abdominal adipose tissue at T1: each unit increase in 
maternal BMI was associated with an increase in internal abdominal adipose 
tissue of 0.002 litres (95% CI 0.000 to 0.003; p=0.02; adjusted R2 0.24).  After 
similar adjustments for gender, weight at T2 and adiposity measures at T1, no 
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significant association was found between maternal BMI and total adipose 
tissue at T2: B=0.009 litres (95% CI -0.013 to 0.032; p=0.4), or LnIHCL: B= -
0.023 (95% CI -0.083 to 0.037; p=0.43). 
 
Figure 5.6: Scatter plot showing relationship between maternal BMI and 
internal abdominal adipose tissue at T2. Internal abdominal adipose tissue data 
adjusted for weight at second scan. 
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5.6 Discussion  
Data presented here demonstrate that in healthy, term, fully breastfed, 
appropriate weight for gestational age babies, longitudinal adipose tissue 
accretion during the first 3 months occurs primarily within subcutaneous, as 
opposed to internal depots (figure 5.4).  Over the same period hepatic lipid 
increases significantly (figure 5.3).   
 
Sex differences in total adiposity and in adipose tissue partitioning are not 
detectable in the immediate neonatal period. By 3 months gender differences 
in adjusted adipose tissue distribution, similar to those seen in later life are 
detectable (figure 5.5). 
 
By 3 months a significant association between increasing maternal BMI and 
increasing internal abdominal adipose tissue is seen, in keeping with that 
described in the newborn period (figure 5.6). 
 
 5.6.1 Adiposity and ectopic lipid in the first 3 months 
Adipose tissue distribution and hepatic lipid are strongly associated with 
insulin resistance and metabolic syndrome in older children and adults 
(Despres and Lemieux, 2006, Fabbrini et al., 2009, Caprio, 1999, Bennett et 
al., 2012), yet little is known about how adipose tissue or hepatic lipid change 
during infancy.  The increase in total adipose tissue seen here is as 
anticipated: the proportion of body mass comprised by fat more than doubles 
between birth and 3 months, figure 5.1 (Butte et al., 2000a).  What was 
previously unknown, but quantified here, was how adipose tissue distribution 
and hepatic ectopic lipid change over this period. 
 
A key result is the preferential expansion of subcutaneous relative to internal 
adipose tissue depots, manifest in the decreasing ratio of internal abdominal 
adipose tissue:abdominal superficial subcutaneous adipose tissue and 
internal abdominal adipose tissue:non-abdominal superficial subcutaneous 
adipose tissue between birth and 3 months (table 5.4, figure 5.4). In adults 
and older children, where delineation of abdominal deep subcutaneous 
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adipose tissue from abdominal superficial subcutaneous adipose tissue is 
more difficult, the ratio of internal abdominal adipose tissue:abdominal 
subcutaneous adipose tissue (where abdominal subcutaneous adipose tissue 
comprises abdominal superficial subcutaneous adipose tissue+abdominal 
deep subcutaneous adipose tissue) is widely measured and correlates with 
insulin resistance.  The results presented here are in keeping with the size 
and direction of the difference previously described in internal abdominal 
adipose tissue: abdominal subcutaneous adipose tissue in infants (Modi et al., 
2006), which lends supports to the validity of these findings, despite the 
modest difference detected and the small sample size.  In adults, healthy lean 
men have a higher ratio of internal abdominal adipose tissue: abdominal 
subcutaneous adipose tissue (0.6) than healthy lean women (0.2) (Thomas et 
al., 2012b), a difference thought to arise during puberty (Fox et al., 2000).  
Among healthy pre-pubertal children internal abdominal adipose tissue: 
abdominal subcutaneous adipose tissue ratios are similar between sexes: 
0.39 and 0.31 in 11 year old girls and boys respectively (Fox et al., 2000).  For 
comparison, median values for the ratio internal abdominal adipose tissue: 
abdominal subcutaneous adipose tissue in the cohort presented in this 
chapter are 0.16 and 0.10 for boys at T1 and T2, and 0.13 and 0.08 for girls at 
T1 and T2.  These values at 2-3 months (T2) are considerably lower, than 
those seen in pre-pubertal children (0.31/0.39, boys/girls (Fox et al., 2000)) 
and suggest that substantial accretion of internal abdominal adipose tissue 
relative to abdominal subcutaneous adipose tissue occurs in later childhood.  
The decreasing ratio seen between birth and three months demonstrates that 
adipose tissue growth over this period is made up predominantly by 
subcutaneous adipose tissue expansion.  These findings are in keeping with 
changes proposed by the adipose tissue overflow hypothesis (Sniderman et 
al., 2007, Despres and Lemieux, 2006) and the adiposopathy hypothesis 
(Bays et al., 2005), and support the premise that “primary” or “physiological” 
adipose tissue, such as subcutaneous depots, is able to expand rapidly to 
store the large amounts of energy accumulated during milk feeding without 
overflow into “secondary” adipose tissue stores such as the internal 
abdominal compartment.  
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These hypotheses also predict accumulation of lipid outside adipose tissue 
only after or in parallel with expansion of “secondary” adipose tissue depots 
(such as internal abdominal), a finding not supported by the data presented 
here: a significant increase in IHCL by 2-3 months.  Increasing IHCL with 
increasing postnatal age, while documented in post-mortem studies 
examining stillbirths and neonatal deaths (Aherne, 1965, Dorkin and 
Weinberg, 1949), is a novel finding in healthy human infants.  To place the 
median IHCL values recorded at T2 (1.84) in context, while levels in adults 
above 5.5 are regarded as elevated (Thomas et al., 2005, Browning et al., 
2004), lean fit individuals have virtually undetectable levels of IHCL: a 
geometric mean (SD) 0.41 (0.54) in slim, fit, active men (O'Donovan et al., 
2009) and a median [range] 0.55 [0.08-1.57] in healthy adults (Thomas et al., 
2008); both measured using magnetic resonance spectroscopy.  Furthermore, 
unlike in adults (Kotronen et al., 2011) IHCL did not correlate with internal 
abdominal adipose tissue in my cohort.  This suggests an alternative 
mechanism to that proposed in adults (excess energy intake overwhelming 
the storage capacity of adipose tissue leading to ectopic deposition) operates 
in infancy.  Animal models support this; liver does not express lipoprotein 
lipase (LPL) in adult humans or animals, but high levels of LPL and lipid are 
found the neonatal liver of rats (Llobera et al., 1979) and other animals 
(Olivecrona et al., 1986).  Furthermore, hepatic LPL activity parallels hepatic 
triacylglyerol accumulation in animal models (Grinberg et al., 1985). Hepatic 
LPL expression has not been examined in human infants, but if present would 
allow direct transfer of triacyglycerol from the intestine to the liver via 
chylomicrons, increasing hepatic lipid flux, potentially explaining the increase 
in IHCL seen here.  Further examination of this novel hypothesis should 
concentrate on determining the natural course of IHCL, in particular whether 
IHCL declines in later infancy in keeping with falling hepatic LPL expression 
and triacyglycerol seen over this period in animal models (Herrera and 
Amusquivar, 2000), and seeking to identify hepatic LPL expression in human 
infants. 
 
These findings test the current understanding of energy storage mechanisms 
in infancy and question the presumption that IHCL is “ectopic”.  In Chapter 2 I 
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demonstrated that healthy breast-fed babies have higher fat mass than their 
formula fed counterparts at 3-4 months.  If we accept the presumption that 
breastfeeding represents the ideal diet at this point, then optimal nutrition 
promotes the greatest accretion of adipose tissue prior to weaning. That 
maximal body adipose tissue is beneficial in early infancy is supported by 
evolutionary theories, in which it is proposed that increasing adiposity allows 
the development of larger brains by providing constant substrate for the 
continuous energy requirements of this organ (Cunnane and Crawford, 2003). 
Hepatic lipid, despite being considered almost universally pathological in adult 
practice (Targher et al., 2010), may represent an additional physiological 
energy store in human infants, similar to that seen in migratory birds prior to 
seasonal journeys (and exploited for foie gras).  This would explain the 
increasing hepatic lipid seen here in healthy fully breast-fed infants, and 
suggests an inconsistency similar to the “athletes paradox” (whereby 
endurance athletes, who are exquisitely insulin sensitive, have intramuscular 
triacylglycerol stores often exceeding those seen in diabetic patients 
(Goodpaster et al., 2001)).  Caution is necessary in interpreting the results 
presented here: sample numbers are low and no data on insulin sensitivity of 
the infants are available, so it is conceivable that the increase in IHCL seen is 
associated with insulin resistance.  At the very least however, the possibility 
that hepatic lipid accumulation is physiological in some instances, initially 
raised over 60 years ago (Dorkin and Weinberg, 1949), must be reconsidered. 
 
5.6.2 Gender related differences in adiposity 
Sexual dimorphism in body composition is well described (Wells, 2007b): at 
birth boys have greater lean mass but similar fat mass to girls, both then 
accumulate relative fat mass which peaks at approximately 6 months. 
Relative fat mass then declines in boys and girls up to 6 years, after which 
girls accumulate fat mass while boys accumulate lean tissue (Fomon et al., 
1982).  This divergent pattern continues during puberty, accentuating gender 
differences (Maynard et al., 2001) and resulting in increased relative fat mass 
in female adults compared to males.  Gender differences in the distribution of 
adult adipose tissue have also long been recognised (Vague, 1956), 
characterised by higher internal abdominal adipose tissue and lower 
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subcutaneous adipose tissue in men, and are thought to be linked with higher 
cardiovascular risk seen in males compared to pre-menopausal females.  
However, the age when differences begin to manifest remains to be 
elucidated.  Small differences in adipose tissue distribution are seen in 
newborns: total, abdominal and non-abdominal compartments are larger in 
girls (Modi et al., 2011), and prior to puberty differences in keeping with those 
described in adults are established (He et al., 2002).  Gender related 
divergence in adipose tissue distribution must therefore occur between birth 
and puberty.  The data presented here demonstrates that significant changes 
occur in the first three months, leading to increased relative adipose tissue 
volume in females, distributed in subcutaneous depots (figure 5.5).  Gender 
related adiposity differences have been attributed to sex hormones: 
testosterone mediates deposition of adipose tissue in abdominal regions and 
oestrogen in gluteo-femoral regions (Norgan, 1997), and androgen receptors 
are more densely expressed in visceral than in subcutaneous adipose tissue 
(Rosenbaum and Leibel, 1999). In keeping with my findings there exists a 
“minipuberty of early infancy”: although luteinising hormone (LH), follicle 
stimulating hormone (FSH) and sex hormones are generally low in childhood 
there is surge shortly after birth, in boys FSH, LH and testosterone 
concentrations increase during the first week before decreasing by about 6 
months, while in girls FSH, LH and eostrogen increase shortly after birth and 
remain raised until 2-3 years (Grumbach, 2005).  I suggest that the gender 
related divergence in regional adiposity seen here is mediated by this 
“minipuberty” which may be in part responsible for the differences in fat 
distribution established prior to puberty. 
 
5.6.3 Maternal BMI and infant adiposity 
The novel association found between increasing maternal BMI and greater 
offspring internal abdominal adipose tissue at 3 months (figure 5.12), 
describes the relationship between maternal BMI and adiposity beyond the 
immediate post-partum – where a direct association between maternal BMI 
and offspring total adipose tissue, internal abdominal adipose tissue and IHCL 
has been previously described (Modi et al., 2011).  Intriguingly, I find no 
evidence of an association between maternal BMI and total adipose tissue. 
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This may simply reflect type 2 error given the small sample size, however if 
correct it suggests that the association between maternal BMI and offspring 
adiposity is different in infancy - where an association between maternal BMI 
and offspring adipose tissue partitioning exists - compared to the immediate 
postnatal period - where the association is with total adiposity.  This premise 
is supported by results showing that following adjustment for adiposity at T1 a 
significant association remains, illustrating that rather than increased internal 
abdominal adipose tissue tracking from birth, internal abdominal adipose 
tissue accumulates at an increasing rate with increasing maternal BMI.  There 
is biological plausibility in this: differences in breast milk macronutrient 
composition, insulin (Ley et al., 2012), adipokines (Martin et al., 2006), and 
appetite regulating hormones (Miralles et al., 2006b) are well described in 
relation to maternal BMI, and systemic absorption of enteral hormones has 
been described in animal models (Sanchez et al., 2005).  If replicated, these 
findings have the potential to lead to postnatal strategies, such as dietary 
interventions for breastfeeding mothers, aiming to ameliorate effects of high 
maternal BMI on offspring adiposity.  
 
5.6.4 Strengths and limitations 
Strengths of the results presented here include the use of gold standard direct 
measurement methods and the inclusion of breastfed babies only, controlling 
for the effect of feeding.  While all babies received at least 80% of feeds as 
maternal breastmilk, I was unable to use WHO defined exclusive 
breastfeeding due to the number of parents giving small amounts of non-
breastmilk liquids to their babies, commonly a formula “top up” at evening 
feeds or water throughout the day.  Breastfeeding data was collected 
prospectively using a feeding diary, reducing the potential for recall bias.  An 
important limitation is the unequal gender distribution, with a predominance of 
male babies.  This has implications for analyses of between gender 
differences, but would be expected to lead underestimation of any true 
difference.  If changes in body composition differ between genders, as we 
find, then this could lead over-representation of male patterns of development 
in pooled analyses.  Any difference should however be minimal in longitudinal 
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analyses as the magnitude of difference between genders is substantially 
lower than the differences seen over time.  
 
5.6.5 Summary 
Determining the changes in adiposity characterising early development is vital 
to understanding lipid metabolism during the perinatal transition, when 
predominantly lipid milk feeds replace the exclusive carbohydrate and protein 
substrates supplied in-utero.  To my knowledge, this is the first longitudinal 
description of adipose tissue and ectopic hepatic lipid reported in breastfed 
babies.  While the preferential accumulation of subcutaneous rather than 
internal abdominal adipose tissue is in keeping with accepted theories of 
adipose tissue metabolism, the increase in IHCL seen is novel. 
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Chapter 6 
Infant feeding and adiposity 
 
6.1 Introduction  
A potential mechanism by which infant feeding mediates later metabolic 
health is via adipose tissue function.  In human adults and children adipose 
tissue morphology and function differs in relation to anatomical location 
(Wajchenberg, 2000, Grohmann et al., 2005); therefore it is reasonable to 
suggest that adipose tissue distribution, which can be non-invasively 
quantified, can be considered a surrogate marker for adipose tissue function.  
In Chapter 3 I have demonstrated significant differences in fat mass between 
breastfed and formula fed infants.  These findings suggest an association 
between infant feeding and adipose tissue size, but provide only the most 
rudimentary data on adipose tissue distribution.  It remains uncertain therefore 
whether it is simply adipose tissue size that is associated with infant feeding, 
or whether distribution (and therefore potentially function) is also affected.  To 
further investigate the hypothesis that infant feeding is associated with 
alterations in adipose tissue, I will directly measure the volume and 
distribution of adipose tissue in infancy in relation to breast and formula 
feeding.  
 
Intrahepatocellular lipid, while strongly linked with insulin resistance and 
dysregulated metabolism in adults (Fabbrini et al., 2009), appears almost 
universal among healthy breastfed babies by 2-3 months (Chapter 5).  In the 
early life setting, normally characterised by massive increases in adiposity 
(Fomon, 1967, Fomon and Nelson, 2002), I propose that increasing IHCL 
represents a physiological energy store.  It is worth considering what effect 
formula feeding would exert on IHCL in this context: in chapter 3 I describe 
significantly lower fat mass in formula-fed when compared to breastfed infants 
at 3 months, I therefore expect similar findings in hepatic lipid – namely lower 
IHCL in the formula fed group.  I will test this hypothesis using in-vivo hepatic 
magnetic resonance spectroscopy to quantify IHCL. 
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6.2 Aims  
The primary aims are to compare directly quantified total adipose tissue 
volume, adipose tissue distribution and hepatic lipid between breastfed and 
formula fed infants.   
 
6.3 Hypotheses  
I will test the following null hypotheses: 
1. No differences are detectable in total adipose tissue volume at 2-3 
months or in change in total adipose tissue volume between birth and 
2-3 months, between breastfed and formula fed infants. 
2. No differences are detectable in adipose tissue distribution at 2-3 
months or in change in adipose tissue distribution between birth and 2-
3 months, between breastfed and formula fed infants. 
I will test the following hypothesis: 
3. Intrahepatocellular lipid at 2-3 months, and in change in IHCL between 
birth and 2-3 months, is lower in formula fed when compared to 
breastfed infants.  
 
6.4 Experimental design 
Prospective cohort study as described in chapter 2. 
 
6.4.1 Timing of magnetic resonance investigations 
The primary outcomes are variable at birth and correlated with antenatal 
factors such as maternal BMI (Modi et al., 2011).  To minimise this variation 
paired investigations were undertaken to examine change in body 
composition.  The first MR investigation was carried out as soon after birth as 
possible (T1) and the second between 8 and 12 weeks age (T2).  The age for 
T2 was chosen for two reasons: Firstly, lipid accretion is maximal between 
two and three month’s age (Butte et al., 2000a, Fomon et al., 1982), therefore 
any alteration to adipose tissue growth should be most readily detectable at 3 
months.  Secondly, investigations were performed in natural sleep to avoid 
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the risks associated with oral sedation, and this is increasingly difficult to 
achieve when infants are greater than 12 weeks old (Hansen, 2009, Sury et 
al., 2005, Harrington et al., 2004). 
 
6.4.2 Sample size 
One previous study examined longitudinal changes in directly measured 
adipose tissue volume among healthy term infants, between birth and 
approximately 6 weeks.  This study included 15 infants and percentage 
adiposity at 6 weeks was 26.0% in breastfed infants and 27.5% in formula fed 
infants (Modi et al., 2006).  Assuming a correlation of 0.6 between baseline 
measurements at birth and outcome measurements before 12 weeks, 28 
infants are required in both exclusively formula fed and exclusively breastfed 
groups.  These figures are calculated based on 80% power and 5% 
significance using analysis of covariance with measurements at 12 weeks as 
the outcome measure and adjusting for the baseline measurement at birth. In 
this cohort 33% received mixed feeds and 18% dropped-out between the first 
and second scan. To allow for similar attrition target recruitment was 100 
infants, to complete longitudinal scans on 84 (28 in each group: exclusively 
breast, exclusively bottle and mixed feeding).    
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6.5 Results - all feeding groups 
6.5.1 Recruitment 
Recruitment is outlined in figure 6.1.  In total 53 infants were recruited and 
attended for imaging at T1 and T2. Complete data suitable for analysis at T1 
and T2 was obtained from 49 infants; three datasets at T1 and one dataset at 
T2 were incomplete (due to technical problems).  
 
 
Figure 6.1: Flow chart showing recruitment for prospective cohort study. N 
indicates the number of participants at each stage. 
 
Interim analysis demonstrated higher than expected recruitment in the 
breastfed group, lower numbers of mixed fed infants and particular difficulties 
in recruiting formula fed infants, therefore recruitment in the final year was 
targeted to formula fed infants.   Despite this, recruitment in the formula fed 
group was insufficient to meet the sample size calculation, so 17 infants (6 
formula fed, 5 mixed fed and 6 breastfed) investigated as part of a previous 
study (Modi et al., 2006) (using identical longitudinal imaging and analysis 
techniques) were included.  The final cohort included 87 infants who 
underwent at least one investigation.  Descriptive data are presented in table 
Successful 
longitudinal scans 
n=53 
Attended at T1 
n=74 
Recruited 
n=107 
Unable to scan at 
T1 n=4 
Dropped out prior to 
T1 n=33 
Successful scan at 
T1 n=70 
Dropped out prior to 
T2 n=5 
Attended at T2 
n=65 
Unable to scan at 
T2 n=12 
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6.1.  Seventy-three infants underwent paired magnetic resonance 
investigations. 
 
 Birth T1 T2 
n 87 87 73 
Age (days)* - 13 [8-19] 63 [57-70] 
Gestational age 
(weeks+days)* 
40+1 [39+0-41+0] 42+0 [40+5-43+0] 49+0 [47+5-50+4] 
Weight (kg) 3.456 (0.447) 3.656 (0.548) 5.402 (0.661) 
Weight SDS 0.04 (0.92) -0.13 (0.91) 0.01 (0.87) 
Weight gain SDS - - -0.03 (0.84) 
Length (m) - 0.528 (0.025) 0.592 (0.027) 
Length SDS - 0.46 (1.00) 0.65 (1.09) 
OFC (cm) 34.8 (1.2) 36.2 (1.5) 39.6 (1.4) 
OFC SDS 0.21 (1.00) 0.66 (0.94) -0.03 (0.84) 
Table 6.1 Demographic data for cohort: Values are mean (standard deviation) except * where 
values are median [interquartile range]. OFC: occipito-frontal circumference, SDS: standard 
deviation score. Weight gain SDS is calculated between birth weight and weight at T2. 
 
6.5.2 Method of feeding 
Fifty infants were fully or predominantly breastfed at T1, eight were mix fed 
and 28 were fully or predominantly formula fed.  Thirty-nine infants were fully 
or predominantly breastfed at T2, six were mix fed and 28 were fully or 
predominantly formula fed.  Definitions from Chapter 2 were used to ascribe a 
single feeding group to each infant with longitudinal data (n=73): 38 in the 
breastfed group, nine in the mixed fed group and 26 in the formula fed group.  
 
6.5.3 Anthropometric characteristics by method of feeding 
Descriptive and birth anthropometric data by longitudinal feeding group are 
given in table 6.2.  Anthropometric data at T1 and T2 by feeding group are 
given in table 6.3.  No significant differences in anthropometric measures 
were detected between feeding groups at birth, T1 or T2 (by one-way 
ANOVA).  When breastfed and formula-fed groups were compared using 
independent sample t-tests, weight SDS was significantly higher in the 
formula fed group (p=0.045), with a trend towards higher weight gain SDS in 
the formula fed group between T1 and T2 (p=0.071).  No other significant 
differences were detected between groups. 
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 Breastfed Mixed fed Formula fed 
Male gender 71% 56% 38% 
Caucasian 84% 67% 77% 
Maternal BMI 23.5 (4.6) 22.9 (1.2) 24.7 (4.2) 
Maternal graduate 55% 33% 42% 
Gestational age 
(weeks+days)* 
40+2 [39+0-41+2] 40+3 [38+4-40+5] 39+4 [38+4-40+5] 
Weight (kg) 3.452 (0.394) 3.355 (0.423) 3.391 (0.451) 
Weight SDS -0.02 (0.79) -0.17(0.86) -0.05 (0.93) 
OFC (cm) 34.9 (1.2) 35.7 (1.3) 34.6 (1.2) 
OFC SDS 0.14 (0.88) 0.77 (1.44) 0.21 (1.16) 
Table 6.2 Descriptive and birth data by longitudinal feeding group: Values are mean 
(standard deviation) except * where values are median [interquartile range]. OFC: occipito-
frontal circumference, SDS: standard deviation score. 
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 T1 T2 
Breastfed Mixed fed Formula fed Breastfed Mixed fed Formula fed 
n 38 9 26 38 9 26 
Age (days)* 13 (9-17) 2 (1-11) 16 (6-20) 63 (58-69) 59 (45-72) 64 (56-74) 
Gestational age 
(weeks+days)* 
42+2 (40+5-
43+0) 
40+5 (39+5-
41+3) 
49+0 (47+1-
50+6) 
49+3 (47+6-
50+4) 
48+1 (46+5-
50+0) 
49+0 (47+1-
50+6) 
Weight (kg) 3.664 (0.419) 3.332 (0.478) 3.598 (0.595) 5.399 (0.661) 5.317 (0.667) 5.435 (0.682) 
Weight SDS -0.23 (0.78) -0.26 (0.98) -0.12 (0.99) -0.17 (0.87)** 0.12 (1.23) 0.25 (0.69)** 
Weight gain SDS - - - -0.22 (0.84) 0.19 (1.09) 0.15 (0.73) 
Length (m) 0.533 (0.024) 0.510 (0.025) 0.521 (0.026) 0.596 (0.025) 0.582 (0.031) 0.589 (0.029) 
Length SDS 0.54 (0.89) 0.08 (1.30) 0.30 (1.00) 0.67 (0.84) 0.43 (1.56) 0.71 (1.18) 
OFC (cm) 36.6 (1.4) 38.7 (2.1) 35.9 (1.6) 39.9 (1.2) 38.7 (2.1) 39.4 (1.3) 
OFC SDS 0.77 (0.91) 0.39 (1.24) 0.60 (1.06) 0.78 (0.88) 0.39 (1.24) 0.76 (0.96) 
Table 6.3: Anthropometric data by feeding group at T1 and T2. Values are mean (standard deviation) except * where values are median (interquartile 
range). OFC: occipito-frontal circumference, SDS: standard deviation score. ** denotes p<0.05 by independent sample t-test 
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6.5.4 Adiposity by method of feeding 
Total and regional adipose tissue volumes and IHCL by feeding group 
(breastfed, mixed-fed or formula-fed) are represented in table 6.4. Adipose 
tissue indices (adjusting for length) and ratios, by feeding group (breastfed, 
mixed-fed or formula-fed), are presented in table 6.5. No significant 
differences were detected between feeding groups at T1 or T2 when tested by 
one-way ANOVA (of natural log transformed data where required) or by 
independent samples Kruskal-Wallis test for non-parametric data (see 
Chapter 4).  Intrahepatocellular lipid increased significantly between T1 and 
T2 in all feeding groups in parallel with increasing total adiposity, figure 6.2. 
 
 
Figure 6.2: Line chart showing change in total adipose tissue (TAT) in black 
and intrahepatocellular lipid (IHCL) in red over time, in days.  Data are median 
values. 
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Table 6.4: Adipose tissue compartments (litres) and IHCL at T1 and T2 by feeding group. Values are median [interquartile range]. p 
values calculated from 1-way ANOVA except where * denotes 1-way ANOVA preformed on natural log transformed data and where ** denotes 
independent samples Kruskal-Wallis test. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial 
subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; 
NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 T1 T2 
Breastfed Mixed fed Formula fed p Breastfed Mixed fed Formula fed p 
n 37 9 25  37 9 25  
TAT 
0.718 [0.634-
0.914] 
0.802 [0.543-
1.052] 
0.722 [0.593-
0.940] 0.98* 
1.494 [1.336-
1.780] 
1.763 [1.391-
1.913] 
1.534 [1.324-
1.930] 0.48 
ASSCAT 
0.099 [0.078-
0.125] 
0.110 [0.074-
0.157] 
0.103 [0.075-
0.151] 0.77* 
0.251 [0.206-
0.308] 
0.323 [0.222-
0.361] 
0.261 [0.216-
0.324] 0.38 
NASSCAT 0.512 [0.462-0.686] 
0.572 [0.382-
0.756] 
0.521 [0.431-
0.653] 0.99* 
1.085 [1.632-
2.250] 
0.339 [0.270-
0.591] 
1.085 [0.926-
1.338] 0.65* 
ADSCAT 0.015 [0.011-0.021] 
0.013 [0.009-
0.024] 
0.019 [0.011-
0.022] 0.72* 
0.039 [0.030-
0.048] 
0.044 [0.039-
0.057] 
0.036 [0.031-
0.051] 0.46 
NADSCAT 0.012 [0.009-0.015] 
0.012 [0.012-
0.015] 
0.013 [0.011-
0.017] 0.31* 
0.019 [0.016-
0.023] 
0.023 [0.020-
0.026] 
0.019 [0.015-
0.023] 0.33** 
IAAT 0.017 [0.014-0.022] 
0.022 [0.014-
0.028] 
0.017 [0.012-
0.025] 0.77* 
0.028 [0.021-
0.040] 
0.029 [0.025-
0.045] 
0.034 [0.24-
0.042] 0.68* 
NAIAT 0.055 [0.045-0.066] 
0.061 [0.044-
0.080] 
0.052 [0.027-
0.073] 0.70* 
0.086 [0.068-
0.117] 
0.081 [0.064-
0.092] 
0.098 [0.074-
0.127] 0.38* 
n 32 4 20  31 4 20  
IHCL 0.653 [0.367-1.900] 
1.126 [0.666-
1.608] 
1.197 [0.670-
1.690] 0.41* 
1.837 [1.408-
2.429] 
0.850 [0.538-
3.124] 
1.840 [1.384-
3.125] 0.25** 
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Table 6.5: Adipose tissue indices and ratios at T1 and T2 by feeding group. Values are median [interquartile range]. p values calculated 
from 1-way ANOVA except where * denotes 1-way ANOVA preformed on natural log transformed data and where ** denotes independent 
samples Kruskal-Wallis test. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous adipose 
tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-abdominal 
internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
 
 T1 
Breastfed Mixed fed Formula fed p Breastfed Mixed fed Formula fed p 
n 37 9 25  37 9 25  
TATI 
2.57 [2.24-
3.06] 
2.97 [2.18-
4.04] 
2.67 [2.27-
3.21] 0.51* 
4.18 [3.80-
4.95] 
4.80 [4.00-
5.84] 
4.51 [3.80-
5.32] 0.17 
ASSCATI 
0.36 [0.29-
0.43] 
0.41 [0.27-
0.63] 
0.38 [0.30-
0.53] 0.37* 
0.71 [0.60-
0.89] 
0.96 [0.68-
1.04] 
0.78 [0.66-
0.90] 0.15 
NASSCATI 1.88 [1.63-2.25] 
2.12 [1.54-
2.59] 
1.94 [1.62-
2.27] 0.60* 
3.69 [3.27-
4.38] 
0.97 [0.84-
1.72] 
4.02 [3.38-
4.94] 0.71* 
ADSCATI 0.05 [0.04-0.08] 
0.06 [0.03-
0.09] 
0.07 [0.04-
0.08] 0.84* 
0.11 [0.09-
0.14] 
0.13 [0.10-
0.17] 
0.11 [0.09-
0.14] 0.27 
NADSCATI 0.04 [0.03-0.05] 
0.05 [0.04-
0.06] 
0.05 [0.04-
0.06] 0.07* 
0.05 [0.04-
0.07] 
0.07 [0.06-
0.08] 
0.06 [0.04-
0.06] 0.96** 
IAATI 0.06 [0.05-0.08] 
0.07 [0.06-
0.10] 
0.06 [0.04-
0.08] 0.60* 
0.08 [0.06-
0.11] 
0.09 (0.07-
0.13] 
0.09 [0.07-
0.12] 0.51* 
NAIATI 0.20 [0.15-0.23] 
0.24 [0.18-
0.28] 
0.20 [0.18-
0.25] 0.26* 
0.25 [0.19-
0.33] 
0.22 [0.20-
0.27] 
0.29 [0.22-
0.36] 0.39* 
IAAT:ASSCAT 0.19 [0.14-0.23] 
0.16 [0.13-
0.25] 
0.16 [0.12-
0.20] 0.44* 
0.11 [0.09-
0.17] 
0.11 [0.08-
0.15] 
0.13 [0.08-
0.16] 0.85* 
IAAT:NASSCAT 0.03 [0.02-
0.04] 
0.03 [0.02-
0.05] 
0.03 [0.02-
0.04] 0.76* 
0.03 [0.02-
0.03] 
0.10 [0.06-
0.13] 
0.03 [0.02-
0.04] 0.72** 
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6.6 Results - Breastfed compared to formula fed infants  
Primary outcomes relate to comparisons between breastfed and formula fed 
infants and power calculations were performed for comparisons between two 
groups.  In addition, the mixed feeding group was small and heterogeneous 
with regard to method of feeding (ranging from >20% to <80% formula feeds).  
For these reasons further analysis was between breastfed and formula fed 
groups (after removal of the mixed feeding group). Results are presented as 
differences in adipose tissue volumes at T1 and T2, before presenting 
adiposity indices and ratios (thus adjusting for length) at T1 and T2. 
 
6.6.1 Adipose tissue volume and intrahepatocellular lipid in breastfed 
compared to formula-fed infants 
No significant differences in total or regional adipose tissue volumes or IHCL 
were detected between breastfed and formula-fed infants, table 6.6.  Different 
statistical techniques were required to account for the non-normal distribution 
of some data (see Chapter 4). 
 T1 T2 
 Difference (95%CI) p  Difference (95%CI) p  
Total AT  0.9% (-12.4, 16.2)* 0.90† 0.117 (-0.085, 0.318) 0.25 
ASSCAT  6.4% (-11.4, 27.8)* 0.50† 0.023 (-0.020, 0.066) 0.29 
NASSCAT  -0.06% (13.6, 14.2)* 0.93† 8.2% (-5.2, 23.5)* 0.23† 
ADSCAT  1.5% (-18.1, 25.9)* 0.89† 0.000 (-0.008, 0.008) 0.99 
NADSCAT  12.7% (-4.3, 33.0)* 0.15† ** 0.96†† 
IAAT  -5.6% (-24.3, 17.5)* 0.60† 9.7% (-11.4, 35.9)* 0.39† 
NAIAT  6.1% (-10.0, 25.0)* 0.47† 4.9% (-12.6, 26.1)* 0.60† 
IHCL 45.5% (-18.6, 260.3)* 0.14 † ** 0.85†† 
Table: 6.6: Difference in total adipose tissue (litres), regional adipose 
tissue depots (litres) and intrahepatocellular lipid (ratio CH2:H2O), 
formula-fed babies compared to breastfed babies at T1 and T2.  
Difference represents mean difference except where * denotes mean 
percentage difference, and ** denotes unable to calculate as non-parametric 
test.  p value from independent samples t-test except where † denotes 
independent samples t-test of natural log converted data and †† denotes 
independent samples Mann-Whitney U test. ADSCAT: Abdominal deep 
subcutaneous adipose tissue; ASSCAT: Abdominal superficial subcutaneous 
adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: Non-abdominal 
superficial subcutaneous adipose tissue; NAIAT: Non-abdominal internal adipose 
tissue; NASSCAT: Non-abdominal deep subcutaneous adipose tissue. 
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To place these results in context I have compared them with results obtained 
from the meta-analysis (Chapter 3).  For this purpose mean difference (95% 
confidence intervals) in total adipose tissue volume (from table 6.6) was 
converted to mean difference (95% confidence intervals) in total fat mass 
between breastfed and formula-fed babies at T2 as described in Chapter 2.  
Results are presented with mean differences in fat mass over the first year, 
from Chapter 3, in figure 6.3. 
Figure 6.3: Pooled mean differences and 95% confidence intervals for fat-mass 
(kg) in formula-fed infants relative to breast-fed infants, by age. Black diamonds 
represent fat mass data from Chapter 4 where a fixed effects meta-analysis was 
undertaken in RevMan5 using the inverse variance method.  The red square 
represents fat mass data derived from MRI measured total adipose tissue volume at 
T2: 0.05kg (95% CI -0.03, 0.12). 
6.6.2 Adipose tissue distribution in breastfed compared to formula-fed 
infants 
No significant differences were detected in the adipose tissue distribution; 
represented as percentage of total adipose tissue for each compartment, 
between feeding groups at T1 or T2, figure 6.4.  
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Figure 6.4: Stacked bar chart showing mean regional adipose tissue volumes 
as a proportion of total adipose tissue volume at T1 and T2, by feeding. 
ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal 
superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; 
NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-
abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous 
adipose tissue. 
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6.6.3 Adipose tissue indices and ratios in breastfed compared to 
formula-fed infants 
No significant differences in adiposity indices adjusted for length or in the 
ratios internal abdominal adipose tissue:abdominal superficial subcutaneous 
adipose tissue or internal abdominal adipose tissue:non-abdominal superficial 
subcutaneous adipose tissue were detected between breastfed and formula-
fed infants, table 6.7. Different statistical techniques were required to account 
for the non-normal distribution of some data (see Chapter 4). 
 T1 T2 
 Difference (95%CI) p  Difference (95%CI) p  
TAT index 4.6% (-7.6, 18.3)* 0.47† 0.43 (-0.08, 0.93) 0.09 
ASSCAT index 10.2% (-6.7, 30.3)* 0.25† 0.08 (-0.03, 0.19) 0.16 
NASSCAT index -2.9% (8.8, 16.3)* 0.64† 11.3% (-1.5, 25.6)* 0.08† 
ADSCAT index 5.2% (-14.1, 28.8)* 0.62† 0.00 (-0.02, 0.02) 0.89 
NADSCAT index 16.7% (0.5, 35.6)* 0.04† ** 0.67†† 
IAAT index -2.3% (-21.3, 21.4)* 0.83† 12.4% (-9.5, 40.7)* 0.28† 
NAIAT index 9.9% (-5.7, 28.1)* 0.22† 7.9% (-8.9, 27.9)* 0.37† 
IAAT:ASSCAT -11.4% (-26.7, 7.2)* 0.21† -0.4% (-17.9, 20.7)* 0.96† 
IAAT:NASSCAT -5.1% (-21.7, 15.1)* 0.59† ** 0.85†† 
Table: 6.7: Difference in adiposity indices and regional adipose tissue ratios, 
formula-fed babies compared to breastfed babies at T1 and T2.  Difference 
represents mean difference except where * denotes mean percentage difference, 
and ** denotes unable to calculate as non-parametric test.  p value from independent 
samples t-test except where † denotes independent samples t-test of natural log 
converted data and †† denotes independent samples Mann-Whitney U test. 
ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal 
superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; 
NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-
abdominal internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous 
adipose tissue. 
 
 
6.6.4 Change in adiposity in breastfed compared to formula-fed infants 
To minimise the influence of antenatal factors I examined the association 
between method of feeding and change in adipose tissue compartments 
between T1 and T2. Multivariable regression analyses were used, adjusting 
adipose tissue volume at T2 for adipose tissue volume at T1, for gender, and 
for weight SDS at T2 (to control for the effect of body size and of post-
conceptual age at T2), table 6.8.  No significant differences were found 
between feeding groups. 
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Table 6.8: Adiposity at T2 after adjustment for gender, weight SDS at T2 
and adiposity at T1. Data are mean and (95% confidence intervals) and p 
values from multivariable regression, except where * denotes geometric mean 
and (95% confidence intervals) and where ** denotes p values from 
multivariable regression of natural log transformed data (performed using 
transformed data due to non-normal distribution of residuals). ADSCAT: 
Abdominal deep subcutaneous adipose tissue; ASSCAT: Abdominal superficial 
subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue; NADSCAT: 
Non-abdominal superficial subcutaneous adipose tissue; NAIAT: Non-abdominal 
internal adipose tissue; NASSCAT: Non-abdominal deep subcutaneous adipose 
tissue. 
Breastfed Formula fed p 
TAT 1.536 (1.417, 1.656) 1.578 (1.441, 1.715) 0.65 
ASSCAT 0.262 (0.235, 0.288) 0.269 (0.238, 0.299) 0.74 
NASSCAT 1.079 (0.999, 1.160) 1.118 (1.027, 1.210) 0.53 
ADSCAT 0.040 (0.035, 0.046) 0.037 (0.031, 0.043) 0.46 
NADSCAT 0.020 (0.017, 0.024)* 0.019 (0.015, 0.022)* 0.54** 
IAAT 0.032 (0.027, 0.038) 0.034 (0.028, 0.041) 0.62 
NAIAT 0.098 (0.085, 0.111) 0.100 (0.085, 0.114) 0.86 
IHCL 1.855 (1.383, 2.489)* 1.781 (1.276, 2.482)* 0.85** 
IAAT:ASSCAT 0.126 (0.109, 0.143) 0.138 (0.118, 0.158) 0.37 
IAAT:NASSCAT 0.030 (0.025, 0.034) 0.033 (0.027, 0.038) 0.41 
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6.7 Discussion  
In this prospective cohort study I examined the hypothesis that method of 
infant feeding is associated with changes in directly measured adipose tissue, 
adipose tissue distribution and hepatic lipid accumulation, in infancy. I found 
no significant differences between feeding groups in these parameters at T2 
or in the change in parameters between T1 and T2.  Therefore I am unable to 
reject the null hypotheses that no differences exist in relation to feeding 
method.  The increase in IHCL described in healthy breastfed infants in 
Chapter 5 is replicated among formula fed and mixed fed infants. 
 
6.7.1 Infant feeding and total adipose tissue  
Growth is well known to differ between breastfed and formula fed infants, with 
formula fed infants growing more rapidly during the first year (Dewey, 1998, 
Dewey et al., 1995), a pattern replicated in this cohort, as evidenced by the 
significantly higher weight SDS at T2 among formula fed infants.  One 
potential explanation for this is differences in macronutrient intakes between 
feeding groups.  The newborn diet is rich in lipids (triacylglycerol makes up 
half of the energy content of breastmilk (Pierce et al., 1964)), the absorption 
and digestion of which differs in infancy compared to later childhood or adult 
life.  Important components that compensate for the infant’s low endogenous 
capacity to digest dietary fat (Lindquist and Hernell, 2010) such as bile salt-
stimulated lipase, are found in breast milk but not in artificial formula (Nyberg 
et al., 1998).  Correspondingly, a lower level of dietary fat absorption is seen 
in formula fed compared to breastfed infants (Lindquist and Hernell, 2010), 
while formula fed infants consume a greater proportion and quantity of protein 
(de Bruin et al., 1998).  This is consistent with findings from the meta-analysis 
presented in Chapter 3 (significantly higher fat mass in breastfed infants at 3-
4 months), yet appears at odds with the results presented here: higher, rather 
than lower, total adipose tissue volume among formula fed infants at 2-3 
months (table 6.3 and figure 6.2). 
 
One explanation is that examination of adipose tissue was performed too 
early in this study to detect a significant increase in adipose tissue among 
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breastfed infants.  Adipose tissue expands dramatically and non-linearly in 
infancy (Chapter 5, figure 5.1) and the relationship between infant feeding and 
adiposity is complex (Chapter 3, figure 3.7).  The median age at examination 
here was 2 months whereas significant differences were only detected from 3-
4 months in the meta-analysis (Chapter 3).  Furthermore, the magnitude and 
direction of the difference seen here at 2 months is in keeping with the pooled 
mean difference found at 1-2 months in this meta-analysis, figure 6.3.   
 
Results presented here, in conjunction with meta-analysis data (Chapter 3), 
suggests a pattern where initial differences in adiposity among formula fed 
relative to breastfed infants are negligible before higher adiposity in breastfed 
infants manifests between 3 and 6 months.  This implies that the greatest 
differences between breast and formula fed infants in accretion of adiposity 
occur between 3 and 6 months.  This has implications for artificial formulas, 
suggesting that current artificial formulas stimulate too little adiposity after 3 
months and implying that the current standard formula, designed from birth to 
6 months, may not adequately meet the changing nutritional needs of a 
healthy infant.   
 
Other possibilities are that results of the meta-analysis are incorrect, reflecting 
the inaccuracies inherent in deriving fat mass from indirect measurements, or 
that the results presented here are incorrect, reflecting type II error.  These 
explanations seem unlikely given the apparent consistency between results 
from the meta-analysis and those presented here (figure 6.3), but direct 
longitudinal measurement of adiposity in relation to infant feeding in further 
cohorts would be helpful to corroborate these data. 
 
6.7.2 Infant feeding, regional adiposity and intrahepatocellular lipid 
The results presented here do not suggest any association between method 
of feeding and alterations in the distribution of adipose tissue, figure 6.4, or in 
the accumulation of hepatic lipid, figure 6.2.  Furthermore, the striking 
similarity in adipose tissue distribution and IHCL between feeding groups, 
while not evidence of lack of an association, suggests that if one exists it is of 
limited magnitude at 2-3 months.   
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This study unfortunately leaves unanswered the key question as to whether 
feeding group differences are detectable in the distribution of adipose tissue 
or in IHCL between 3 and 6 months – when the greatest differences in fat 
mass are seen between breastfed and formula fed groups (figure 3.7, Chapter 
3).  
 
The similarity seen across feeding methods in adipose tissue distribution and 
IHCL seen adds add validity to the findings presented in Chapter 5: during 
maximal adipose tissue expansion relative the body weight (between birth and 
2-3 months) increases in the superficial subcutaneous compartments 
predominate and IHCL increases.  This further supports the proposal that the 
accumulation of hepatic lipid is physiological, rather than pathological, over 
this period. 
 
6.7.3 Strengths and weaknesses 
A major limitation of previous studies has been the use of indirect methods to 
estimate body fat and hence adiposity.  These methods assume constant 
values for density of body tissues; assumptions demonstrated to be incorrect 
in infancy (Dju et al., 1958).  In contrast, a key strength of my study is the use 
of a gold-standard technique to directly measure adipose tissue volume.  To 
avoid variability and bias, MR images were independently analysed, blinded 
to feeding group.  Retrospective ascertainment of breastfeeding status has 
been shown to introduce bias (Agampodi et al., 2011) and was avoided by 
prospective data collection, and the inclusion of only healthy appropriate 
weight for gestational age infants reduced the risk selection bias; small for 
gestational age are both more likely to be formula fed (Biosca Pamies et al., 
2013) and have altered adiposity (Modi et al., 2006).  This study is not without 
limitations, the most important of which relate to the difficulties encountered 
recruiting formula fed infants.  This resulted in lower than expected numbers 
in the formula fed group and necessitated the inclusion of infants examined as 
part of another study.  These infants had been examined earlier, at 6-8 
weeks, lowering the median age at T2.  In order to avoid introducing 
differences between feeding groups, infants from this previous cohort were 
included in both formula and breastfed groups.  While powered to detect 
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differences in total adipose tissue, the sizes of the feeding groups limits my 
ability to detect differences in secondary outcomes, such as individual 
adipose tissue compartments and adipose tissue compartment ratios.  As a 
result clinically important differences in IHCL and adipose tissue distribution 
may not have been identified here. 
In keeping with previous observational studies of infant feeding, breastfed and 
formula fed groups differed in ethnicity and maternal education (non-
significantly), although a marker of the latter (maternal university graduate) 
was extremely high in both groups, table 6.2.  Other potential sources of bias 
include confounding by indication: whereby infants who gain weight slowly 
while breast-feeding are commenced on formula milk, and contamination bias: 
some degree of mixed feeding occurred in both formula and breastfed groups. 
Creating “pure” feeding groups to avoid these bias would have had been 
logistically and ethically unfeasible and would result in groups 
unrepresentative of contemporary infant feeding practice.  These limitations 
would be expected to result in the underestimation of any difference between 
groups, a factor that should be considered when interpreting these results. 
6.7.4 Conclusions 
In summary: 
• No significant differences between breastfed and formula fed infants
were detected in directly measured adipose tissue volume, adipose
tissue distribution or IHCL at 2-3 months.
• Accumulation of adipose tissue occurs predominantly within
subcutaneous, rather than internal, adipose tissue depots between
birth and 2-3 months.
• Increasing IHCL is seen in both breastfed and formula fed infants
between birth and 2-3 months.
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Chapter 7 
Early growth and adiposity 
 
7.1 Introduction  
In this and the following chapter I will explore potential mediators of altered 
infant adiposity – aspects where breastfed and formula fed infant differ.  
Initially I will concentrate on differential growth.  That growth rates between 
breastfed and formula fed infants diverge over the first year is well described 
(Dewey, 1998, Dewey et al., 1995).  In addition there exists a wealth of 
studies demonstrating an association between the trajectory of growth in early 
life (fetal and early postnatal periods) and later life body composition and 
cardio-metabolic disease risk.  The strongest associations tend to be seen in 
infants born small (implying poor fetal growth) with subsequent rapid weight 
gain (often referred to as catch-up growth) and increased fat mass and 
cardiovascular and metabolic disease risk in later life (Wells, 2007a).  
However rapid weight gain in the first year (even in the absence of impaired 
fetal growth) is associated with increased incidence of obesity and overweight 
(Monteiro et al., 2003, Baird et al., 2005), dyslipidaemia, insulin resistance 
and central obesity (Leunissen et al., 2009) in adult life. Therefore it is 
plausible that postulated “long-term health effects of infant feeding” are in fact 
“long-term health effects of rapid infant growth”, rather than differences 
between breast and formula feeding per se. 
 
Rapid early growth is also associated with greater fat mass in childhood 
(Chomtho et al., 2008), adolescence (Ekelund et al., 2006) and adult life 
(Demerath et al., 2007), suggesting that alterations to adipose tissue arising 
early in life and tracking through to adulthood may mediate any effect.  
Furthermore early infancy appears to be a key window: rapid weight gain in 
the first 3-6 months is positively correlated with childhood fat mass index and 
central fat distribution (Chomtho et al., 2008) and with adult dyslipidaemia, 
insulin resistance and central obesity (Leunissen et al., 2009), while weight 
gain over the last 6 months of infancy is not.  That associations are detectable 
between early weight gain and indirect measures of central obesity such as 
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waist hip ratio (Leunissen et al., 2009) and DEXA (Chomtho et al., 2008), 
suggests that adipose tissue partitioning may be affected in addition to 
adipose tissue mass.  However the association between early growth and 
directly measured adipose tissue distribution in infancy has not, to my 
knowledge, been investigated. 
 
7.2 Aims  
To examine the association between the rate of early infancy weight gain and 
directly quantified adipose tissue distribution and hepatic lipid. 
 
7.3 Hypotheses  
I will test the following null hypotheses: 
1. Weight gain SDS is not associated with adipose tissue distribution at 2-
3 months or in change in adipose tissue distribution between birth and 
2-3 months. 
2. Weight gain SDS is not associated with IHCL at 2-3 months or in 
change in IHCL between birth and 2-3 months. 
 
7.4 Experimental design  
Prospective cohort study as described in chapter 2.  Infants from all feeding 
groups were included in analysis.  Statistical techniques are outlined in 
Chapter 2. 
 
7.5 Results 
7.5.1 Recruitment 
Cohort recruitment is described in 6.5.1 and descriptive data are presented in 
table 6.1 (Chapter 6) and table 4.1 (Chapter 4).  Seventy-three infants 
underwent paired magnetic resonance investigations. 
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7.5.2 Relationship between birth weight and subsequent weight gain 
There was no significant correlation between birthweight SDS and weight-gain 
SDS (r=-0.89, p=0.45 from Pearson correlation), figure 7.1. 
Figure 7.1:Scatter plot showing relationship between birthweight SDS and weight gain 
SDS. 
7.5.3 Relationship between weight gain and adiposity at T2 
To examine the relationship between weight gain and regional AT depots and 
IHCL at second scan, multivariable regression analyses were used regressing 
adipose tissue volume and IHCL at T2 on weight gain SDS, adjusting for 
gender and birthweight SDS, table 7.1.  After adjustment, a significant positive 
association is found between weight gain SDS and all adipose tissue 
compartments.  A significant negative association seen between weight gain 
SDS and the ratio internal abdominal adipose tissue:abdominal superficial 
subcutaneous adipose tissue.  
!"#$%&'"(%$)*+*
3.002.001.00.00-1 .00-2 .00
,
'"
(%
$)(
-"
.)
*+
*
2.00
1.00
.00
-1 .00
-2 .00
Page 1
Newborn feeding and infant phenotype 
 168 
7.5.4 Relationship between weight gain and change in adiposity between 
T1 and T2 
In order to examine the association between weight gain and change in 
adiposity and hepatic lipid between birth and 2-3 months, multivariable 
regression analyses were performed with additional adjustment for adiposity 
or IHCL at T1.  The associations detected were largely unchanged, table 7.2. 
 
 ! SE p-value r2 
Total AT 0.298 0.040 <0.001 0.52 
ASSCAT 0.060 0.010 <0.001 0.40 
NASSCAT 0.202 0.028 <0.001 0.52 
ADSCAT 0.009 0.002 <0.001 0.27 
NADSCAT 19.4%* 6.4%* 0.01** 0.11** 
IAAT 0.006 0.002 0.01 0.05 
NAIAT 0.019 0.005 <0.001 0.22 
IHCL* -0.7%* 14.6%* 0.96** 0.06** 
IAAT:ASSCAT -0.015 0.007 0.03 0.17 
IAAT:NASSCAT -0.1%* 0.2%* 0.50** 0.11** 
Table 7.1: Regression of adiposity at T2 on weight gain SDS between birth and 
T2, adjusted for birthweight SDS and gender. Data are from multivariable 
regression, except where * percentage change and where ** p values, both from 
multivariable regression of natural log transformed data (performed using 
transformed data due to non-normal distribution of residuals). Red = significant at 
p≤0.05. ADSCAT: Abdominal deep subcutaneous adipose tissue; ASSCAT: 
Abdominal superficial subcutaneous adipose tissue; IAAT: Internal abdominal 
adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous adipose tissue; 
NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-abdominal deep 
subcutaneous adipose tissue. 
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 ! SE p-value r2 
Total AT 0.289 0.042 <0.001 0.54 
ASSCAT 0.058 0.009 <0.001 0.47 
NASSCAT 0.188 0.029 <0.001 0.55 
ADSCAT 0.009 0.002 <0.001 0.29 
NADSCAT 20.4%* 6.2%* 0.003** 0.21** 
IAAT 0.006 0.002 0.007 0.07 
NAIAT 0.017 0.005 <0.001 0.20 
IHCL* 4.0%* 14.6%* 0.77** -0.05** 
IAAT:ASSCAT -0.012 0.007 0.07 0.24 
IAAT:NASSCAT -0.1%* 0.2%* 0.70** 0.13** 
Table 7.2: Regression of adiposity at T2 on weight gain SDS between birth and 
T2, adjusted for birthweight SDS, gender and adiposity or IHCL at T1. Data are 
from multivariable regression, except where * denotes percentage change and ** 
denotes p values, both from multivariable regression of natural log transformed data 
(performed using transformed data due to non-normal distribution of residuals). Red 
= significant at p≤0.05. ADSCAT: Abdominal deep subcutaneous adipose tissue; 
ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue; NADSCAT: Non-abdominal superficial subcutaneous 
adipose tissue; NAIAT: Non-abdominal internal adipose tissue; NASSCAT: Non-
abdominal deep subcutaneous adipose tissue. 
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7.6 Discussion  
The positive association between rate of weight gain and adipose tissue 
volume is not unexpected.  Postnatal adipose tissue expansion is maximal 
during early infancy (Butte et al., 2000a), so it is predictable that larger 
increases in body weight over this period would be associated with larger 
increases in adiposity. Of interest is the relationship between early weight 
gain and adipose tissue partitioning and IHCL. 
 
7.6.1 Adipose tissue partitioning 
Two ratios were used to characterise adipose tissue partitioning, internal 
abdominal adipose tissue:abdominal superficial subcutaneous adipose tissue 
and internal abdominal adipose tissue:non-abdominal superficial 
subcutaneous adipose tissue.  Of these, the ratio internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue represents 
partitioning within the abdominal compartment.  Results presented here 
demonstrate that rate of early weight gain is inversely associated with internal 
abdominal adipose tissue:abdominal superficial subcutaneous adipose tissue 
at 2-3 months, signifying that greater early infancy weight gain is associated 
with a pattern of  adipose tissue distribution considered more beneficial in 
later life: lower internal abdominal adipose tissue relative to abdominal 
superficial subcutaneous adipose tissue.  Furthermore, a trend towards this 
pattern of distribution persists when examining the association between early 
weight gain and change in internal abdominal adipose tissue:abdominal 
superficial subcutaneous adipose tissue between birth and 2-3 months. That 
no association was seen with internal abdominal adipose tissue:non-
abdominal superficial subcutaneous adipose tissue may simply reflect the 
greater size of the non-abdominal superficial subcutaneous compartment (the 
single largest adipose tissue depot) relative to the internal abdominal depot, 
resulting in reduced power to detect an association.  These results support 
rejection of my null hypothesis and are unexpected given the direct 
relationship identified between weight gain in the first 3 months and 
abdominal circumference (a proxy marker for internal abdominal adipose 
tissue) in adults (Leunissen et al., 2009) and DEXA measured abdominal fat 
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in children (Chomtho et al., 2008).  This disparity in results may reflect the 
different techniques used: Leunissen et al. used waist circumference to 
assess their adult population, which although correlated with single slice CT 
measured visceral adipose tissue (Pouliot et al., 1994) is an indirect measure 
with limited reproducibility (Cornier et al., 2011).  Chomtho et al. (2008) 
measured regional body fat distribution indirectly using DEXA, which while 
correlated with CT derived abdominal fat mass (Glickman et al., 2004) cannot 
differentiate between subcutaneous and internal abdominal adipose tissue. 
The higher abdominal fat found in these studies (Leunissen et al., 2009, 
Chomtho et al., 2008) may therefore represent higher abdominal 
subcutaneous adipose tissue, rather than higher internal abdominal adipose 
tissue, in keeping with results presented here.  Another potential explanation 
may lie in the relative oversampling of small for gestational age babies in 
other studies (Leunissen et al., 2009) contrasting with the exclusion of these 
babies here.  Small for gestational age children are well known to have 
pronounced early growth and subsequently increased visceral adiposity 
(Ibanez et al., 2008b, Ibanez et al., 2008a), so results from Leunissen et al. 
may better reflect the long-term outcome of infants born small for gestational 
age rather than those undergoing rapid early growth more generally.  
These results are from a small cohort with limited follow up, and require 
corroboration.  If confirmed results presented here suggest that rapid early 
weight gain is associated with a pattern of adipose tissue partitioning 
considered healthier in later life.  This reflects early life adipose tissue 
development in average weight for gestational age babies, rather than small 
for gestational age infants (which are frequently oversampled in studies 
finding increased markers of internal abdominal obesity associated with rapid 
growth).  Amongst these babies however, this argues against rapid early 
weight gain altering adipose tissue partitioning in early life and subsequently 
tracking into adulthood, as a mediator of later metabolic risk.   
In relation to infant feeding, although slower growth by 12 months among 
breastfed compared to formula fed infants has been compellingly 
demonstrated (Dewey et al., 1995) whether a similar relationship exists during 
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the first 3 months is less clear: large, high quality studies conversely 
demonstrate more rapid weight gain amongst breastfed infants over this 
period (Dewey, 1998).  As the link between early growth and adverse later 
metabolic health appears strongest with weight gain over the first 3 months 
(Stettler and Iotova, 2010), this argues against rate of early growth being the 
primary mediator of the later life metabolic risk associated with formula 
feeding, and is in keeping with results presented here. 
 
7.6.2 Hepatic lipid 
Based upon findings presented in Chapter 5 I have proposed that 
accumulation of IHCL in early infancy may be physiological, rather than 
reflecting metabolic dysfunction.  If correct then this would not predict an 
association between early life predictors of metabolic disease (such as rapid 
infant weight gain) and IHCL – in keeping with findings presented here.  
Clearly results from this relatively small cohort spanning only the first 2-3 
months do not demonstrate lack of an association, and further confirmatory 
work is needed.   
 
7.6.3 Strengths and weaknesses 
Strengths of this investigation include the application of gold standard 
techniques for the first time to directly measure adipose tissue distribution and 
IHCL in infancy in relation to rate of weight gain.  The exclusion of small for 
gestational age infants means that results can be generalised to the wider 
population of appropriate weight for gestational age infants.  The small 
sample size means that important associations may not have been detected, 
in particular with IHCL, which is non-normally distributed necessitating non-
parametric tests that have a lower power to detect differences. 
 
7.6.4 Summary 
• As expected, rapid weight gain between birth and 2-3 months is strongly 
associated with increasing adipose tissue in all adipose tissue 
compartments.   
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• A direct association is seen between more rapid weight gain and a higher 
ratio of abdominal superficial subcutaneous relative to abdominal internal 
adipose tissue, suggesting that rate of early infant weight gain influences 
adipose tissue partitioning. 
• No association is seen between rate of infant weight gain and IHCL at 2-3 
months, in keeping with physiological accumulation IHCL in infancy. 
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Chapter 8 
Breast milk composition and infant adiposity 
8.1 Introduction 
Hormones found in breast milk are candidate mediators of the differences in 
adiposity associated with different infant feeding methods (Chapter 3). 
Hormones such as insulin, leptin, adiponectin and resistin play important roles 
in skeletal muscle and adipose tissue fatty acid metabolism, and in 
conjunction with other hormones such as ghrelin, influence food intake and 
energy expenditure centrally (Galic et al., 2010).  Insulin (Fields and 
Demerath, 2012), leptin (Ozarda et al., 2012, Karatas et al., 2011, Miralles et 
al., 2006a, Houseknecht et al., 1997), ghrelin (Ozarda et al., 2012, Karatas et 
al., 2011, Cesur et al., 2012), adiponectin (Cesur et al., 2012, Ozarda et al., 
2012, Karatas et al., 2011) and resistin (Ozarda et al., 2012, Savino et al., 
2012) have all been identified in breast milk, and animal studies demonstrate 
systemic absorption following enteral administration of hormones in the 
neonatal period (Sanchez et al., 2005).  Furthermore, a negative association 
has been demonstrated between breast milk leptin concentrations and both 
infant weight gain (Schuster et al., 2011, Doneray et al., 2009) and BMI 
(Miralles et al., 2006a), suggesting enteral hormones may influence human 
adipose tissue.  However, body weight is a crude surrogate for adiposity and 
studies examining the relationship between breast milk hormones and infant 
fat mass using DEXA (Fields and Demerath, 2012) and BIA (Savino et al., 
2008) have been inconclusive.  This may reflect limitations in measurement 
methods; no study to date has reported directly measured adipose tissue in 
relation to breast milk hormone intake. 
Bioactive metabolites represent another mechanism by which breast milk 
might mediate infant adiposity.  Hundreds of metabolites have been identified 
in breast milk, complicating investigation of their relationship with infant 
adiposity using conventional methods.  High throughput techniques such as 
nuclear magnetic resonance spectroscopy measure the global profile of 
compounds present in a sample, and chemometric analysis techniques such 
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as PCA and PLS-DA have high power for identifying compounds driving 
differences between groups.  These multivariable techniques offer great 
potential for the initial analysis of heterogeneous, incompletely elucidated 
compounds such as breast milk.  To my knowledge, high throughput 
techniques such as NMR spectroscopy have not, to date, been used to 
examine the relationship between breast milk composition and infant 
physiology. 
 
8.2 Aims  
To determine whether infant adiposity is correlated with breast milk hormone 
concentration or metabolite composition. 
 
8.3 Hypotheses  
The work undertaken in this chapter, examining the association between 
breast milk hormone and metabolite concentrations and offspring adiposity is 
exploratory: generating hypotheses and examining novel measurement and 
analysis techniques.  Therefore I will test the following null hypotheses: 
1. No significant correlation is detectable between the concentration of 
insulin, leptin, ghrelin, adiponectin or resistin in breast milk and infant 
total adipose tissue volume or IHCL. 
2. No compounds can be identified in breast milk, using NMR 
spectroscopy, that are significantly associated with differences in infant 
total adipose tissue volume or IHCL.  
 
8.4 Methods  
Prospective cohort study as described in chapter 2. Hind-milk samples were 
hand expressed by the mother while attending infant MR investigations and 
stored as described in Chapter 2. 
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8.4.1 Statistical methods 
To avoid type II error related to multiple testing, three measures of infant 
adiposity were used for analyses: total adipose tissue volume (litres), IHCL 
(ratio of CH2 to H2O) and the ratio internal abdominal adipose 
tissue:abdominal superficial subcutaneous adipose tissue.   
NMR spectra were obtained from aqueous and lipid fractions of breast milk 
using a Bruker 600MHz spectrometer. Sample preparation, measurement 
protocol, spectra preprocessing and analysis are described in Chapter 2. 
Regression of NMR spectra data to adiposity and age was performed with 
correction for multiple testing carried out using a false discovery rate threshold 
of 0.10.  Quality control for NMR spectroscopic analyses was carried out 
every tenth sample using samples prepared from pooled aliquots of all 
samples.   
8.5 Results: Breast milk hormone analyses 
8.5.1 Cohort demographic details 
Breast milk samples for hormone analysis with corresponding infant adiposity 
measures were collected from 23 and 19 mother infant dyads at T1 and T2 
respectively.  Mean (SD) pre-pregnancy BMI was 23.4 (3.9).  Ethnicity 
distribution of the mothers was predominantly Caucasian, 84% (16% Mixed). 
Median (IQR) gestational age at birth was 40+3 (39+5-41+3).   
8.5.2 Descriptive statistics 
Descriptive statistics for infant growth and adiposity measures at T1 and T2 
are presented in table 8.1. 
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 Birth T1 T2 
Age (days)* - 13 [9-21] 64 [62-71] 
Weight (kg) 3.486 (0.422) 3.756 (0.534) 5.594 (0.584) 
Weight SDS 0.05 (0.82) -0.12 (0.87) -0.12 (0.57) 
Length (m) - 0.539 (0.026) 0.607 0.025) 
 Length SDS - 0.81 (0.94) 0.89 (0.94) 
OFC (cm) 34.9 (1.2) 37.1 (1.2) 40.2 (1.1) 
OFC SDS 0.20 (0.89) 1.11 (1.01) 0.75 (0.84) 
Weight gain SDS - - -0.01 (0.76) 
Total AT (litres)* 
- 0.732 [0.634-
0.937] 
1.569 [1.340-
1.936] 
Total AT index (l/m2)* 
- 2.62 [2.13-
2.98] 
4.06 [3.79-5.14] 
IHCL* 
- 0.656 [0.352-
2.673] 
1.846 [1.452-
2.567] 
IAAT:ASSCAT* 
- 0.17 [0.12-
0.22] 
0.10 [0.08-0.15] 
Table 8.1 Descriptive data for infants (breast milk hormone analyses): Values 
are mean (standard deviation) except * where values are median [interquartile 
range]. OFC: occipito-frontal circumference, SDS: standard deviation score. 
ASSCAT: Abdominal superficial subcutaneous adipose tissue; IAAT: Internal 
abdominal adipose tissue. 
 
 
8.5.3 Breast milk hormone concentrations 
Summary statistics for measured breast milk hormone concentrations at T1 
and T2 are shown in table 8.2. 
 
 T1 T2 
Insulin µU/ml 10.7 (2.0-28.5) 10.4 (0.8-33.5) 
Resistin (ng/ml) 2.2 (0.2-82.2) 0.3 (0.1-76.7) 
Table 8.2 Descriptive data for breast milk hormone concentrations: Values are 
median (range). 
 
In all samples the measured concentrations of human leptin, active human 
ghrelin and high molecular weight (HMW) adiponectin were below the limit of 
detection (0.78ng/ml for human leptin, 26pg/ml for active human ghrelin and 
1.56ng/ml for HMW adiponectin).  Insulin and resistin were not detectable in 
any of the four artificial formulas examined.  Lower limits of detection: 2µl/ml 
for insulin and 0.16ng/ml for resistin.  Concentrations of insulin and resistin in 
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breast milk were non-normally distributed at T1 and T2 and remained so 
following log transformation therefore non-parametric techniques were used, 
Appendix 5, figures 5A-5H. 
 
8.5.4 Correlation between breast milk hormones and with maternal BMI 
There was no significant correlation between insulin and resistin at T1 or at T2 
(T1: Spearman’s correlation (rs)=-0.30, p=0.17; T2: rs=-0.11, p=0.68).  No 
significant differences were found between breast milk insulin concentrations 
at T1 compared to T2 or resistin concentrations at T1 compared to T2 (p=0.88 
and p=0.29 respectively, related samples Wilcoxon signed rank tests).  There 
were no significant correlations seen between breast milk insulin or resistin 
concentrations and maternal BMI (insulin at T1 rs=0.13, p=0.55 and at T2 
rs=0.21, p=0.40; resistin at T1 rs=-0.35, p=0.12 and at T2 rs=-0.07, p=0.78).  
 
8.5.5 Correlation between breast milk hormones and infant adiposity 
There were no significant correlations seen between the concentration of 
insulin or resistin in breast milk and infant anthropometrics at T1 or T2 
(Appendix 5, tables 5A and 5B). Correlation coefficients and p values for the 
relationship between breast milk hormone concentrations and adiposity at T1 
and T2 are shown in table 8.3.  
 
Significant correlations were seen between breast milk insulin concentration 
at T1 and total adipose tissue, and between breast milk insulin concentration 
at T2 and the ratio internal abdominal adipose tissue:abdominal superficial 
subcutaneous adipose tissue (figures 8.1 and 8.2.). 
 T1 T2 
Insulin Resistin Insulin Resistin 
rs p rs p rs p rs p 
TAT (l) 0.43 0.05 -0.27 0.25 0.15 0.55 0.06 0.83 
TAT index 
(l/m2) 
0.40 0.06 -0.17 0.47 0.22 0.39 0.81 0.76 
IAAT:ASSCAT 0.54 0.81 0.17 0.47 -0.53 0.03 0.26 0.31 
IHCL 0.04 0.86 -0.23 0.31 0.06 0.82 0.24 0.36 
Table 8.3: Spearman correlation coefficients (rs) and p values (p) for 
correlation between breast milk hormones and adipose tissue at T1 and T2. 
Red = significant at p≤0.05. ASSCAT: Abdominal superficial subcutaneous adipose 
tissue; IAAT: Internal abdominal adipose tissue. 
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Figure 8.1: Correlation between breast milk insulin concentration and total 
adipose tissue at T1 (Spearman’s correlation coefficient 0.43, p=0.05). 
 
 
Figure 8.2: Correlation breast milk insulin concentration and the ratio of 
internal abdominal adipose tissue to abdominal subcutaneous adipose tissue 
at T2 (Spearman’s correlation coefficient -0.53, p=0.03). ASSCAT: Abdominal 
superficial subcutaneous adipose tissue; IAAT: Internal abdominal adipose tissue. 
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To examine whether the changes in adiposity associated with breast milk 
insulin concentration found in the neonatal period persisted in later infancy 
breast milk insulin concentration at T1 was examined against adiposity at T2. 
No correlation was detected between breast milk insulin concentration at T1 
and TAT or TATI at T2 (TAT rs=0.11, p=0.65; TATI rs=0.18, p=0.45).  No 
significant association (p=0.59) was seen in multivariable regression of TAT at 
T2 against breast milk insulin at T1 adjusting for TAT at T1, indicating no 
evidence of an association between breast milk insulin in the neonatal period 
and change in total adipose tissue in later infancy. 
8.6 Results: Breast milk metabolic profiling 
8.6.1 Cohort demographic details 
Breast milk samples for proton NMR metabolite profile analysis and 
corresponding infant adiposity measures were collected from 16 mother-infant 
dyads at T1 and 16 at T2.  Mean (SD) pre-pregnancy BMI was 24.0 (4.4). 
Ethnicity distribution of the mothers was predominantly Caucasian, 77% (19% 
Mixed, 4% Afro-Caribbean).  Median (IQR) gestational age at birth was 40+5 
(39+6-41+3).   
8.6.2 Descriptive statistics 
Descriptive statistics for infant growth and adiposity measures at T1 and T2 
are presented in table 8.4.  
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 Birth T1 T2 
Age (days)* - 16 (9-23) 63 [59-68] 
Weight (kg) 3.549 (0.526) 4.041 (0.613) 5.384 (0.448) 
Weight SDS 0.20 (1.07) 0.20 (1.05) -0.20 (0.51) 
Length (m) - 0.544 (0.030) 0.599(0.023) 
Length SDS - 0.86 (1.01) 0.73 (0.81) 
OFC (cm) 34.7 (1.2) 37.1 (1.0) 39.9 (0.8) 
OFC SDS 0.09 (0.87) 0.85 (0.86) 0.72 (0.66) 
Weight gain SDS - - -0.03 (0.79) 
Total AT (litres)* 
- 0.775 [0.663-
1.017] 
1.402 [1.328-
1.692] 
IHCL* 
- 0.666 [0.377-
2.508] 
1.855 [1.408-
2.659] 
Table 8.4 Descriptive data for infants (breast milk NMR metabolic profile 
analyses): Values are mean (standard deviation) except * where values are median 
[interquartile range]. OFC: occipito-frontal circumference, SDS: standard deviation 
score. 
 
 
8.6.3 Proton NMR spectra 
Proton NMR spectra were acquired from the aqueous and lipid phases of all 
samples; median spectra are displayed in figure 8.3. 
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Figure 8.3: Median proton nuclear magnetic resonance spectra from lipid (A) 
and aqueous (B) fractions of human breast milk. Frequency (parts per million) is 
expressed along the x-axis and intensity in arbitrary units is recorded on the y-axis. 
Compounds corresponding with spectral peaks are denoted. 
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8.6.4 Breast milk aqueous phase metabolite profile  
Initial analysis was carried out using PCA to examine different methods of 
scaling.  UV, Pareto and Centro scaling all provided good models, Appendix 5 
figures 5I-5K, UV scaling providing the closest clustering and was applied for 
subsequent analyses. 
Quality control samples, placed at equal intervals throughout the sample run, 
were used to examine within run variation.  Principal component analysis 
demonstrated tight clustering of the quality control samples, figure 8.4, 
indicating minimal measurement variation over the course of a single NMR 
run. 
 
Figure 8.4: Principal component analysis of aqueous breast milk phase with 
quality control samples.  Baseline corrected to TSP, normalised to mean area and 
UV scaled, x and y axes represent principal component 1 (PC1) and principal 
component 2 (PC2) respectively, measured in arbitrary units. Red circles indicate 
samples collected at T1, blue diamonds samples collected at T2 and black squares 
quality controls samples.  Grey oval highlights tight clustering of quality control 
samples.  R2X=0.52, Q2=0.41. 
 
Quality control samples were removed for subsequent analyses.  Principal 
component analysis demonstrated that postnatal age at sample collection (T1 
or T2) was the principal component driving differences between breast milk 
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samples, signified by the clear clustering by time point seen in figure 8.5.  Due 
to the potential confounding effect of temporal differences in metabolite 
profile, post-hoc analysis of the relationship with postnatal age was carried 
out. 
Figure 8.5: Principal component analysis of aqueous breast milk phase without 
quality control samples.  Baseline corrected to TSP, normalised to mean area and 
UV scaled, x and y axes represent principal component 1 (PC1) and principal 
component 2 (PC2) respectively, measured in arbitrary units. Red circles indicate 
samples collected at T1 and blue diamonds samples collected at T2. R2X=0.50, 
Q2=0.40. 
8.6.4.1 Breast milk aqueous phase metabolite profile and postnatal age 
Postnatal age was further explored in the aqueous phase breast milk 
metabolite profile using a supervised model: PLS-DA, which constructs a 
linear combination of all peak intensities that maximises the separation 
between the specified groups (T1 and T2). The scores plot from the PLS-DA 
comparison between samples collected at T1 and those collected at T2 
showed excellent separation, figure 8.6, R2Y was 0.90, indicating that the 
model was robust, and Q2Y was 0.83 indicating that the model was highly 
predictive for sample class identity, Y (T1 or T2). 
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Figure 8.6: Partial least-squares discriminant analysis scores plot of breast 
milk aqueous phase spectra comparing samples collected at T1 (red circles) 
with those collected at T2 (blue squares).  Baseline corrected to TSP, normalised 
to mean area and UV scaled, x and y axes represent principal component 1 (PC1) 
and principal component 2 (PC2) respectively, measured in arbitrary units.  
R2X=0.90, Q2=0.83. 
 
Further examination of discriminant spectral components was performed 
using a supervised analysis: OPLS-DA.  This supervised model separates out 
the purely predictive variation of the first component by dividing the variation 
of the X-block (spectral data) into two parts; one which models the co-
variation between X (spectral data) and Y (class membership: T1 or T2) and a 
second part which captures the variation in X which is unrelated, orthogonal, 
to Y.  The scores plot from the OPLS-DA comparing T1 and T2 samples 
demonstrates excellent separation, figure 8.7, R2Y 0.96, Q2Y 0.83. 
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Figure 8.7: Orthogonal partial least-squares discriminant analysis scores plot 
of breast milk aqueous phase spectra comparing samples collected at T1 (red 
circles) with those collected at T2 (blue squares).  Baseline corrected to TSP, 
normalised to mean area and UV scaled, x and y axes represent principal 
component 1 (PC1) and principal component 2 (PC2) respectively, measured in 
arbitrary units.  R2X=0.96, Q2=0.83. 
The OPLS-DA loadings plot identified a number of spectral peaks that were 
highly discriminant between T1 and T2, figure 8.8 and table 8.5. 
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Figure 8.8 (previous page): Orthogonal partial least-squares discriminant 
analysis loadings plot of breast milk aqueous phase spectra comparing 
samples collected at T1 with those collected at T2.  Baseline corrected to TSP, 
normalised to mean area and UV scaled. R2X=0.96, Q2=0.83. Colours projected onto 
the spectrum indicate the OPLS-DA coefficients of the spectral peaks (indicating the 
degree to which the spectral peaks explain the class difference between samples 
collected at T1 and T2). The direction of the spectral peaks indicates whether they 
are discriminant with T1 or T2 and the magnitude of the spectral peaks indicate the 
concentration of the metabolite represented by that peak within the sample.  
Discriminant with T2 
Spectra peaks Metabolite 
 5.24 (d), 4.67 (d), 4.46 (d), 3.94 (m), 
3.78 (m), 3.66 (m), 3.60 (d), 3.55 
(m), 3.30 (t) 
Lactose 
Discriminant with T1 
Spectra peaks Metabolite 
5.11 (d) 
4.18 (q) 
2.72 (dd) 
2.06(s) 
2.04(s) 
N-acetyl glucosamine 
Fucose 
N-acetylaspartic 
N-acetyl neuraminic acid 
N-acetyl glucosamine 
Table 8.5: Spectral peaks and associated metabolites identified from OPLS-DA 
loadings plot (figure 8.8).  d: doublet, dd: doublet of doublets, t: triplet, m: multiplet. 
Further analysis of the association between postnatal age and metabolite 
profile was carried out by regression of metabolite spectra against postnatal 
age in days at samples collection, figure 8.9, table 8.6. 
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Figure 8.9 (previous page): Median spectrum of aqueous phase of breast milk 
(T1 and T2 combined) with linked Manhatten plot representing significance of 
correlation coefficient between spectral point and postnatal age in days, 
calculated from linear regression.  The median NMR spectrum is derived from 32 
samples.  The Manhattan plot below has frequency in ppm on the x axis 
corresponding to the median spectra above, the y axis represents the significance of 
the correlation between that spectral point and total adipose tissue.  Significance 
thresholds are presented as red lines corresponding to a p value of 0.05 adjusted 
using Bonferroni correction for 22,290 spectral points (corresponding to p<4×10-6). 
Positive deflection represents the metabolite represented by that spectral peak is 
associated with increasing postnatal age, negative deflection indicates an association 
with decreasing postnatal age. Spectral points on the Manhattan plot achieving 
significance at this level are displayed in green. 
Associated with lower postnatal age 
Spectra peaks Metabolite 
5.11 (d) 
4.18 (q) 
4.42 (s) 
2.04(s) 
2.06(s) 
1.749 (m) 
1.189 (d) 
N-acetyl glucosamine 
Fucose 
Unknown 
N-acetyl glucosamine 
N-acetyl neuraminic acid 
Unknown (potentially lysine) 
Fucose 
Associated with higher postnatal age 
Spectra peaks Metabolite 
3.27 (t) 
3.52-5.96 (multiple peaks) 
4.45 (d)  
Lactose 
Table 8.6: Spectral peaks and associated metabolites identified from linear 
regression (figure 8.9).  d: doublet, t: triplet, m: multiplet. 
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8.6.4.2 Breast milk aqueous phase metabolite profile and adiposity 
Linear regression was used to examine the relationship between breast milk 
aqueous metabolite profile and total adiposity and IHCL. Adipose tissue 
volume and IHCL approximately double between T1 and T2 (Chapter 5, table 
5.2) and metabolite profile of breast milk is highly discriminant between T1 
and T2, figure 8.7, therefore linear regression was carried out correcting for 
postnatal age in days.   
A significant correlation was detected between breast milk aqueous 
metabolite spectra and total adipose tissue, after applying a false discovery 
rate of 0.10, figure 8.10, corresponding to a singlet peak at 5.11ppm, however 
no metabolite was identified with this spectral peak.  No significant 
correlations were detected when a Bonferroni correction at p=0.05 was 
applied, Appendix 8, figure I.   
No significant correlations were detected between breast milk metabolites and 
offspring IHCL using a FDR of 0.10, appendix 8, figure J. 
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Figure 8.10 (previous page): Modified Manhattan Plot showing linear 
regression of proton NMR metabolite profile of the aqueous fraction breast 
milk on infant total adipose tissue, at T1 and T2 combined, adjusted for 
postnatal age at sample and assessment of adiposity in days.  The NMR 
spectrum represents the median spectrum from 32 samples.  The Manhattan plot 
below has frequency in ppm on the x-axis corresponding to the median spectrum 
above, the y-axis represents the significance of the correlation between that spectral 
point and total adipose tissue.  Positive values indicate a positive correlation between 
the spectral point and total adipose tissue and negative values indicate a negative 
correlation.  The red lines indicate the threshold for significance for a false discovery 
rate of 0.10. Spectral points on the Manhattan plot achieving significance at this level 
are displayed in green. 
8.6.5 Breast milk lipid phase metabolite profile 
Principal component analysis was used to explore different methods of 
scaling the spectra.  As found with the aqueous phase, UV scaling provided 
the closest clustering and was applied for subsequent analyses. 
Assessment of quality control samples using PCA demonstrated tight 
clustering compatible with minimal within run variation, figure 8.11.  Quality 
control samples were removed for subsequent analyses.   
8.6.5.1 Breast milk lipid phase metabolite profile and postnatal age 
The principal component driving differences between lipid phase breast milk 
samples was not postnatal age (T1 or T2), as indicated by the lack of 
clustering by time point in figure 8.11.  Supervised analysis of the relationship 
between lipid metabolite profile and postnatal age using PLS-DA resulted in a 
poorly predictive model, R2Y 0.58, Q2Y 0.34, figure 8.12.  Examination of the 
loadings plot from the PLS-DA demonstrated that spectral points driving 
discrimination in the supervised PLS-DA model corresponded exclusively to 
the baseline and not to identifiable spectral peaks, therefore no further 
supervised analyses were undertaken. 
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Figure 8.11: Principal component analysis of lipid breast milk phase with 
quality control samples.  Baseline corrected to TSP, normalised to mean area and 
UV scaled, x and y axes represent principal component 1 (PC1) and principal 
component 2 (PC2) respectively, measured in arbitrary units. Red circles indicate 
samples collected at T1, blue diamonds samples collected at T2 and black squares 
quality controls samples.  R2X=0.61, Q2=0.48. 
Figure 8.12: Partial least-squares discriminant analysis scores plot of breast 
milk lipid phase spectra comparing samples collected at T1 (red circles) with 
those collected at T2 (blue squares).  Baseline corrected to TSP, normalised to 
mean area and UV scaled, x and y axes represent principal component 1 (PC1) and 
principal component 2 (PC2) respectively, measured in arbitrary units.  R2X=0.58, 
Q2=0.34. 
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Examination of the relationship between breast milk lipid phase metabolite 
profile and postnatal age in days by linear regression revealed no significant 
correlations using an FDR of 0.10. 
 
8.6.5.2 Breast milk lipid metabolite profile and adiposity 
Linear regression was used to examine the relationship between breast milk 
lipid metabolite profile and adiposity.  No significant associations were found 
with total adipose tissue or IHCL using an FDR of 0.10. 
 
8.7 Discussion  
Breast milk hormones have been proposed as mediators of infant adiposity 
(Savino et al., 2009).  This is the first time, to my knowledge, that the 
concentration of breast milk hormones has been examined in relation to 
directly measured infant adipose tissue.  In keeping with previous studies 
(Fields and Demerath, 2012, Ozarda et al., 2012, Savino et al., 2012) insulin 
and resistin are detected in breast milk.  In addition, I demonstrate a novel 
correlation between breast milk insulin and adipose tissue volume in the 
neonatal period. 
 
Proton nuclear magnetic resonance spectroscopy allows global, untargeted 
measurement of metabolites in biofluids.  It has been widely used to examine 
serum, urine, tissue (Beckonert et al., 2007) and stool water (Monleon et al., 
2009), and has recently been applied to breast milk (Marincola et al., 2012).  
Multivariable chemometric statistical techniques, such as PCA and OPLS-DA, 
allow exploration of the correlation between global metabolite profile and 
physiological factors of interests, but to my knowledge have yet to be applied 
in the examination of breast milk composition and infant physiology.  Using 
these techniques I have confirmed known correlations between breast milk 
carbohydrate concentrations and postnatal age, substantiating multivariable 
chemometric analysis of metabolomic data as a suitable method for the 
investigation of breast milk. 
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8.7.1 Insulin 
Insulin mediates a range of human anabolic processes (Frayn, 2003), and in 
infants circulating concentrations are inversely related to feed quantity in the 
first week (James et al., 2007) indicating a potential role in initiating infant 
feeding behavior.  It is therefore biologically plausible that exogenous insulin, 
provided by breast milk, might mediate effects on infant body composition.  
The key factor is whether insulin is absorbed from the gut into the systemic 
circulation retaining biological activity. Insulin is not systemically absorbed 
following enteral administration in adults, however, oral administration in the 
neonatal period results in hypoglycaemia in rat (Hirsova and Koldovsky, 1969) 
piglet (Asplund et al., 1962a) and calf models (Pierce et al., 1964), and insulin 
receptors in the ileal and jejenal brush border membranes have been 
identified (Gingerich et al., 1987).   If enteral absorption occurs in human 
infants it may be limited to a window prior to the decline in gut permeability 
seen over the first postnatal week (Weaver et al., 1987), analogous to the 
concept of “gut closure” well described in veterinary literature (Vellengat et al., 
1985).  This may explain why no effect on blood glucose was seen in a small 
human trial where insulin was administered orally to preterm infants after age 
4 days (Shulman, 2002), and would be in keeping with the results presented 
here: the insulin concentration of breast milk is directly correlated with adipose 
tissue in the early neonatal period (T1) but not in later infancy (T2).  Human 
insulin was present in all breast milk samples and was undetectable in infant 
formula, therefore the direct association seen here with infant adiposity 
suggests a potential candidate pathway explaining the previously documented 
link between breastfeeding with higher adiposity.  Caution must be expressed 
however, as no sustained association between early breast milk insulin and 
later adiposity (at T2) was detected, mitigating against this explanation.  This 
may relate to the limited sample size of this study or to other limitations, such 
as the variation in postnatal ages at T1 and T2 and the relatively large number 
of analyses carried out, and demonstrates that further studies should be 
undertaken aiming to replicate these findings.  
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8.7.2 Resistin 
Detectable concentrations of resistin were detected in breast milk, in keeping 
with concentrations previously reported (Savino et al., 2012).  Leptin, ghrelin 
and high molecular weight adiponectin were not detectable by the ELISA kits 
used.  As these hormones have previously been described in breast milk this 
likely reflects my use of collection and storage processes unsuitable for 
preservation of these hormones.  Resistin, a hormone secreted largely by 
macrophages (Jung et al., 2006) and proposed as a mediator of insulin 
resistance (Steppan et al., 2001), was readily identifiable in breast milk in my 
cohort.  Resistin opposes the action of insulin in peripheral tissues such as 
adipose tissue (Steppan et al., 2001) and is present in cord blood, where 
significantly lower levels are seen in offspring of diabetic pregnancies when 
compared to non-diabetic pregnancies (Ng et al., 2004a), and has therefore 
been proposed as an inhibitor of adipogenesis in fetal and neonatal life.  The 
lack of correlation between breast milk resistin concentration and infant 
adiposity seen here is in keeping similar findings from a previous study 
examining offspring body mass (Savino et al., 2012), and does not support 
breast milk resistin as a mediator of infant adiposity. 
 
8.7.3 Breast milk metabolomics 
Principal component analysis of aqueous phase breast milk samples in 
relation to postnatal age (T1 compared to T2) revealed clear separation, 
figure 8.5, and OPLS-DA modeling with 3 components resulted in a highly 
predictive model, figure 8.7 (R2X=0.96, R2=0.83).  Analysis of the OPLS-DA 
loadings plot (figure 8.8) revealed metabolites contributing to this model, table 
8.5.  To examine the statistical significance of the correlation between 
metabolite profile and postnatal age, adjusted for multiple testing, spectra 
were regressed against postnatal age in days using significance thresholds 
corresponding to a p value of 0.05 after a Bonferroni correction for 22,290 
spectral points, figure 8.9.  This conservative model identified multiple spectral 
peaks exceeding significance thresholds, corresponding to the compounds 
listed in table 8.6.  As expected the metabolites explaining most of the 
variation between time points T1 and T2 (figure 8.8 and table 8.5) were 
consistent with those correlating significantly with postnatal age in days (figure 
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8.9 and table 8.6).  Furthermore, the associations detected using these two 
techniques: increasing lactose with increasing postnatal age, decreasing n-
actecyl glucosamine, fucose and n-acetyl neuraminic acid with increasing 
postnatal age, are well described (Miller et al., 1994, Thurl et al., 2010, 
Gingerich et al., 1987).  This supports the validity of proton NMR 
spectroscopic quantification and multivariable chemometric analysis of the 
aqueous phase of breast milk.  Examination of the lipid phase of breast milk 
revealed identifiable spectral peaks corresponding to known lipid components 
of breast milk (figure 8.3).  That no significant correlation was detected 
between lipid components of breast milk and postnatal age is also in keeping 
with previous studies, where only minor temporal changes in breast milk fatty 
acid composition have been demonstrated (Genzel-Boroviczeny et al., 1997). 
 
The breast milk constituents identified here as temporally discriminant: N-
acetyl glucosamine, n-acetyl neuraminic acid and fucose, are three of the five 
monosaccharides from which human milk oligosaccharides (HMOs) are 
composed (the other two being glucose and galactose). Human milk 
oligosaccharides comprise a lactose molecule at the reducing end, elongated 
by variable length polysaccharide chains.  Over 100 different HMOs have 
identified in human milk (Kobata, 2010) and synthesis is highly variable 
between women, mirroring Lewis blood group (Kumazaki and Yoshida, 1984).  
While a large proportion of HMOs resist degradation or digestion and so are 
detectable intact in faeces (Chaturvedi et al., 2001) others are absorbed and 
reach the systemic circulation (Rudloff et al., 2012).  Human milk 
oligosaccharides have a range of purported beneficial effects: most widely as 
prebiotics promoting growth of beneficial gastrointestinal microflora (Sela et 
al., 2008), but also as anti-adhesive antimicrobials (Morrow et al., 2004), 
modulators of both local intestinal epithelial cell and systemic immune 
responses (Gingerich et al., 1987) and potentially as nutrients key to optimal 
brain development (Wang et al., 2003). The relative importance of individual 
or combinations of HMOs in mediating beneficial effects remains to be 
delineated (Gingerich et al., 1987), in part due to high number and variation in 
HMOs found in breast milk.   
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A key advantage of NMR spectroscopy and chemometric multivariable 
analysis is that it offers the ability to examine the correlation between the 
global profile of breast milk (rather than individual compounds measured in 
isolation) and offspring physiology.  Regressing the metabolite profile of 
breast milk against infant adiposity and IHCL (after adjustment for postnatal 
age in aqueous phase analyses) detected no significant correlations after 
adjusting for multiple testing, using Bonferroni correction.  Because of 
concerns that applying a Bonferroni correction may be too conservative, 
analyses were repeated applying a false discovery rate of 0.1.  That no 
significant correlations were detectable after FDR adjustment likely relates to 
low power secondary to the small number of breast milk sample and infant 
adiposity pairs.  Application of these techniques in larger samples has the 
potential to identify important correlates between breast milk composition and 
infant physiological development, and offers advantages over sequential 
targeted analyses (such as those applied to examine breast milk hormones) in 
it’s ability to discern the components most important in explaining 
physiological variation and to delineate synergistic relationships.  Furthermore 
paired metabolomic examination of breast milk and infant urine offers a 
potential method to investigate in-vivo metabolic effects of absorbed HMOs. 
 
8.7.4 Summary 
• Breast milk insulin concentration is linked with adiposity in neonatal 
period but not later.   
• Resistin is present in breast milk but no significant correlation with 
infant adiposity was seen.  
• Proton NMR spectroscopy is effective at identifying compounds in 
breast milk and detects previously described correlations between 
carbohydrate concentrations and postnatal age.  
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Chapter 9 
Discussion 
 
9.1 Introduction 
The aim of this thesis was to test the hypothesis that method of infant feeding 
is associated with alterations in quantity and distribution of adipose tissue, 
and in altered IHCL accumulation in infancy.  The prospective cohort that I 
established in order to examine this question also enabled examination of 
changing adipose tissue partitioning and IHCL in early infancy and its 
associations.  Original contributions from this work include: 
 
1. I have delineated the changes in adipose tissue volume and distribution, 
and in IHCL which occur during early infancy among healthy, breastfed 
infants: 
a. Longitudinal accretion of adipose tissue occurs primarily within the 
subcutaneous as opposed to internal compartments. 
b. Significant longitudinal increases occur in IHCL. 
2. By meta-analysing published literature I have identified a significant 
association between method of feeding and two-component body 
composition: 
a. Breastfed infants have increased fat mass when compared to their 
formula fed counterparts at 3-4 and 6 months. 
b. By 12 months this appears reversed with a trend towards higher fat 
mass seen among formula fed infants. 
c. Formula fed infants have increased fat-free mass throughout the 
first 12 months 
3. I find no significant difference between breastfed and formula fed infants in 
total adipose tissue, adipose tissue partitioning or IHCL at 2-3 months. 
4. I have demonstrated a significant association between the following 
factors and adipose tissue partitioning at 2-3 months: 
a. Maternal BMI. 
b. Rate of weight gain in early infancy. 
c. Gender. 
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5. Conversely, no factors have been identified that are significantly 
associated with IHCL at 2-3 months. 
6. I have demonstrated high levels of regional heterogeneity in IHCL in early 
infancy. 
7. I have demonstrated the effectiveness of proton NMR metabolomics and 
chemometric analysis techniques as a high throughput method of 
examining the global metabolite profile of breast milk. 
8. I have demonstrated a novel relationship between breast milk insulin 
concentrations and infant total adiposity. 
9. I have confirmed the presence of resistin in breast milk. 
10. I have determined observer variability related to measurement of IHCL by 
proton MRS in infancy: 
a. Intra-observer variability by an experienced practitioner is minimal. 
b. Inter-observer variability can be considerable. 
 
9.2 Infant feeding, adipose tissue and intrahepatocellular lipid 
In Chapter 3 I demonstrated that method of feeding was associated with 
detectable differences in two-component infant body composition: a complex 
relationship characterised by increased fat mass among breastfed infants 
during the first 6 months, no longer detectable in the second 6 months. 
Further examination however, using gold standard direct measurement 
techniques (presented in Chapter 6), did not detect a significant association 
between method of feeding and total adipose tissue, adipose tissue 
distribution or IHCL.  This apparent discrepancy most likely reflects the lower 
postnatal age of the infants examined in Chapter 6 (median age 8 weeks): 
significant differences in fat mass were not detectable at 1-2 months in the 
meta-analysis data (Chapter 3).  Consequently, despite demonstrating a 
significant association between infant feeding with fat mass, it remains 
uncertain whether an association exists with either adipose tissue structure 
(implied by adipose tissue partitioning) or IHCL. 
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9.3 Adipose tissue and intrahepatocellular lipid in early life 
In Chapter 5 I delineate the changes occurring in adipose tissue distribution 
and IHCL among healthy infants.  The most notable finding is the increase in 
IHCL between 2 and 8 weeks.  This is novel and suggests that ectopic hepatic 
lipid accumulation, rather than being regarded as universally pathological, 
may perform a key role in early life energy storage.  The absence of any 
detectable association between accumulating hepatic lipid and factors 
associated with later metabolic ill health (formula feeding – Chapter 6; rapid 
early weight gain – Chapter 8; increasing maternal BMI – Chapter 5) is in 
keeping with this being a physiological process, although the small sample 
size upon which these findings are based must be appreciated. 
 
The changes described in Chapter 5 in adipose tissue distribution are more 
expected: during the period of maximal postnatal adipose tissue expansion 
(between birth and 2-3 months (Butte et al., 2000a)) accumulation of 
subcutaneous rather than internal adiposity predominates.  Furthermore, an 
altered pattern of adipose tissue distribution, characterised by increased 
internal abdominal adipose tissue, is associated with factors linked with adult 
metabolic disease such as increasing maternal BMI.  This suggests that 
altered infant adipose tissue distribution may act as a marker of, and a 
potential mediator of, later life metabolic dysfunction – possibly via effects on 
adipose tissue cellularity and function. 
 
The other striking finding, seen in Chapters 3, 5, 6 and 8, is that during the 
first 3-6 months the optimal infant phenotype is associated with maximal 
adiposity and IHCL: while decreased body fat is seen among formula fed 
infants, at no point is increased total adiposity associated with factors linked to 
later life adverse health.  This suggests that in early infancy at least, “fatter” 
babies may in fact be healthier babies.  While this appears to run counter to 
work finding strong links between “infant obesity” and later obesity (Leiner et 
al., 2011, McCormick et al., 2010), it must be borne in mind that these studies 
diagnosed “infant obesity” using length and weight only, potentially 
categorising infants with more lean mass, rather than more adipose infants, 
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as obese.  This highlights the limitations of using measures based on weight 
and length in infancy a markers of body fat, and the importance of accurately 
measuring adiposity. 
 
9.4 Breast milk composition, adipose tissue and intrahepatocellular lipid 
In Chapter 8 I examined one proposed mechanism explaining the link 
between breast-feeding and adiposity: breast milk hormones.  By directly 
quantifying adiposity I was able to address a major limitation of previous 
studies that have used indirect or proxy measures of infant body fat.  While I 
was able to detect a novel, biologically plausible, direct correlation between 
breast milk insulin concentration and infant adiposity at 1-2 weeks using 
conventional ELISAs, the biological significance of this finding remains 
unclear without better understanding how other compounds in breast milk 
relate to adiposity. 
 
Metabolic profiling of breast milk, as demonstrated in Chapter 8, provides a 
global profile detailing the thousands of organic compounds found in human 
milk.  Chemometric analytical techniques facilitate examination of this 
multivariable data, separating the correlation seen between adiposity and 
different milk components in order to determine the milk constituents that 
explain most of the variation.  This offers the ability to not only detect 
compounds associated with adiposity, but to identify those that best explain 
the variation in adiposity, encompassing synergistic and antagonistic 
relationships between components.  While no significant associations were 
detected in the small cohort for whom paired adiposity and breast milk 
metabolite profiles were available, the results corroborate finding from 
alternate techniques and suggest that proton NMR metabolic profiling is valid 
for analysis of breast milk. 
 
9.5 Future directions 
Although I have been unable to refute my null hypothesis, in delineating the 
period in which the greatest difference in fat mass, in association with infant 
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feeding method, is seen I have defined the study required do so: longitudinal 
examination of directly measured adiposity and IHCL in relation to feeding 
after birth and at 3-4 months.  Furthermore, the magnitude of the association 
between other factors (such as increasing maternal BMI) and adipose tissue 
partitioning provides data to ensure such a study is adequately powered.  
Importantly, data presented here moves the field of infant body composition 
forward: delineating the changes that occur during normal infancy within the 
individual lipid compartments comprising fat mass, rather than the previously 
described changes that occur to fat mass as a whole.  This will allow adiposity 
data from other studies to placed into context, and may lead to identification of 
adipose tissue parameters which are of metabolic importance, are alterable in 
infancy with subsequent tracking into adult life: accurate early life biomarkers 
of later metabolic health. 
 
Further exploration of hepatic lipid physiology is another area of import 
stemming from this thesis.  Initial confirmatory studies are required to ensure 
the pattern of increasing IHCL is consistent across healthy, breastfed 
populations.  Further work should concentrate on defining the longitudinal 
pattern of lipid accumulation within the liver, to determine whether the 
transient physiological increase seen in other animals is replicated, and 
examining for ectopic lipid in other organs such as pancreas and muscle.  
Examination of hepatic tissue, potentially from surgical infants, would allow 
lipid metabolism to be explored to determine whether biochemical differences 
such as expression of LPL are involved in infant IHCL accumulation. 
 
Also of importance is determining whether alterations in adipose tissue 
partitioning track through life, offering a mechanistic explanation for 
epidemiological associations.  Further examination of cohort presented here 
in later childhood would not provide the power necessary to detect such 
changes, necessitating a larger prospective study.  Such a study should also 
involve an intervention targeted at altering early life adipose tissue partitioning 
to answer the related question concerning whether altered adiposity has a 
causal relationship with later health.  Application of metabolite profiling 
techniques as part of such an undertaking would allow detailed examination of 
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infant intake and it’s association with phenotype, but should also aim to 
investigate metabolic by-products excreted in urine to provide an insight into 
infant metabolism and how it is influenced by dietary factors. 
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Chapter 10 
Publications and presentations arising 
10.1 Publications – see Appendix 6 for full versions 
Gale C, Jeffries S, Logan KM, Chappell KE, Uthaya SN, Modi N. Avoiding 
sedation in research MRI and spectroscopy in infants: our approach, 
success rate and prevalence of incidental findings; Arch Dis Child Fetal 
Neonatal Ed. 2012 Sep 26 [Epub ahead of print]. PMID: 23013611  
 
Gale C, Logan KM, Santhakumaran S, Parkinson JRC, Hyde MJ, Modi N. The 
effect of breast versus formula feeding on infant body composition: a 
systematic review and meta-analysis. Am J Clin Nutr. 2012 Mar;95(3):656-
69. PMID: 22301930 
 
10.2 Presentations 
Gale C, Jeffries S, Logan KM, Parkinson JRC, Uthaya S, Thomas EL, Durigel 
G, Bell JD, Modi N. Adiposity of healthy, full-term breast-fed and formula-
fed infants: a prospective cohort study. Royal College of Paediatrics and 
Child Health Annual Conference, June 2013, Glasgow. 
 
Gale C, Jeffries S, Logan KM, Parkinson JRC, Uthaya S, Thomas EL, Durigel 
G, Bell JD, Modi N. Change in regional adipose tissue and 
intrahepatocellular lipid development in healthy fully breast-fed babies, 
between birth and three months.  European Association of Paediatric 
Societies, October 2012, Istanbul. 
 
Gale C, Logan KM, Santhakumaran S, Parkinson JRC, Hyde MJ, Modi N. The 
effect of breast versus formula feeding on infant body composition: a 
systematic review and meta-analysis. Neonatal Society Summer Meeting, 
May 2012, Canterbury 
 
 
Newborn feeding and infant phenotype 
 207 
Gale C, Logan KM, Santhakumaran S, Parkinson JRC, Hyde MJ, Modi N. The 
effect of breast versus formula feeding on infant body composition: a 
systematic review and meta-analysis. International Conference on Nutrition 
and Growth, March 2012, Paris 
 
Gale C, Jeffries S, Parkinson JRC, Logan KM, Santhakumaran S, Hyde MJ, 
Durighel G, Thomas EL, Bell JD, Modi N. Longitudinal change of 
intrahepatocellular lipid in early infancy. Neonatal Society, Nov 2011, 
London 
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Appendix 1 
Background  
  Breast milk SMA First Infant Milk Aptamil 1 Cow & Gale 1 Hipp Organic First Infant Milk 
Energy (kcal100ml-1) 65 67 66 66 67 
Protein (g100ml-1) 1.0 1.3 1.3 1.3 1.4 
Whey:casein ratio 60:40 60:40 60:40 60:40 60:40 
Carbohydrate (g100ml-1) 
- of which lactose 
9.4 
7.0 
7.3 
7.3 
7.3 
7.0 
7.3 
7.0 
7.1 
6.8 
Fat (g100ml-1) 3.8 3.6 3.5 3.5 3.6 
Table 1A: Macronutrient content of breast milk and artificial formulas used by study families.  Breast milk values from 
(Lawrence and Lawrence, 2005), formula values from (Crawley and Westland, 2011)
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Appendix 3 
The association between infant feeding and body composition: a systematic review 
and meta-analysis 
 
  
  
Figure 3A: Difference in percentage fat-mass between formula-fed and breast-fed 
infants at 1-2 months. 
 
 
Figure 3B: Difference in percentage fat-mass between formula-fed and breast-fed 
infants at 3-4 months. 
 
 
Figure 3C: Difference in percentage fat-mass between formula-fed and breast-fed 
infants at 6 months. 
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 Figure 3D: Difference in percentage fat-mass between formula-fed and breast-fed 
infants at 8-9 months. 
 
Figure 3E: Difference in percentage fat-mass between formula-fed and breast-fed 
infants at 12 months. 
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Percentage fat-mass (fixed effects) 
Figure 3F: Funnel plots for studies reporting differences in body composition 
between formula-fed and breast-fed infants at 1-2 months. MD: mean difference, 
SE(MD): standard error of mean difference. 
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Figure 3G: Funnel plots for studies reporting differences in body composition 
between formula-fed and breast-fed infants at 3-4 months. MD: mean difference, 
SE(MD): standard error of mean difference. 
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Figure 3H: Funnel plots for studies reporting differences in body composition 
between formula-fed and breast-fed infants at 6 months. MD: mean difference, 
SE(MD): standard error of mean difference. 
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Figure 3I: Funnel plots for studies reporting differences in body composition between 
formula-fed and breast-fed infants at 8-9 months. MD: mean difference, SE(MD): 
standard error of mean difference. 
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Figure 3J: Funnel plots for studies reporting differences in body composition between 
formula-fed and breast-fed infants at 12 months. MD: mean difference, SE(MD): 
standard error of mean difference. 
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Forest plot: difference in percentage fat-mass at 3-4 months, studies measuring body 
composition using ADP 
 
 
 
Funnel plot for studies reporting differences in percentage fat-mass, using ADP, between 
formula-fed and breast-fed infants at 3-4 months (fixed effects). 
 
Figure 3K: Forest and funnel plot of studies reporting differences in percentage fat-
mass, using ADP, at 3-4 months. FF: formula-fed, MD: mean difference, SE(MD): standard 
error of mean difference. 
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Forest plot: difference in percentage fat-mass at 3-4 months, studies measuring body 
composition using isotope dilution. 
 
 
 
Funnel plot for studies reporting differences in percentage fat-mass, using isotope dilution, 
between formula-fed and breast-fed infants at 3-4 months (random effects) 
 
Figure 3L: Forest and funnel plot of studies reporting differences in percentage fat-
mass, using isotope dilution, at 3-4 months. FF: formula-fed, MD: mean difference, 
SE(MD): standard error of mean difference. 
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Forest plot: difference in fat-mass (kg) at 3-4 months, studies measuring body composition 
using isotope dilution. 
 
 
 
Funnel plot for studies reporting differences in fat-mass (kg), using isotope dilution, between 
formula-fed and breast-fed infants at 3-4 months (fixed effects) 
 
Figure 3M: Forest and funnel plot of studies reporting differences in fat-mass (kg), 
using isotope dilution, at 3-4 months. FF: formula-fed, MD: mean difference, SE(MD): 
standard error of mean difference. 
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Forest plot: difference in fat-free mass (kg) at 3-4 months, studies measuring body 
composition using isotope dilution. 
 
 
 
Funnel plot for studies reporting differences in fat-free mass (kg), using isotope dilution, 
between formula-fed and breast-fed infants at 3-4 months (fixed effects) 
 
Figure 3N: Forest and funnel plot of studies reporting differences in fat-free mass (kg), 
using isotope dilution, at 3-4 months. FF: formula-fed, MD: mean difference, SE(MD): 
standard error of mean difference. 
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Appendix 2D 
  
 
 
Forest plot: difference in percentage fat-mass at 6 months, studies measuring body 
composition using isotope dilution. 
 
 
 
Funnel plot for studies reporting differences in percentage fat-mass, using isotope dilution, 
between formula-fed and breast-fed infants at 6 months (fixed effects) 
 
Figure 3O: Forest and funnel plot of studies reporting differences in percentage fat-
mass, using isotope dilution, at 6 months. FF: formula-fed, MD: mean difference, 
SE(MD): standard error of mean difference. 
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Appendix 4 
Examination and validation of statistical methods 
 
  
 Figure 4A: Correlation between IAAT:ASSCAT and ASSCAT (litres) at T1. 
 
Figure 4B: Correlation between IAAT:ASSCAT and ASSCAT (litres) at T2. 
 Figure 4C: Correlation between IAAT:NASSCAT and NASSCAT (litres) at T1.
 
Figure 4D: Correlation between IAAT:NASSCAT and NASSCAT (litres) at T2. 
  
 
Figure 4E: Histograms of total adipose tissue at T1 and T2.  Results from Shapiro-Wilk: 
T1 p<0.01, T2 p=0.13. 
 
 
 
 
 
Figure 4F: Histograms of abdominal superficial subcutaneous adipose tissue at T1 
and T2. Results from Shapiro-Wilk: T1 p<0.01, T2 p=0.36. 
 
 
  
Figure 4G: Histograms of non-abdominal superficial subcutaneous adipose tissue at 
T1 and T2. Results from Shapiro-Wilk: T1 p<0.01, T2 p<0.01. 
 
 
 
 
 
Figure 4H: Histograms of abdominal deep subcutaneous adipose tissue at T1 and T2. 
Results from Shapiro-Wilk: T1 p<0.01, T2 p=0.61. 
 
 
 
 Figure 4I: Histograms of non-abdominal deep subcutaneous adipose tissue at T1 and 
T2. Results from Shapiro-Wilk: T1 p=0.03, T2 p,0.01. 
 
 
 
 
 
Figure 4J: Histograms of internal abdominal adipose tissue at T1 ad T2. Results from 
Shapiro-Wilk: T1 p<0.01, T2 p<0.01. 
 
 
 
 
 Figure 4K: Histograms of non-abdominal internal adipose tissue at T1 and T2. Results 
from Shapiro-Wilk: T1 p<0.01, T2 p<0.01. 
 
 
 
 
 
Figure 4L: Histograms of intra-hepatocellular lipid at T1 and T2. Results from Shapiro-
Wilk: T1 p<0.01, T2 p<0.01. 
 
 
  
 T1 T2 
Total AT (l) <0.01 0.11 
ASSCAT (l) <0.01 0.31 
NASSCAT (l) <0.01 0.20 
ADSCAT (l) <0.01 0.64 
NADSCAT (l) <0.01 <0.01 
IAAT (l) <0.01 <0.01 
NAIAT (l) <0.01 <0.01 
IHCL <0.01 <0.01 
TAT index (l/m2) <0.01 0.66 
ASSCAT index (l/m2) <0.01 0.84 
NASSCAT index (l/m2) <0.01 0.58 
ADSCAT index (l/m2) <0.01 0.81 
NADSCAT index (l/m2) <0.01 <0.01 
IAAT index (l/m2) <0.01 <0.01 
NAIAT index (l/m2) <0.01 <0.01 
IAAT:ASSCAT <0.01 <0.01 
IAAT:NASSCAT <0.01 <0.01 
Table 4A: Results from Shapiro-Wilk test for normality of distribution of adiposity and 
adipose tissue indices for the combined cohort.  Large and small for gestational age 
infants and infants of diabetic mothers removed. Values <0.05 signify rejection of the null 
hypothesis (that the distribution is normally distributed) and suggest a non-normal 
distribution. 
 
  
  
 
 
Appendix 5 
Breast milk composition and infant adiposity 
 
  
 Figure 5A: Histogram of breast milk insulin concentrations 
 
Figure 5B: Normal Q-Q plot of breast milk insulin concentrations 
 Figure 5C: Histogram of breast milk resistin concentrations 
 
Figure 5D: Normal Q-Q plot for breast milk resistin concentrations 
  
Figure 5E: Histogram of breast milk LnInsulin concentrations 
 
Figure 5F: Normal Q-Q plot of breast milk LnInsulin concentrations 
 Figure 5G: Histogram of breast milk LnRresistin concentrations 
 
Figure 5H: Normal Q-Q plot for breast milk LnResistin concentrations 
  
 Insulin Resistin 
 coefficient p value coefficient p value 
Weight (kg) 0.24 0.26 -0.40 0.07 
Length (m) 0.03 0.90 -0.37 0.09 
OFC (cm) 0.11 0.63 -0.28 0.22 
Table 5A: Correlation coefficients and p values between breast milk hormones and 
infant anthropometrics at T1. Correlation coefficients calculated for insulin using Pearson 
correlation between natural log transformed insulin and untransformed anthropometric 
measures. Correlation coefficients calculated for resistin using Spearman’s correlation 
between untransformed resistin and untransformed anthropometric measures. 
 
 Insulin Resistin 
 coefficient p value coefficient p value 
Weight (kg) -0.18 0.48 0.24 0.37 
Length (m) -0.29 0.26 -0.25 0.34 
OFC (cm) -0.24 0.36 -0.24 0.36 
Table 5B: Correlation coefficients and p values between breast milk hormones and 
infant anthropometrics at T2. Correlation coefficients calculated for insulin using Pearson 
correlation between natural log transformed insulin and untransformed anthropometric 
measures. Correlation coefficients calculated for resistin using Spearman’s correlation 
between untransformed resistin and untransformed anthropometric measures. 
 
 
 Figure 5I: Principal component analysis of aqueous breast milk phase: UV scaling.  
Baseline corrected to TSP, normalized to mean area.  Red circles indicate samples collected 
at T2, blue diamonds samples collected at T1, green crosses samples collected at baseline, 
orange triangles repeat samples and black squares quality controls samples. 
 
Figure 5J: Principal component analysis of aqueous breast milk phase: Pareto 
scaling.  Baseline corrected to TSP, normalized to mean area.  Red circles indicate 
samples collected at T2, blue diamonds samples collected at T1, green crosses samples 
collected at baseline, orange triangles repeat samples and black squares quality controls 
samples. 
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 Figure 5K: Principal component analysis of aqueous breast milk phase: Centro 
scaling.  Baseline corrected to TSP, normalized to mean area.  Red circles indicate 
samples collected at T2, blue diamonds samples collected at T1, green crosses samples 
collected at baseline, orange triangles repeat samples and black squares quality controls 
samples. 
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Figure I: Modified Manhattan Plot showing linear regression of proton NMR metabolite profile of the aqueous fraction breast milk on 
infant total adipose tissue, at T1.  The NMR spectra represents the median spectra from 16 samples.  The Manhattan plot below has 
frequency in ppm on the x axis corresponding to the median spectra above, the y axis represents the significance of the correlation between 
that spectral point and total adipose tissue.  Positive values indicate a positive correlation between the spectral point and total adipose tissue 
and negative values indicate a negative correlation.  The red lines indicate the threshold for significance for a false discovery rate of 0.10, 
spectral points on the Manhattan plot achieving significance at this level are displayed in green. 
 
 
 
 
  
 
Figure J: Modified Manhattan Plot showing linear regression of proton NMR metabolite profile of the aqueous fraction breast milk on 
infant total adipose tissue, at T2.  The NMR spectra represents the median spectra from 16 samples.  The Manhattan plot below has 
frequency in ppm on the x axis corresponding to the median spectra above, the y axis represents the significance of the correlation between 
that spectral point and total adipose tissue.  Positive values indicate a positive correlation between the spectral point and total adipose tissue 
and negative values indicate a negative correlation.  The red lines indicate the threshold for significance for a false discovery rate of 0.10, 
spectral points on the Manhattan plot achieving significance at this level are displayed in green. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure K: Modified Manhattan Plot showing linear regression of proton NMR metabolite profile of the aqueous fraction breast milk on 
infant IHCL at T1 and T2 combined.  The NMR spectra represents the median spectra from 32 samples.  The Manhattan plot below has 
frequency in ppm on the x axis corresponding to the median spectra above, the y axis represents the significance of the correlation between 
that spectral point and total adipose tissue.  Positive values indicate a positive correlation between the spectral point and total adipose tissue 
and negative values indicate a negative correlation.  The red lines indicate the threshold for significance for a false discovery rate of 0.10, 
spectral points on the Manhattan plot achieving significance at this level are displayed in green.
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ABSTRACT
Performing magnetic resonance investigations in a
paediatric population can be difﬁcult; image acquisition is
commonly complicated by movement artefact and non-
compliance. Sedation is widely used for clinically
indicated investigations, but there is controversy when
used for research imaging. Over a 10-year period we
have performed whole body MRI on over 450 infants and
hepatic magnetic resonance spectroscopy on over 270
infants. These investigations have been accomplished
without the use of sedation in infants up to 3 months of
age. Our overall success rate in achieving good quality
images free of movement artefact is 94%. The
prevalence of incidental ﬁndings on whole body
(excluding brain) MRI in our cohort was 0.8%. We
conclude that the use of sedation for research MRI in
this group is not necessary. Our approach to MRI in
infancy is also described.
INTRODUCTION
Ensuring an infant remains settled for the duration
of any investigational protocol, whether clinically
indicated or for research, is important if reliable,
high quality results are to be obtained. Repeating
an investigation is wasteful of time and money,
imposes additional burdens upon families and
staff, delays results and may add to risks. For clinic-
ally indicated magnetic resonance (MR) procedures
oral sedation and general anaesthesia are widely
used even though associated with adverse events.
When oral sedation has been used, hypoxia requir-
ing supplemental oxygen has been reported in up
to 20% of cases1 with more serious adverse events
such as seizures (0.4%)2 and unexpected hospital
admissions (0.33%)1 occurring more rarely. Where
an investigation is clinically indicated, the beneﬁts
of timely, high quality images potentially out-
weigh the risk of adverse events. Increasingly MRI
and spectroscopy are used in newborn and infant
research, and in these situations the use of sedation
is controversial. A small number of studies describe
MR investigations performed in infants without
sedation and report success rates of between 75%
and 90%.3 4 However these studies report results
from imaging carried out for clinical indications,
predominantly brain MR studies, and do not
provide information on the prevalence of incidental
ﬁndings. Over the past decade we have carried out
whole body MR research investigations in over
400 infants without the use of sedation. Here we
describe our approach, our success rate and the
prevalence of incidental ﬁndings.
OUR APPROACH TO RESEARCH MR
INVESTIGATIONS IN INFANTS
We aim to ensure that families arrive at least
45 min before their scheduled imaging slot, and
ask participating families to time their baby’s
feeds so that one is due shortly after arrival. We
use simple checklists (a health questionnaire, the
infant metal check and a resuscitation equipment
checklist) to document that the infant is ﬁt for the
procedure and that safety protocols are followed.
We settle the family in a quiet, comfortable,
private room with the ability to dim the lighting,
and carry out the infant metal check and obtain
length, weight and occipitofrontal circumference
measurements. For noise shielding, dental putty is
applied to the infant’s ears (Coltene/Whaledent,
Altstatten, Switzerland; reduces sound levels by
22 dB) before covering them with protective ear-
muffs (MiniMuffs, Natus Medical Incorporated,
San Carlos, California, USA; reduces sound levels
by 7 dB), held in place with a hat. We attach
single-use chest electrodes (Neo Quadtrodes,
Invivo, Gainesville, Florida, USA) before ﬁrmly
swaddling the baby. Once the infant is soundly
asleep we gently move them to the MR prepar-
ation room and onto the scanning trolley where
foam padding is positioned around the infant’s
head to provide a ﬁnal layer of noise shielding
(reducing noise levels by a further 10 dB). A clin-
ician trained in neonatal resuscitation is present at
all times. We use speciﬁc research MR monitoring
equipment and do not recommend having infants
arrive for scanning with monitors in place. We use
chest ECG electrodes and a pedal pulse oximeter to
monitor the infant’s heart rate and oxygen satur-
ation continuously. These parameters are recorded
at 5-min intervals throughout the procedure and
documented in the infant’s research ﬁle. An
increased heart rate is commonly the ﬁrst indica-
tion that a baby is waking, and if the heart rate is
consistently raised or the baby wakes, we interrupt
scanning and resettle the baby. A key aspect is
ensuring that parents feel relaxed, informed and
involved in the process. We invite parents to sit
with the research team during the acquisition of
MRIs, where we explain the investigation and
discuss the research project. We feel this allays any
anxieties that parents might have and involves
them in the research project. The ﬁnal factor is
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ensuring ﬂexibility, from both parents and the scanning depart-
ment. Babies do not fall soundly asleep on cue and are not
always asleep at their appointed time. Having two families in
the department settling their infants allows us to return an
alert baby to their room and bring in another sleeping infant,
making the most efﬁcient use of the available research time. In
our experience parents are very understanding of the uncertain
duration of their visit.
As with many research investigations, MR has the potential
to detect previously unknown ﬁndings of uncertain signiﬁ-
cance.5 This is explained in detail to parents during recruit-
ment, where we also emphasise the differences between
whole-body MRI for research and diagnostic imaging, so
parents do not enrol their babies into the study under the mis-
conception that they will receive a ‘screening total body scan’.
A paediatric radiologist reviews all of our MR research investi-
gations. This information is included in the Research Ethics
Committee approved ‘Parent Information Sheet’ for our studies.
Parents are aware that a paediatrician will inform them should
any unexpected ﬁnding be identiﬁed, and that their general
practitioner will be informed and any further investigations
arranged.
OUR EXPERIENCE TO DATE
To date we have acquired 457 whole body MRI investigations
(386 in the neonatal period and 71 at 6–12 weeks), and 272
hepatic MR spectroscopy investigations (230 in the neonatal
period and 42 at 8–12 weeks) in neonates and infants.
Acquisition time (minutes:seconds) for whole body MRI
ranged from 09 : 26–17 : 42 and for single voxel hepatic MR
spectroscopy from 02 : 23–05 : 17. Our success rate in obtaining
good quality images free of movement artefact is 94%, table 1.
Data for time of arrival at imaging department and cessation of
scanning was only available for more recent investigations, but
where this was recorded we have calculated time spent in the
imaging department, table 2. We have had no adverse events.
While the majority of infants have been scanned in the neo-
natal period, we are increasingly performing imaging in infants
between 8 and 12 weeks of age, and have successfully imaged
infants using these techniques up to 6 months of age. In our
experience, after 46 weeks postmenstrual age babies are more
alert and less easily settled. This is reﬂected in the lower
success rate seen in these older infants, table 1.
Incidental ﬁndings after paediatric brain MRI have previously
been reported but we are unaware of any studies reporting
rates of incidental ﬁndings following paediatric whole body
(excluding brain) research MRI. Amongst our cohort we identi-
ﬁed no incidental ﬁndings in the 253 term infants imaged
and three previously unsuspected ﬁndings in preterm infants (a
dysplastic kidney, an inguinal hernia and renal pelvis dilata-
tion). This gives us an incidental ﬁnding rate of 0.8% (3/386)
all infants, 0% (0/253) term infants and 2.3% (3/133) preterm
infants.
CONCLUSIONS
Our success rate (94%) compares favourably with studies
where clinical brain imaging has been undertaken without the
use of sedation, in which success rates of 75–90% have been
reported.3 4 This cohort is one of the largest reported and
strengthens the evidence for performing MR investigations
without sedation in infants less than 12 weeks of age particu-
larly when performed as an outpatient procedure. When MRI
is clinically indicated in early infancy, the timely acquisition of
high quality images is of primary importance and the beneﬁts
of sedation may outweigh the small risk of adverse events.
When MR scanning is undertaken solely for research purposes,
the risk-beneﬁt calculation is different and we do not consider
the use of sedation necessary or acceptable. We have demon-
strated that our approach is safe, efﬁcient and effective, and
suitable for infants up to 3 months of age. We suggest that our
experience can also inform clinical practice, increasing the pro-
portion of clinical MR investigations performed in infancy
without sedation.
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Effect of breastfeeding compared with formula feeding on infant body
composition: a systematic review and meta-analysis1–3
Chris Gale, Karen M Logan, Shalini Santhakumaran, James RC Parkinson, Matthew J Hyde, and Neena Modi
ABSTRACT
Background: Early-life nutrition may influence later body compo-
sition. The effect of breastfeeding and formula feeding on infant
body composition is uncertain.
Objective: We conducted a systematic review and meta-analysis of
studies that examined body composition in healthy, term infants in
relation to breastfeeding or formula feeding.
Design: PubMed was searched for human studies that reported the
outcomes fat-free mass, fat mass, or the percentage of fat mass in
breastfed and formula-fed infants. Bibliographies were hand searched,
and authors were contacted for additional data. The quality of stud-
ies was assessed. Differences in outcomes between feeding groups
were compared at prespecified ages by using fixed-effects analyses
except when heterogeneity indicated the use of random-effects
analyses.
Results: We identified 15 studies for inclusion in the systematic
review and 11 studies for inclusion in the meta-analysis. In for-
mula-fed infants, fat-free mass was higher at 3–4 mo [mean differ-
ence (95% CI): 0.13 kg (0.03, 0.23 kg)], 8–9 mo [0.29 kg (0.09,
0.49 kg)], and 12 mo [0.30 kg (0.13, 0.48 kg)], and fat mass was
lower at 3–4 mo [20.09 kg (20.18,20.01 kg)] and 6 mo [20.18 kg
(20.34, 20.01 kg)] than in breastfed infants. Conversely, at 12 mo,
fat mass was higher in formula-fed infants [0.29 kg (20.03, 0.61
kg)] than in breastfed infants.
Conclusion: Compared with breastfeeding, formula feeding is as-
sociated with altered body composition in infancy. Am J
Clin Nutr 2012;95:656–69.
INTRODUCTION
The relation between breastfeeding and body composition is of
considerable relevance to human health. Particular interest sur-
rounds the potential role of infant feeding in influencing body
composition, overweight, and obesity in later life. Systematic
reviews that examined associations between early feeding and
later-life obesity or BMI have been inconclusive (1, 2). This is
perhaps unsurprising given the considerable between-study
heterogeneity and the importance of confounding in long-term
observational studies. Any effect of breastfeeding on adult weight
and body composition might be mediated through, or share
common biological pathways with, effects on infant body
composition, and the accumulation of fat mass relative to body
weight is maximal in infancy (3). Therefore, we considered it
relevant to question whether an effect of infant feeding on body
composition can be identified in the preweaning and early
postweaning period when any relation might be expected to be
more pronounced, and the influence of potential confounding
factors are more limited.
Growth patterns differ between breastfed and formula-fed
infants, and by 12 mo of age, formula-fed infants weigh, on
average, 400–600 g more than breastfed infants (4, 5). Attempts
to measure the effect of infant feeding on body composition have
been limited by the variety of techniques used and small sample
sizes, and individual studies have reported conflicting results with
respect to both the direction and magnitude of effect (6–8). Body
composition changes rapidly and nonlinearly over the first year of
life (9), and therefore, comparisons between individual studies
have also been complicated by the range of postnatal ages at
which measurements have been made.
In this study, we present a systematic review and meta-analysis
of longitudinal and cross-sectional studies that were performed in
infancy and examined body composition in vivo in relation to
breastfeeding and formula feeding.
SUBJECTS AND METHODS
Literature search
A systematic review of published studies that reported out-
comes of healthy, term (37–42 wk of gestation) infants (0–12 mo
of age) was undertaken in accordance with guidelines of the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (10). A protocol was developed (by CG) and reviewed
by all authors. The outcomes studied were fat mass (kg), fat-free
mass (kg), and the percentage of fat mass. We included studies
that used a model of 2 compartments with determination of at
least one compartment by using one of the following in-vivo
techniques: TBK4, TOBEC, isotope dilution, ADP, DXA, MRI,
or computerized tomography. Studies in which body composi-
tion was derived through the measurement of skinfold thickness
1 From the Section of Neonatal Medicine, Chelsea & Westminster Hos-
pital Campus, Imperial College London, London, United Kingdom.
2 No funding support was received for this study.
3 Address correspondence to N Modi, Neonatal Medicine, Imperial Col-
lege London, Fourth Floor, Lift Bank D, Chelsea and Westminster Hospital,
369 Fulham Road, London SW10 9NH, United Kingdom. E-mail: n.modi@
imperial.ac.uk.
4 Abbreviations used: ADP, air-displacement plethysmography; DXA,
dual-energy X-ray absorptiometry; TBK, total-body potassium determina-
tion; TOBEC, total-body electrical conductivity.
Received September 26, 2011. Accepted for publication December 13, 2011.
First published online February 1, 2012; doi: 10.3945/ajcn.111.027284.
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were excluded because of the poor ability of this technique to
predict body composition in infancy (11, 12). Types of exposure
were breastfeeding (exclusive or predominant) and formula
feeding (exclusive or predominant) as defined in each study. No
limit was applied with respect to the duration of the feeding
method in either group. For inclusion, formula should have been
a standard, commercial cow milk–based product, comparison of
breastfed and formula-fed groups must have occurred at the
same time points, and at least one measure of body composition
must have been performed in the first postnatal year.
A search was conducted in PubMed (http://www.ncbi.nlm.nih.
gov) for studies published before 24 March 2011 in any language
by using the following MEDLINE Medical Subject Headings
terms, with limitation to human studies: [(breast feeding) OR
(infant formula) OR (infant nutritional physiologic phenomena)]
AND [(body composition) OR (bioelectrical impedance) OR (total
body electrical conductivity) OR (air-displacement plethysmog-
raphy) OR (absorptiometry, photon) OR (total body potassium)
OR (magnetic resonance imaging) OR (tomography, X-ray
computed) OR (isotope dilution)].
Data extraction
A literature search was conducted (by CG and assisted by
JRCP), and relevant studies were identified by evaluating the
abstract or obtaining a full copy of the article if no abstract was
available. Reference lists of articles retrieved were hand searched
for studies appropriate for inclusion. Whenever possible, forward
citations of studies retrieved during the literature search were
traced. Review articles and commentaries were excluded after
hand searching reference lists.
Data on the study design, location, population, exposure
classification, technique of body-composition measurement,
outcome, and potential sources of bias were extracted (in-
dependently by CG and KML and checked by MJH and SS).
Study quality was assessed in relation to the following study
biases: blinding to the feeding group by investigators who
measured outcomes, definition of feeding groups (in particular,
the extent of contamination bias that arose from formula feeding
in the breastfed group), and method of assessment of feeding
status (prospective or retrospective). In studies in which body-
composition data were not presented in a form suitable for
a meta-analysis, efforts were made (by CG) to contact the author
to obtain these data. Authors were asked to provide means and
SDs for fat/adipose tissue mass, fat-free mass, and the percentage
of fat mass by feeding group. If no response to 2 requests was
received, or if the author was unable to provide additional data,
the study was excluded from meta-analyses. When only sex-
specific values were presented, these values were pooled by using
a standard formula for the combination of mean and SD data (13).
Analysis
A meta-analysis was carried out of studies that reported dif-
ferences in outcomes (fat mass, fat-free mass, and the percentage
of fat mass) between formula-fed and breastfed groups at the
following time points: 1–2, 3–4 (representing the preweaning
period), 6 (weaning), 8–9, and 12 (representing the postweaning
period) mo. The mean difference (95% CI) between outcomes in
the formula-fed and breastfed groups was calculated at each
postnatal age point. When a study examined the same population
at 2 postnatal ages and both ages fell within one predefined point,
which, therefore, rendered both ages eligible for inclusion (eg,
when data were collected at 3 and 4 mo), data from the later age
was included in the meta-analysis. When data were obtained from
one population at the same postnatal age by using 2 alternate
methods, the method with the smallest SD was included in the
subsequent meta-analysis. To examine the robustness of these
assumptions, analyses were repeated by using the alternate values
to determine whether this led to a different conclusion.
A fixed-effects meta-analysis was undertaken with RevMan 5
software (The Cochrane Collaboration) by using the inverse-
variance method. This method was performed separately for each
postnatal age point. Heterogeneity was assessed by using the chi-
square test for Cochrane’s Q statistic (14) and by calculating I2
(15). When heterogeneity was present (P , 0.05; chi-square
test), a random-effects meta-analysis was carried out. In this
case, the pooled difference was the estimate of the average effect
across study populations because studies were assumed to have
different underlying effects. In contrast, for fixed-effects anal-
yses, studies were assumed to have the same underlying effect,
which was estimated by using the pooled difference. Results
were illustrated by using forest plots. Funnel plots were used to
investigate asymmetry.
Subgroup analyses were planned of studies that were per-
formed by using the same body-composition technique, when3
studies reported results at comparable postnatal ages, and of sex-
specific values. A subgroup analysis of results by sex may be
subject to selection bias because studies may only report results
by sex if a difference is observed. Therefore, a subgroup analysis
by sex was only carried out if the meta-regression showed sex
differences to be significant, and if data were available for the
majority of studies at the relevant time point.
RESULTS
The literature search is outlined in Figure 1. The search
strategy identified 702 publications; an additional 8 articles were
located after bibliographic review of retrieved articles (16–23).
One article was unavailable (in full or abstract form) for review
(24). After screening of abstracts, the full texts of 35 articles
were reviewed to assess eligibility. Twenty studies were ex-
cluded after full-text review for the following reasons: only
breastfed infants were included, with no comparative formula-
fed group (25); body composition was determined by using
skinfold thickness only (21, 26–30); articles were review articles
(4, 31–34); the feeding method was not provided (19, 22, 35,
36); percentages of fat mass or adiposity data were not provided
(37–39); and study cohorts (40) were part of a larger, included
cohort (41).
Identified studies
Fifteen studies remained for inclusion in the systematic review
(6–8, 16–18, 20, 23, 41–47) (Table 1). For the meta-analysis,
attempts were made to contact authors of 7 studies for additional
data (6, 16, 41–43, 45, 47); 5 authors replied (6, 16, 41, 42, 47),
but one author was unable to provide data (47). There was
considerable heterogeneity with respect to study design. The
majority of studies used a longitudinal design, although 3 studies
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were cross sectional (17, 41, 46). A wide range of techniques
were used to measure body composition [ie, TBK (47), isotope
dilution (8, 23, 41, 44, 46), TOBEC (7, 17, 46), DXA (43, 45),
MRI (20), ADP (16, 18, 42), and a multicomponent technique
that incorporated isotope dilution, TBK, and DXA (6)]. No
studies were shown to assess body composition in infancy by
using computerized tomography. Measurements were performed
at a range of time points during the first year (Table 1).
With respect to study quality, no study reported whether
measurements were performed by investigators blinded to the
feeding group. The feeding method was prospectively defined in
all studies except one study (17), although the definitions used for
feeding groups varied in studies (Table 1). Information provided
on weaning (Table 1) indicated that feeding at time points6 mo
was no longer predominantly breast-milk feeding even in those
groups designated as breastfed groups. Therefore, for time
points 6 mo, the breastfed group represented originally
breastfed infants. In 8 of the 15 studies included, age-specific
values were used for hydration and density of fat-free mass (3).
Individual study values for fat mass, fat-free mass, and the
percentage of fat mass that were represented by feeding group
are shown in Table 2.
Body composition at 1–2 mo
There were no significant mean differences in fat mass, fat-free
mass, or the percentage of fat mass between the formula-fed and
breastfed groups (Tables 3–5; see Figure 1 under “Supplemental
data” in the online issue) at 1–2-mo postnatal age. One study
(45), in which no significant difference was shown in the per-
centage of fat mass at 2 mo, did not report SDs (and these data
were unavailable from the authors) and was, therefore, excluded
from the meta-analysis. For meta-analyses, data of fat mass and
the percentage of fat mass from Butte et al (46) that was ob-
tained by using isotope dilution had a narrower SD than did
values obtained by using TOBEC for the same cohort; therefore,
isotope-dilution data were included; for fat-free mass, data de-
rived by using TOBEC were included. When Anderson (16) and
de Bruin et al (7) reported values at 1 and 2 mo, the 2-mo values
were included. The repetition of analyses by using alternate
values for the studies by Butte et al (46), Anderson (16), and de
Bruin et al (7) did not alter the significance or direction of results.
Body composition at 3–4 mo
Formula-fed infants had significantly lower fat mass, signif-
icantly higher fat-free mass, and a significantly lower percentage
of fat mass than did breastfed infants at 3–4 mo age (Tables 3–5;
see Figure 2 under “Supplemental data” in the online issue).
Despite contact with the author, SDs were unavailable from one
study (47) (which also reported a significantly higher fat-free
mass and lower percentage of fat mass in formula-fed girls, but
not boys, at 3 mo) and was excluded from meta-analyses. Data
determined by using TOBEC by Butte et al (46) had narrower
SDs than did data determined by using dilutional techniques;
therefore, TOBEC data were included in our meta-analysis. The
repetition of analyses by using alternate values for the study by
Butte et al (46) did not alter the significance, direction, or
magnitude of results.
Body composition at 6 mo
Formula-fed infants had significantly lower fat mass and
percentage of fat mass than did breastfed infants at 6 mo. No
significant differences were detected in fat-free mass (Tables 3–5;
see Figure 3 under “Supplemental data” in the online issue). De-
spite attempts to contact authors, additional data were unavailable
for 1 study (43), which was excluded from meta-analyses. The
study (43) reported a significant positive association between
breastfeeding at 6 mo and the percentage of fat mass at 6 mo
measured by using DXA. This association was present for the
truncal percentage of fat mass but not for the peripheral percentage
of fat mass.
Body composition at 8–9 mo
Formula-fed infants had significantly higher fat-free mass than
did breastfed infants at 8–9 mo. No significant differences were
detected in fat mass or the percentage of fat mass (Tables 3–5; see
Figure 4 under “Supplemental data” in the online issue).
Body composition at 12 mo
Formula-fed infants had significantly higher fat-free mass than
did breastfed infants at 12 mo. No significant differences were
detected in fat mass or the percentage of fat mass (Tables 3–5; see
Figure 5 under “Supplemental data” in the online issue).
Funnel plots
Funnel plots of studies at 3–4 mo (see Figure 7 under “Sup-
plemental data” in the online issue) showed no visual evidence of
FIGURE 1. Flowchart of the search strategy used in this review set out
according to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses statement. The relevant number of papers at each point is
provided. BF, breastfed; FF, formula fed; SFT, skinfold thickness.
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asymmetry. There was no evidence of funnel-plot asymmetry for
analyses at other time points (see Figures 6 and 8–10 under
“Supplemental data” in the online issue), although the small
number of studies made this difficult to evaluate reliably.
Pooled differences over the first 12 mo
Pooled differences in fat mass, fat-free mass, and the per-
centage of fat mass between the formula-fed and breastfed
infants by postnatal age are shown in Figures 2, 3, and 4,
respectively.
Meta-analysis of results measured by using a single
technique
Body composition was measured by using the same technique
in 3 studies at 3–4 and 6 mo only. At 3–4 mo, ADP was used
to measure the percentage of fat mass in 3 studies (16, 18, 42);
meta-analysis showed a significant reduction in the percentage
of fat mass [mean difference (95% CI): 21.72% (23.47%,
0.03%) (P = 0.05); fixed effects, heterogeneity I2 = 0%, P =
0.75) in formula-fed compared with breastfed infants (see Figure
11 under “Supplemental data” in the online issue). At 3–4 mo, 5
studies that used isotope dilution reported results for the per-
centage of fat mass (8, 23, 41, 44, 46), and 4 studies that used
isotope dilution reported results for fat mass and fat-free mass
(8, 23, 41, 46). Meta-analysis revealed no significant differences
for the percentage of fat mass [21.36% (23.98%, 1.25%) (P =
0.31); random effects, heterogeneity I2 = 61%, P = 0.04; see
Figure 12 under “Supplemental data” in the online issue], fat
mass [20.11 kg (20.25, 0.03) (P = 0.13); fixed effects, het-
erogeneity I2 = 57%, P = 0.07; see Figure 13 under “Supple-
mental data” in the online issue], fat-free mass [20.01 kg
(20.16, 0.14 kg) (P = 0.89); fixed effects, heterogeneity I2 = 0%,
P = 0.42; see Figure 14 under “Supplemental data” in the online
issue]. At 6 mo, by using isotope dilution, 3 studies reported
results for the percentage of fat mass (8, 23, 44); the meta-
analysis of these studies showed no significant difference
[20.33% (22.39%, 1.72%) (P = 0.75); fixed effects, heteroge-
neity I2 = 45%, P = 0.16; see Figure 15 under “Supplemental
data” in the online issue].
Sex-specific effects on body composition
Studies that reported body composition by sex are summarized
in Table 1. Only 2 studies provided comparable data; De Bruin
et al (7) reported data at 1, 2, 4, 8, and 12 mo, and Butte et al (6)
report data at 0.5, 3, 6, 9, and 12 mo. We combined these studies
by using meta-regression to examine sex differences at 0.5–1, 3–
4, 8–9, and 12 mo so that each cohort only contributed to each
time point once. There was no evidence of a significant sex
difference from the meta-regression at any time point.
DISCUSSION
In this systematic review and meta-analysis that included 15
studies and .1000 infants, we identified significant differences
in body composition between healthy, term breastfed and for-
mula-fed infants 1 y of age. We showed that formula-fed in-
fants had higher fat-free mass throughout the first year of life
than did breastfed infants but changes in fat mass over this
period were more complex. Formula-fed infants had lower fat
mass than did their breastfed counterparts at 3–4 and 6 mo. By
12 mo, this effect was no longer apparent, with a trend toward
reversal and higher fat mass in formula-fed infants. These
findings are biologically plausible. Circulating leptin is higher in
TABLE 3
Mean difference in fat mass between FF and BF infants1
Postnatal
age References
No. of
participants
Statistical
method
Difference in
fat mass2 P
Heterogeneity
I2 P
kg %
1–2 mo 7, 8, 20, 46 95 (BF: 47; FF: 48) Fixed effects 0.03 (20.06, 0.11) 0.49 0 0.61
3–4 mo 6–8, 18, 23, 41, 42, 46 446 (BF: 247; FF: 199) Fixed effects 20.09 (20.18, 20.01) 0.04 44 0.08
6 mo 6, 8, 23 115 (BF: 56; FF: 55) Fixed effects 20.18 (20.34, 20.01) 0.03 8 0.34
8–9 mo 6, 7 122 (BF: 63; FF: 59) Fixed effects 0.03 (20.13, 0.19) 0.70 0 0.42
12 mo 6, 7, 17 201 (BF: 89; FF: 112) Random effects 0.29 (20.03, 0.61) 0.07 80 0.007
1 BF, breastfed; FF, formula-fed.
2 All values are means; 95% CIs in parentheses.
TABLE 4
Mean difference in fat-free mass between FF and BF infants1
Postnatal
age References
No. of
participants
Statistical
method
Difference in
fat-free mass2 P
Heterogeneity
I2 P
kg %
1–2 mo 7, 8, 20, 46 95 (BF: 47; FF: 48) Fixed effects 0.03 (20.13, 0.19) 0.85 21 0.28
3–4 mo 6-8, 18, 23, 41, 42, 46 446 (BF: 247; FF: 199) Fixed effects 0.13 (0.03, 0.23) 0.01 35 0.15
6 mo 6, 8, 23 111 (BF: 56; FF: 55) Random effects 0.19 (20.25, 0.63) 0.48 68 0.04
8–9 mo 6, 7 122 (BF: 63; FF:59) Fixed effects 0.29 (0.09, 0.49) 0.005 0 0.93
12 mo 6, 7, 17 201 (BF: 89; FF: 112) Fixed effects 0.30 (0.13, 0.48) 0.0008 31 0.24
1 BF, breastfed; FF, formula-fed.
2 All values are means; 95% CIs in parentheses.
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breastfed infants than in formula-fed infants 4 mo of age but
not later in infancy (53) in keeping with the greater fat mass in
breastfed infants at 3–4 and 6 mo but not at 12 mo. In addition,
greater protein intake (54) and higher resting energy expenditure
(8) in infancy have been well described in formula-fed com-
pared with breastfed infants, which are consistent with our
finding of higher fat-free mass in the formula-fed group
throughout this period. Although we showed no evidence of
a difference in effect between boys and girls, this absence may
reflect a lack of power because only 2 studies reported sex-
specific results. The variance in difference between feeding
groups in fat and fat-free mass was most marked at 6 mo. We
considered the possibility that this might have been attributable
to data from Motil et al (8). Ten breastfed (7 boys) and 10
formula-fed (2 boys) infants were recruited in this study, but
body-composition data were provided for only 16 infants (sex
distribution was not provided). However, the exclusion of these
data did not alter the direction of results.
Our meta-analysis was based on studies that used different
methods to assess infant body composition. The extent to which
these methods are comparable must be considered. Butte et al
(55) showed significant differences in fat mass estimated by using
TOBEC, TBK, DXA, and 2H2O isotope dilution. However, there
was no evidence of nonsystematic variation (55), which sup-
ported the validity of our analysis that examined the difference
in body composition between feeding groups rather than the
absolute body composition. In addition, we attempted to address
this issue by performing subgroup analyses of studies that re-
ported values measured by using the same technique at a com-
parable postnatal age. Sufficient studies (3 studies) were only
available for a minority of time points. In 4 of 5 cases in which
this subgroup analysis was possible, we showed differences of
the same magnitude and direction as the analyses in which
methods were combined. This result supported our analysis of
results obtained by using different in vivo body-composition–
measurement techniques.
A major limitation of body-composition studies that use in-
direct techniques in pediatric populations is the rapid maturation
of body tissues during childhood (3). Thus, the assumptions
inherent in the derivation of fat or fat-free mass may not be stable
throughout childhood. Therefore, it is reassuring that all studies
included in our meta-analysis used reference standards that are
appropriate for infants. Significant differences in body compo-
sition exist in relation to sex in adults (56). Although differences
in infancy appear less pronounced (57), we intended to examine
the effect of sex but were unable to do so because of the limited
number of studies that reported outcomes by sex. Studies of infant
feeding are liable to important study-level biases such as recall
bias if breastfeeding is assessed retrospectively (58), and con-
tamination bias related to formula feeding in the breastfeeding
TABLE 5
Mean difference in the percentage of fat mass between FF and BF infants1
Postnatal
age References
No. of
participants
Statistical
method
Difference in
fat mass2 P
Heterogeneity
I2 P
%
1–2 mo 7, 8, 16, 20, 46 135 (BF: 74; FF: 61) Fixed effects 0.21 (20.78, 1.21) 0.67 5 0.38
3–4 mo 6-8, 16, 18, 23, 41, 42, 44, 46 586 (BF: 337; FF: 249) Random effects 21.46 (22.75, 20.17) 0.03 50 0.04
6 mo 6, 8, 23, 44 211 (BF: 119; FF: 92) Fixed effects 21.71 (23.14, 20.29) 0.02 57 0.07
8–9 mo 6, 7 122 (BF: 63; FF: 59) Fixed effects 20.49 (21.94, 0.96) 0.51 0 0.39
12 mo 6, 7, 17, 44 301 (BF: 152; FF: 149) Random effects 1.21 (20.46, 2.87) 0.16 76 0.005
1 BF, breastfed; FF, formula fed.
2 All values are means; 95% CIs in parentheses.
FIGURE 2. Pooled mean differences and 95% CIs for fat mass (kg) between formula-fed and breastfed infants by age. A fixed-effects meta-analysis was
undertaken with RevMan 5 software (The Cochrane Collaboration) by using the inverse-variance method. This analysis was performed separately for each
postnatal age point. When heterogeneity was present (P, 0.05; chi-square test), a random-effects meta-analysis was carried out. The meta-analysis technique
used, P value, and number of subjects at each point were as follows: 1–2 mo: fixed effects, P = 0.49, n = 95; 3–4 mo: fixed effects, P = 0.04, n = 446; 6 mo:
fixed effects, P = 0.03, n = 111; 8–9 mo: fixed effects, P = 0.70, n = 122; and 12 mo: random effects, P = 0.07, n = 112.
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group. With a single exception (17), breastfeeding was assessed
prospectively in all included studies, which limited the recall
bias; however, the definition of feeding groups varied widely, and
no study reported the use of WHO criteria for exclusive
breastfeeding, which suggested that a contamination bias may
represent an important source of heterogeneity. The choice of
infant feeding is also subject to a number of important con-
founding influences, such as prematurity and maternal diabetes,
that may also affect body composition. We attempted to limit this
possibility through the use of strict inclusion criteria. An addi-
tional issue was that the limited number of studies at time points
other than 3–4 mo would have resulted in limited power to detect
important differences. This issue was of particular relevance at
12 mo, at which, in contrast to our findings at 3–4 mo, there was
a suggestion that formula-fed infants had higher fat mass than did
infants who were breastfed. Finally, the use of the percentage of
fat mass as a proxy for adiposity in body-composition studies has
been criticized for methodologic and statistical reasons (59, 60);
thus, we included measures of fat and fat-free mass as well as the
percentage of fat mass. The representation of fat mass by using
alternatives such as a fat-mass index to adjust for body size (59)
has been recommended, but we were unable to include such an
alternative in our analyses because such data were only available
in 3 articles (20, 41, 42) and were not at assessed at comparable
time points.
To our knowledge, the pattern of body-composition de-
velopment over the first year of life that we identified is a novel
finding that raises intriguing hypotheses in relation to possible
evolutionary drivers and causal biological mechanisms. Key
differences exist in macronutrient content and bioactive factors
between breast milk and formula. The protein content of formula
is higher than that of pooled breast-milk reference samples.
However, a hallmark of breast milk is that composition varies
widely between mothers and within mothers across feeds by time
of day and duration of lactation (61) and even between different
mammary lobes within the same breast (62). Differences also
FIGURE 3. Pooled mean differences and 95% CIs for fat-free mass (kg) between formula-fed and breastfed infants by age. A fixed-effects meta-analysis
was undertaken with RevMan 5 software (The Cochrane Collaboration) by using the inverse-variance method. This analysis was performed separately for each
postnatal age point. When heterogeneity was present (P, 0.05; chi-square test), a random-effects meta-analysis was carried out. The meta-analysis technique
used, P value, and number of subjects at each point were as follows: 1–2 mo: fixed effects, P = 0.85, n = 95; 3–4 mo: fixed effects, P = 0.01, n = 446; 6 mo:
random effects, P = 0.48, n = 111; 8–9 mo: fixed effects, P = 0.005, n = 122; and 12 mo: fixed effects, P = 0.0008, n = 112.
FIGURE 4. Pooled mean differences and 95% CIs for the percentage of fat mass between formula-fed and breastfed infants by age. A fixed-effects meta-
analysis was undertaken with RevMan 5 software (The Cochrane Collaboration) by using the inverse-variance method. This analysis was performed separately
for each postnatal age point. When heterogeneity was present (P , 0.05; chi-square test), a random effects meta-analysis was carried out. The meta-analysis
technique used, P value, and number of subjects at each point were as follows: 1–2 mo: fixed effects, P = 0.67, n = 135; 3–4 mo: random effects, P = 0.03, n =
586; 6 mo: fixed effects, P = 0.02, n = 211; 8–9 mo: fixed effects, P = 0.51, n = 122; and 12 mo: random effects, P = 0.16, n = 301.
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exist in feeding behaviors between suckled and bottle-fed infants
because suckled infants are more likely to initiate and terminate
feeding sessions (63). Because infants who freely suckled at the
breast appear to self-regulate intake (64), this effect raises the
important question of the true extent to which macronutrient
intake differs from that of formula-fed infants. The large number
of potentially bioactive hormones (65), proteins (66), cytokines
(67), and growth factors (68) in breast milk add additional
dimensions to differences far beyond those attributable to the
macronutrient content.
The higher fat-free mass seen in association with formula
feeding is of note. Fat-free mass reflects a heterogeneous group of
tissues including bone, muscle, organs, and connective tissue, and
hence, the biological implications are uncertain. Future work
should aim to distinguish the specific components of fat-free mass
influenced by infant feeding. The higher fat mass in early infancy
that we showed to be associated with breastfeeding, which is
replicated across mammalian species (69), can be assumed to
represent an evolutionary mechanism to support the infant during
the precarious weaning period. If we accept the presumption that
breast milk represents the ideal nutrition for infants, our finding
that formula-fed infants are insufficiently adipose in the pre-
weaning period suggests that infant formulas are not supporting
the normal trajectory of adipose tissue development. The ap-
parent switch from higher adiposity in breastfed infants at 3–4mo
to greater adiposity in formula-fed infants at 12 mo would also
support the possibility of a programming effect of early infant
feeding on intermediary metabolism or appetite regulation.
Research involving animal models showed that subtle changes
in early feed composition led to alterations in adiposity that
preceded deranged glucose metabolism (70). Accumulating evi-
dence from long-term cohort studies indicates that body compo-
sition in childhood tracks into adult life (71). The data presented in
the current study suggest that initiating events may well arise
earlier in infancy and result from early feeding choices. Although
the differences in fat mass we described are small (of the order of
90 g at 3–4 mo of age and 180 g at 6 mo of age), our findings add to
the developing understanding of the possible contributions of
breastfeeding and formula feeding on risk of obesity in childhood
and adult life. What is now required is long-term follow-up of
adequately powered cohorts to identify the outcomes associated
with these early differences.
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